<?xml version="1.0" encoding="UTF-8"?><search-results xmlns="http://www.w3.org/2005/Atom" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:opensearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:dc="http://purl.org/dc/elements/1.1/"><opensearch:totalResults>2992343</opensearch:totalResults><opensearch:startIndex>500</opensearch:startIndex><opensearch:itemsPerPage>100</opensearch:itemsPerPage><opensearch:Query role="request" searchTerms="heart" startPage="500"/><link ref="self" href="http://api.elsevier.com:80/content/search/index:scopus?start=500&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="first" href="http://api.elsevier.com:80/content/search/index:scopus?start=0&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="prev" href="http://api.elsevier.com:80/content/search/index:scopus?start=400&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="next" href="http://api.elsevier.com:80/content/search/index:scopus?start=600&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="last" href="http://api.elsevier.com:80/content/search/index:scopus?start=4900&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930209664"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930209664?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930209664&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930209664&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0031938415002061"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930209664</prism:url><dc:identifier>SCOPUS_ID:84930209664</dc:identifier><eid>2-s2.0-84930209664</eid><dc:title>Measuring positive emotions in cows: Do visible eye whites tell us anything?</dc:title><dc:creator>Proctor H.</dc:creator><prism:publicationName>Physiology and Behavior</prism:publicationName><prism:issn>00319384</prism:issn><prism:eIssn>1873507X</prism:eIssn><prism:volume>147</prism:volume><prism:pageRange>39-49</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.physbeh.2015.04.011</prism:doi><pii>S0031938415002061</pii><dc:description>© 2015 Elsevier Inc. Insight into the emotional lives of animals is of utmost importance to the welfare of the billions of animals in our care, yet little is known about how to measure these states. Scientific understanding of how to measure and interpret positive emotional states is particularly lacking, although recent years have seen a notable increase in such studies. This study explored whether the percentage of visible eye whites is a valid measure of a low arousal, positive emotional state in dairy cows (. Bos taurus), by using stroking as the positive stimulus. Thirteen dairy cows were studied over a period of two months, and a total of 372 full 15. minute focal observations were performed. Each focal observation comprised three 5. minute phases: pre-stroking (baseline), stroking (stimulus), and post-stroking (post-stimulus), and the focal cow's behaviours were recorded throughout each observation, and the focal eye was filmed for later analysis. Following data collection we calculated the percentage of visible eye white at nine pre-determined measurement points throughout each focal observation.The eye white data were analysed using the one-way repeated measures ANOVA test. The percentage of visible eye white dropped during stroking compared with during both the pre-stroking and post-stroking phases (ANOVA: F&lt;inf&gt;1.242, 14.9&lt;/inf&gt;=4.32, P=0.025). The behaviours were analysed using Friedman's ANOVA and Wilcoxon's signed-rank test. Behaviours known to be associated with positive emotions in cows were performed during the stroking phase of the focal observation, supporting the use of stroking as a stimulus to induce a positive, low arousal emotional state.This study has explored the potential of visible eye whites as a measure of positive emotions and arousal, and our results support previous studies which suggest that eye whites may serve as a dynamic measure of emotion and arousal.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>World Animal Protection</affilname><affiliation-city/><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55787923000</author-url><authid>55787923000</authid><authname>Proctor H.</authname><surname>Proctor</surname><given-name>Helen S.</given-name><initials>H.S.</initials><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24461209300</author-url><authid>24461209300</authid><authname>Carder G.</authname><surname>Carder</surname><given-name>Gemma</given-name><initials>G.</initials><afid/></author><authkeywords>Affective states | Arousal | Cattle | Eye whites | Positive emotions | Welfare assessment</authkeywords><intid>2036081725</intid><source-id>24007</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929378650"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929378650?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929378650&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929378650&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006658"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929378650</prism:url><dc:identifier>SCOPUS_ID:84929378650</dc:identifier><eid>2-s2.0-84929378650</eid><dc:title>The role of thyroid in Takotsubo cardiomyopathy</dc:title><dc:creator>Aggarwal S.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>34</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.402</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000879</affiliation-url><afid>60000879</afid><affilname>Western Michigan University</affilname><name-variant>Western Michigan University</name-variant><affiliation-city>Kalamazoo</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014569</affiliation-url><afid>60014569</afid><affilname>UT Medical Branch at Galveston</affilname><name-variant>University of Texas Medical Branch</name-variant><affiliation-city>Galveston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114711474</affiliation-url><afid>114711474</afid><affilname>Cardiovascular Research Institute</affilname><name-variant>Cardiovascular Research Institute</name-variant><affiliation-city>Kalamazoo</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100497434</affiliation-url><afid>100497434</afid><affilname>Borgess Heart Institute</affilname><name-variant>Heart Institute at Borgess</name-variant><affiliation-city>Kalamazoo</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56643972600</author-url><authid>56643972600</authid><authname>Aggarwal S.</authname><surname>Aggarwal</surname><given-name>Sourabh</given-name><initials>S.</initials><afid>60000879</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644791200</author-url><authid>56644791200</authid><authname>Papani R.</authname><surname>Papani</surname><given-name>Ravikanth</given-name><initials>R.</initials><afid>60014569</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:16416542900</author-url><authid>16416542900</authid><authname>Gupta V.</authname><surname>Gupta</surname><given-name>Vishal</given-name><initials>V.</initials><afid>114711474</afid><afid>100497434</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:16416542900</author-url><authid>16416542900</authid><authname>Gupta V.</authname><surname>Gupta</surname><given-name>Vishal</given-name><initials>V.</initials><afid>114711474</afid><afid>100497434</afid></author><authkeywords>Autonomic nervous system | Hypothyroid | Levothyroxine | Takotsubo cardiomyopathy | Thyroid pathology</authkeywords><intid>1535943505</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929574509"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929574509?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929574509&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929574509&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0149763415001268"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929574509</prism:url><dc:identifier>SCOPUS_ID:84929574509</dc:identifier><eid>2-s2.0-84929574509</eid><dc:title>CACNA1C rs1006737 genotype and bipolar disorder: Focus on intermediate phenotypes and cardiovascular comorbidity</dc:title><dc:creator>Ou X.</dc:creator><prism:publicationName>Neuroscience and Biobehavioral Reviews</prism:publicationName><prism:issn>01497634</prism:issn><prism:eIssn>18737528</prism:eIssn><prism:volume>55</prism:volume><prism:pageRange>198-210</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.neubiorev.2015.04.022</prism:doi><pii>S0149763415001268</pii><dc:description>© 2015 Elsevier Ltd. Recently, multiple genome-wide association studies have identified a genetic polymorphism (CACNA1C rs1006737) that appears to confer susceptibility for BD. This article aims to summarize the existing literature regarding the impact of rs1006737 on functional and structural neuroimaging intermediate phenotypes. Twenty eight articles, representing 2486 healthy participants, 369 patients with BD and 104 healthy first-degree relatives of patients with BD, are incorporated. Multiple studies have demonstrated structural differences, functional differences associated with emotion-related and frontal-executive tasks, and/or differences in behavioral task performance in risk allele carriers (AA or AG). Results comparing participants with BD to health controls are generally less pronounced than within-group genetic comparisons. The review concludes with an integration of how cardiovascular comorbidity may be a relevant mediator of the observed findings, and proposes future directions toward optimized therapeutic use of calcium channel blockers in BD.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029150</affiliation-url><afid>60029150</afid><affilname>Sunnybrook Health Sciences Centre</affilname><name-variant>Sunnybrook Health Sciences Centre</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016849</affiliation-url><afid>60016849</afid><affilname>University of Toronto</affilname><name-variant>University of Toronto</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029150</affiliation-url><afid>60029150</afid><affilname>Sunnybrook Health Sciences Centre</affilname><name-variant>Sunnybrook Health Sciences Centre</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016849</affiliation-url><afid>60016849</afid><affilname>University of Toronto</affilname><name-variant>University of Toronto</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030319</affiliation-url><afid>60030319</afid><affilname>Hospital for Sick Children University of Toronto</affilname><name-variant>University of Toronto</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56650643000</author-url><authid>56650643000</authid><authname>Ou X.</authname><surname>Ou</surname><given-name>Xiao</given-name><initials>X.</initials><afid>60029150</afid><afid>60016849</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56650643000</author-url><authid>56650643000</authid><authname>Ou X.</authname><surname>Ou</surname><given-name>Xiao</given-name><initials>X.</initials><afid>60029150</afid><afid>60016849</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:37092656700</author-url><authid>37092656700</authid><authname>Crane D.</authname><surname>Crane</surname><given-name>David E.</given-name><initials>D.E.</initials><afid>60029150</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005993727</author-url><authid>7005993727</authid><authname>MacIntosh B.</authname><surname>MacIntosh</surname><given-name>Bradley J.</given-name><initials>B.J.</initials><afid>60029150</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56650491600</author-url><authid>56650491600</authid><authname>Young L.</authname><surname>Young</surname><given-name>L. Trevor</given-name><initials>L.T.</initials><afid>60029150</afid><afid>60016849</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56650491600</author-url><authid>56650491600</authid><authname>Young L.</authname><surname>Young</surname><given-name>L. Trevor</given-name><initials>L.T.</initials><afid>60029150</afid><afid>60016849</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56650612200</author-url><authid>56650612200</authid><authname>Arnold P.</authname><surname>Arnold</surname><given-name>Paul</given-name><initials>P.</initials><afid>60016849</afid><afid>60030319</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56650612200</author-url><authid>56650612200</authid><authname>Arnold P.</authname><surname>Arnold</surname><given-name>Paul</given-name><initials>P.</initials><afid>60016849</afid><afid>60030319</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:15053014000</author-url><authid>15053014000</authid><authname>Ameis S.</authname><surname>Ameis</surname><given-name>Stephanie</given-name><initials>S.</initials><afid>60016849</afid><afid>60030319</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:15053014000</author-url><authid>15053014000</authid><authname>Ameis S.</authname><surname>Ameis</surname><given-name>Stephanie</given-name><initials>S.</initials><afid>60016849</afid><afid>60030319</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7402431430</author-url><authid>7402431430</authid><authname>Goldstein B.</authname><surname>Goldstein</surname><given-name>Benjamin I.</given-name><initials>B.I.</initials><afid>60029150</afid><afid>60016849</afid><afid>60016849</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7402431430</author-url><authid>7402431430</authid><authname>Goldstein B.</authname><surname>Goldstein</surname><given-name>Benjamin I.</given-name><initials>B.I.</initials><afid>60029150</afid><afid>60016849</afid><afid>60016849</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7402431430</author-url><authid>7402431430</authid><authname>Goldstein B.</authname><surname>Goldstein</surname><given-name>Benjamin I.</given-name><initials>B.I.</initials><afid>60029150</afid><afid>60016849</afid><afid>60016849</afid></author><authkeywords>Bipolar disorder | CACNA1C | Calcium channel blockers | Cognition | Magnetic resonance imaging</authkeywords><intid>1785981968</intid><source-id>18045</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929461738"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929461738?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929461738&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929461738&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008207"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929461738</prism:url><dc:identifier>SCOPUS_ID:84929461738</dc:identifier><eid>2-s2.0-84929461738</eid><dc:title>CYP2C19 LOF alleles confer no risk for HTPR but higher risk for recurrent ischemic events in clopidogrel treated elderly ACS patients</dc:title><dc:creator>Yang J.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>225-227</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.097</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114725903</affiliation-url><afid>114725903</afid><affilname>General Hospital of Chinese People's Liberation Army</affilname><name-variant>General Hospital of Chinese People's Liberation Army</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56451881900</author-url><authid>56451881900</authid><authname>Yang J.</authname><surname>Yang</surname><given-name>Jie</given-name><initials>J.</initials><afid>114725903</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56453569700</author-url><authid>56453569700</authid><authname>Wang X.</authname><surname>Wang</surname><given-name>Xuyun</given-name><initials>X.</initials><afid>114725903</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56452139000</author-url><authid>56452139000</authid><authname>Peng L.</authname><surname>Peng</surname><given-name>Li</given-name><initials>L.</initials><afid>114725903</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56452641200</author-url><authid>56452641200</authid><authname>Zhang L.</authname><surname>Zhang</surname><given-name>Lanning</given-name><initials>L.</initials><afid>114725903</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55745848000</author-url><authid>55745848000</authid><authname>Li X.</authname><surname>Li</surname><given-name>Xiaoqi</given-name><initials>X.</initials><afid>114725903</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56647984600</author-url><authid>56647984600</authid><authname>Liu J.</authname><surname>Liu</surname><given-name>Jia</given-name><initials>J.</initials><afid>114725903</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56274752500</author-url><authid>56274752500</authid><authname>Zhang Y.</authname><surname>Zhang</surname><given-name>Yuxiao</given-name><initials>Y.</initials><afid>114725903</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56470055100</author-url><authid>56470055100</authid><authname>Xu Q.</authname><surname>Xu</surname><given-name>Qiang</given-name><initials>Q.</initials><afid>114725903</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56274696700</author-url><authid>56274696700</authid><authname>Lu C.</authname><surname>Lu</surname><given-name>Caiyi</given-name><initials>C.</initials><afid>114725903</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56647148700</author-url><authid>56647148700</authid><authname>Chen Y.</authname><surname>Chen</surname><given-name>Yundai</given-name><initials>Y.</initials><afid>114725903</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:55628277400</author-url><authid>55628277400</authid><authname>Yin T.</authname><surname>Yin</surname><given-name>Tong</given-name><initials>T.</initials><afid>114725903</afid></author><authkeywords>ACS | Clopidogrel | CYP2C19 | Elderly | Loss-of-function allele</authkeywords><intid>1535964568</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84919338721"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84919338721?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84919338721&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84919338721&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0958166914002183"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84919338721</prism:url><dc:identifier>SCOPUS_ID:84919338721</dc:identifier><eid>2-s2.0-84919338721</eid><dc:title>How to measure metabolic fluxes: A taxonomic guide for 13C fluxomics</dc:title><dc:creator>Niedenführ S.</dc:creator><prism:publicationName>Current Opinion in Biotechnology</prism:publicationName><prism:issn>09581669</prism:issn><prism:eIssn>18790429</prism:eIssn><prism:volume>34</prism:volume><prism:pageRange>82-90</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.copbio.2014.12.003</prism:doi><pii>S0958166914002183</pii><dc:description>© 2014 Elsevier Ltd. Metabolic reaction rates (fluxes) contribute fundamentally to our understanding of metabolic phenotypes and mechanisms of cellular regulation. Stable isotope-based fluxomics integrates experimental data with biochemical networks and mathematical modeling to 'measure' the in vivo fluxes within an organism that are not directly observable. In recent years, 13C fluxomics has evolved into a technology with great experimental, analytical, and mathematical diversity. This review aims at establishing a unified taxonomy by means of which the various fluxomics methods can be compared to each other. By linking the developed modeling approaches to recent studies, their challenges and opportunities are put into perspective. The proposed classification serves as a guide for scientific 'travelers' who are striving to resolve research questions with the currently available 13C fluxomics toolset.</dc:description><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007774</affiliation-url><afid>60007774</afid><affilname>Forschungszentrum Jülich (FZJ)</affilname><name-variant>Forschungszentrum Jülich</name-variant><affiliation-city>Julich</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:45961510800</author-url><authid>45961510800</authid><authname>Niedenführ S.</authname><surname>Niedenführ</surname><given-name>Sebastian</given-name><initials>S.</initials><afid>60007774</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003376595</author-url><authid>7003376595</authid><authname>Wiechert W.</authname><surname>Wiechert</surname><given-name>Wolfgang</given-name><initials>W.</initials><afid>60007774</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:8356621900</author-url><authid>8356621900</authid><authname>Nöh K.</authname><surname>Nöh</surname><given-name>Katharina</given-name><initials>K.</initials><afid>60007774</afid></author><intid>1534297552</intid><source-id>15579</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929325921"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929325921?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929325921&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929325921&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008165"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929325921</prism:url><dc:identifier>SCOPUS_ID:84929325921</dc:identifier><eid>2-s2.0-84929325921</eid><dc:title>Inadequately investigated drugs in acute peripartum cardiomyopathy</dc:title><dc:creator>Yildirim B.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>198</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.093</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114656172</affiliation-url><afid>114656172</afid><affilname>Muʇla Sitki Koçman University</affilname><name-variant>Muʇla Sitki Koçman University</name-variant><affiliation-city/><affiliation-country>Turkey</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018872</affiliation-url><afid>60018872</afid><affilname>Mugla Universitesi</affilname><name-variant>Muǧla University</name-variant><affiliation-city>Mugla</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56625674400</author-url><authid>56625674400</authid><authname>Yildirim B.</authname><surname>Yildirim</surname><given-name>Birdal</given-name><initials>B.</initials><afid>114656172</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36472957600</author-url><authid>36472957600</authid><authname>Başaran Ö.</authname><surname>Başaran</surname><given-name>Özcan</given-name><initials>Ö.</initials><afid>60018872</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003293301</author-url><authid>7003293301</authid><authname>Soylu M.</authname><surname>Soylu</surname><given-name>Mustafa Özcan</given-name><initials>M.Ö.</initials><afid>60018872</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56374644600</author-url><authid>56374644600</authid><authname>Altun I.</authname><surname>Altun</surname><given-name>Ibrahim</given-name><initials>I.</initials><afid>60018872</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:23491272900</author-url><authid>23491272900</authid><authname>Biteker M.</authname><surname>Biteker</surname><given-name>Murat</given-name><initials>M.</initials><afid>60018872</afid></author><authkeywords>Drugs | Peripartum cardiomyopathy | Treatment</authkeywords><intid>2035939661</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929404947"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929404947?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929404947&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929404947&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0195666315002299"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929404947</prism:url><dc:identifier>SCOPUS_ID:84929404947</dc:identifier><eid>2-s2.0-84929404947</eid><dc:title>Increasing portion sizes of fruits and vegetables in an elementary school lunch program can increase fruit and vegetable consumption</dc:title><dc:creator>Miller N.</dc:creator><prism:publicationName>Appetite</prism:publicationName><prism:issn>01956663</prism:issn><prism:eIssn>10958304</prism:eIssn><prism:volume>91</prism:volume><prism:pageRange>426-430</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.appet.2015.04.081</prism:doi><pii>S0195666315002299</pii><dc:description>© 2015 Elsevier Ltd. Increasing portion size can increase children's consumption of food. The goal of this study was to determine whether increasing the portion sizes of fruits and vegetables in an elementary school cafeteria environment would increase children's consumption of them. We measured each child's consumption of the fruit and vegetables served in a cafeteria line on a control day (normal cafeteria procedures) and on two intervention days. When we increased the portion size of 3 of the 4 fruits and vegetables by about 50%, children who took those foods increased their consumption of them. Although this was an effective strategy for increasing fruit and vegetable consumption among students who took those foods, many children chose not to take any fruits or vegetables. Further efforts are needed to increase children's selection and consumption of fruits and vegetables in an environment of competing foods of higher palatability.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005745</affiliation-url><afid>60005745</afid><affilname>University of Minnesota System</affilname><name-variant>University of Minnesota</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005745</affiliation-url><afid>60005745</afid><affilname>University of Minnesota System</affilname><name-variant>University of Minnesota</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005745</affiliation-url><afid>60005745</afid><affilname>University of Minnesota System</affilname><name-variant>University of Minnesota</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005745</affiliation-url><afid>60005745</afid><affilname>University of Minnesota System</affilname><name-variant>University of Minnesota</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56645601200</author-url><authid>56645601200</authid><authname>Miller N.</authname><surname>Miller</surname><given-name>Nicole</given-name><initials>N.</initials><afid>60005745</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56525407200</author-url><authid>56525407200</authid><authname>Reicks M.</authname><surname>Reicks</surname><given-name>Marla</given-name><initials>M.</initials><afid>60005745</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:23490233000</author-url><authid>23490233000</authid><authname>Redden J.</authname><surname>Redden</surname><given-name>Joseph P.</given-name><initials>J.P.</initials><afid>60005745</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56536120900</author-url><authid>56536120900</authid><authname>Mann T.</authname><surname>Mann</surname><given-name>Traci</given-name><initials>T.</initials><afid>60005745</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56525406900</author-url><authid>56525406900</authid><authname>Mykerezi E.</authname><surname>Mykerezi</surname><given-name>Elton</given-name><initials>E.</initials><afid>60005745</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7004906233</author-url><authid>7004906233</authid><authname>Vickers Z.</authname><surname>Vickers</surname><given-name>Zata</given-name><initials>Z.</initials><afid>60005745</afid></author><authkeywords>Elementary school students | Portion size | Vegetable consumption</authkeywords><intid>535957226</intid><source-id>29994</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929309917"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929309917?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929309917&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929309917&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008323"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929309917</prism:url><dc:identifier>SCOPUS_ID:84929309917</dc:identifier><eid>2-s2.0-84929309917</eid><dc:title>Reply: Health status, geriatric syndromes and prescription of oral anticoagulant therapy in elderly medical in-patients with atrial fibrillation: A prospective observational study</dc:title><dc:creator>Bo M.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>67</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.109</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Città Della Salute E Della Scienza - Molinette</affilname><name-variant>SCDU Geriatria E Malattie Metaboliche dell'Osso</name-variant><affiliation-city>Torino</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:106709037</affiliation-url><afid>106709037</afid><affilname>AOU San Luigi Gonzaga</affilname><name-variant>A.O.U. San Luigi Gonzaga</name-variant><affiliation-city>Orbassano</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Città Della Salute E Della Scienza - Molinette</affilname><name-variant>SCDU Cardiologia</name-variant><affiliation-city>Torino</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56539510700</author-url><authid>56539510700</authid><authname>Bo M.</authname><surname>Bo</surname><given-name>M.</given-name><initials>M.</initials><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8538257300</author-url><authid>8538257300</authid><authname>Puma F.</authname><surname>Puma</surname><given-name>F. Li</given-name><initials>F.L.</initials><afid/></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56640669300</author-url><authid>56640669300</authid><authname>Martini M.</authname><surname>Martini</surname><given-name>M. Badinella</given-name><initials>M.B.</initials><afid/></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56663046900</author-url><authid>56663046900</authid><authname>Falcone Y.</authname><surname>Falcone</surname><given-name>Y.</given-name><initials>Y.</initials><afid/></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36666561100</author-url><authid>36666561100</authid><authname>Iacovino M.</authname><surname>Iacovino</surname><given-name>M.</given-name><initials>M.</initials><afid/></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55885443900</author-url><authid>55885443900</authid><authname>Grisoglio E.</authname><surname>Grisoglio</surname><given-name>E.</given-name><initials>E.</initials><afid/></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55763499900</author-url><authid>55763499900</authid><authname>Bonetto M.</authname><surname>Bonetto</surname><given-name>M.</given-name><initials>M.</initials><afid/></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:24467983700</author-url><authid>24467983700</authid><authname>Isaia G.</authname><surname>Isaia</surname><given-name>G.</given-name><initials>G.</initials><afid>106709037</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56640989700</author-url><authid>56640989700</authid><authname>Ciccone G.</authname><surname>Ciccone</surname><given-name>G.</given-name><initials>G.</initials><afid/></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:24779415100</author-url><authid>24779415100</authid><authname>Isaia G.</authname><surname>Isaia</surname><given-name>G. C.</given-name><initials>G.C.</initials><afid/></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56233008400</author-url><authid>56233008400</authid><authname>Gaita F.</authname><surname>Gaita</surname><given-name>F.</given-name><initials>F.</initials><afid/></author><authkeywords>Atrial fibrillation | Elderly | Geriatric syndromes | Health status | Older medical in-patients | Oral anticoagulants</authkeywords><intid>535946595</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929329528"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929329528?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929329528&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929329528&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006695"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929329528</prism:url><dc:identifier>SCOPUS_ID:84929329528</dc:identifier><eid>2-s2.0-84929329528</eid><dc:title>Coronary artery fistula from the left circumflex to coronary sinus in infant: Case report with literature review</dc:title><dc:creator>Guang S.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>37-39</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.406</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008872</affiliation-url><afid>60008872</afid><affilname>China Medical University Shenyang</affilname><name-variant>China Medical University</name-variant><affiliation-city>Shenyang</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008872</affiliation-url><afid>60008872</afid><affilname>China Medical University Shenyang</affilname><name-variant>China Medical University</name-variant><affiliation-city>Shenyang</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008872</affiliation-url><afid>60008872</afid><affilname>China Medical University Shenyang</affilname><name-variant>China Medical University</name-variant><affiliation-city>Shenyang</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644429700</author-url><authid>56644429700</authid><authname>Guang S.</authname><surname>Guang</surname><given-name>Song</given-name><initials>S.</initials><afid>60008872</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:12778453700</author-url><authid>12778453700</authid><authname>Ren W.</authname><surname>Ren</surname><given-name>Weidong</given-name><initials>W.</initials><afid>60008872</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56643594600</author-url><authid>56643594600</authid><authname>Tang L.</authname><surname>Tang</surname><given-name>Lian</given-name><initials>L.</initials><afid>60008872</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56643647500</author-url><authid>56643647500</authid><authname>Hou Y.</authname><surname>Hou</surname><given-name>Yang</given-name><initials>Y.</initials><afid>60008872</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56643767500</author-url><authid>56643767500</authid><authname>Zhou K.</authname><surname>Zhou</surname><given-name>Ke</given-name><initials>K.</initials><afid>60008872</afid></author><authkeywords>Coronary artery fistula | Coronary sinus | Extremely low birth weight infant | Left circumflex | Stenosis</authkeywords><intid>1785944601</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929145299"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929145299?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929145299&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929145299&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0268401215000377"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929145299</prism:url><dc:identifier>SCOPUS_ID:84929145299</dc:identifier><eid>2-s2.0-84929145299</eid><dc:title>Extracting and evaluating conversational patterns in social media: A socio-semantic analysis of customers' reactions to the launch of new products using Twitter streams</dc:title><dc:creator>Lipizzi C.</dc:creator><prism:publicationName>International Journal of Information Management</prism:publicationName><prism:issn>02684012</prism:issn><prism:volume>35</prism:volume><prism:issueIdentifier>4</prism:issueIdentifier><prism:pageRange>490-503</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijinfomgt.2015.04.001</prism:doi><pii>S0268401215000377</pii><dc:description>© 2015 Elsevier Ltd. All rights reserved. In this paper we use Twitter data to assess customers early reactions to the launch of two new products by Apple and Samsung by analyzing the streams generated in a 72 h window around the two events. We present a methodology based on conversational analysis to extract concept maps from Twitter streams and use semantic and topological metrics to compare the conversations. Our findings show that there are significant differences in the structural patterns of the two conversations and that the analysis of these differences can be highly informative about early customers perceptions and value judgments associated with the competing products.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027392</affiliation-url><afid>60027392</afid><affilname>Stevens Institute of Technology</affilname><name-variant>Stevens Inst of Technology</name-variant><affiliation-city>Hoboken</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017293</affiliation-url><afid>60017293</afid><affilname>Universita degli Studi di Napoli Federico II</affilname><name-variant>University of Naples Federico II</name-variant><affiliation-city>Naples</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100849670</affiliation-url><afid>100849670</afid><affilname>Graduate School</affilname><name-variant>Graduate School</name-variant><affiliation-city>Guadalajara</affiliation-city><affiliation-country>Mexico</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56641865100</author-url><authid>56641865100</authid><authname>Lipizzi C.</authname><surname>Lipizzi</surname><given-name>Carlo</given-name><initials>C.</initials><afid>60027392</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6505601934</author-url><authid>6505601934</authid><authname>Iandoli L.</authname><surname>Iandoli</surname><given-name>Luca</given-name><initials>L.</initials><afid>60027392</afid><afid>60017293</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6505601934</author-url><authid>6505601934</authid><authname>Iandoli L.</authname><surname>Iandoli</surname><given-name>Luca</given-name><initials>L.</initials><afid>60027392</afid><afid>60017293</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6506312498</author-url><authid>6506312498</authid><authname>Ramirez Marquez J.</authname><surname>Ramirez Marquez</surname><given-name>José Emmanuel</given-name><initials>J.E.</initials><afid>60027392</afid><afid>100849670</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6506312498</author-url><authid>6506312498</authid><authname>Ramirez Marquez J.</authname><surname>Ramirez Marquez</surname><given-name>José Emmanuel</given-name><initials>J.E.</initials><afid>60027392</afid><afid>100849670</afid></author><authkeywords>Actionable intelligence | Competitive analysis | Competitive intelligence | Competitor intelligence | Consumer electronics industry | Content analysis | Social media | Text mining | Twitter Case study</authkeywords><intid>1035912664</intid><source-id>15631</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929630041"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929630041?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929630041&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929630041&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0960077915001344"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929630041</prism:url><dc:identifier>SCOPUS_ID:84929630041</dc:identifier><eid>2-s2.0-84929630041</eid><dc:title>Human photoplethysmogram: New insight into chaotic characteristics</dc:title><dc:creator>Sviridova N.</dc:creator><prism:publicationName>Chaos, Solitons and Fractals</prism:publicationName><prism:issn>09600779</prism:issn><prism:volume>77</prism:volume><prism:pageRange>53-63</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.chaos.2015.05.005</prism:doi><pii>S0960077915001344</pii><dc:description>© 2015 The Authors. Published by Elsevier Ltd. The photoplethysmogram is widely used in medical settings and sports equipment to measure biological signals. The photoplethysmogram, which is measured noninvasively, can provide valuable information about cardiovascular system performance. The present study sought to investigate the underlying dynamics of photoplethysmographic signals from healthy young human subjects. In previous studies the photoplethysmogram was claimed to be driven by deterministic chaos [Tsuda 1992, Sumida 2000]; however, the methods applied for chaos detection were noise sensitive and inconclusive. Therefore, to reach a consistent conclusion it is important to employ additional nonlinear time series analysis tools that can test different features of the signal's underlying dynamics. In this paper, methods of nonlinear time series analysis, including time delay embedding, largest Lyapunov exponent, deterministic nonlinear prediction, Poincaré section, the Wayland test and method of surrogate data were applied to photoplethysmogram time series to identify the unique characteristics of the photoplethysmogram as a dynamical system. Results demonstrated that photoplethysmogram dynamics is consistent with the definition of chaotic movement, and its chaotic properties showed some similarity to Rossler's single band chaos with induced dynamical noise. Additionally it was found that deterministic nonlinear prediction, Poincaré section and the Wayland test can reveal important characteristics of photoplethysmographic signals that will be important tools for theoretical and applied studies on the photoplethysmogram.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004853</affiliation-url><afid>60004853</afid><affilname>Tokyo University of Agriculture and Technology</affilname><name-variant>Tokyo Univ. of Agric. and Technology</name-variant><affiliation-city>Fuchu</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004853</affiliation-url><afid>60004853</afid><affilname>Tokyo University of Agriculture and Technology</affilname><name-variant>Tokyo Univ. of Agric. and Technology</name-variant><affiliation-city>Fuchu</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602957052</author-url><authid>6602957052</authid><authname>Sviridova N.</authname><surname>Sviridova</surname><given-name>Nina</given-name><initials>N.</initials><afid>60004853</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7404663277</author-url><authid>7404663277</authid><authname>Sakai K.</authname><surname>Sakai</surname><given-name>Kenshi</given-name><initials>K.</initials><afid>60004853</afid></author><intid>35988734</intid><source-id>25347</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926466773"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926466773?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926466773&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926466773&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0747563215002691"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926466773</prism:url><dc:identifier>SCOPUS_ID:84926466773</dc:identifier><eid>2-s2.0-84926466773</eid><dc:title>Psychometric modeling of the pervasive use of Facebook through psychophysiological measures: Stress or optimal experience?</dc:title><dc:creator>Cipresso P.</dc:creator><prism:publicationName>Computers in Human Behavior</prism:publicationName><prism:issn>07475632</prism:issn><prism:volume>49</prism:volume><prism:pageRange>576-587</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.chb.2015.03.068</prism:doi><pii>S0747563215002691</pii><dc:description>© 2015 Elsevier Ltd. All rights reserved. Social network sites have been studied extensively with an aim to understand users' experience during their use. Facebook is the most frequently used social network site, with more than one billion active users. However, despite 819 million of active Facebook users currently accessing it using their mobile device, only a limited number of studies have investigated their experiences with Facebook. Our goal was to objectively verify in an experimental setting the subjective experience of users accessing Facebook through a PC and through a smart phone, which has a higher pervasiveness. Psychophysiological correlates of 28 subjects were measured using wearable biosensors, which record signals through an electrocardiogram; a 14-channel Electroencephalogram; facial Electromyography; an Electrooculogram, and a chest Respiration strip. An accurate signal processing permitted to compute twenty psychophysiological measures for the statistical analysis. The results showed significant patterns in arousal, valence, attention, and anxiety, indicating a subjects' engagement during Facebook navigation, which was also more evident during the mobile session, suggesting an optimal experience during the pervasive use of Facebook. Some hypotheses and the directions for future studies are presented, in particular, the suggestion to make further studies with higher ecological validity, outside the lab, to assess the ubiquitous use of Facebook.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006646</affiliation-url><afid>60006646</afid><affilname>IRCCS Istituto Auxologico Italiano</affilname><name-variant>IRCCS Istituto Auxologico Italiano</name-variant><affiliation-city>Milan</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024053</affiliation-url><afid>60024053</afid><affilname>Universita Cattolica del Sacro Cuore</affilname><name-variant>Università Cattolica del Sacro Cuore</name-variant><affiliation-city>Milan</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006646</affiliation-url><afid>60006646</afid><affilname>IRCCS Istituto Auxologico Italiano</affilname><name-variant>IRCCS Istituto Auxologico Italiano</name-variant><affiliation-city>Milan</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36717478000</author-url><authid>36717478000</authid><authname>Cipresso P.</authname><surname>Cipresso</surname><given-name>Pietro</given-name><initials>P.</initials><afid>60006646</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:54910848200</author-url><authid>54910848200</authid><authname>Serino S.</authname><surname>Serino</surname><given-name>Silvia</given-name><initials>S.</initials><afid>60006646</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:54997759200</author-url><authid>54997759200</authid><authname>Gaggioli A.</authname><surname>Gaggioli</surname><given-name>Andrea</given-name><initials>A.</initials><afid>60006646</afid><afid>60024053</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:54997759200</author-url><authid>54997759200</authid><authname>Gaggioli A.</authname><surname>Gaggioli</surname><given-name>Andrea</given-name><initials>A.</initials><afid>60006646</afid><afid>60024053</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55244136700</author-url><authid>55244136700</authid><authname>Albani G.</authname><surname>Albani</surname><given-name>Giovanni</given-name><initials>G.</initials><afid>60006646</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7004566307</author-url><authid>7004566307</authid><authname>Mauro A.</authname><surname>Mauro</surname><given-name>Alessandro</given-name><initials>A.</initials><afid>60006646</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7102592020</author-url><authid>7102592020</authid><authname>Riva G.</authname><surname>Riva</surname><given-name>Giuseppe</given-name><initials>G.</initials><afid>60006646</afid><afid>60024053</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7102592020</author-url><authid>7102592020</authid><authname>Riva G.</authname><surname>Riva</surname><given-name>Giuseppe</given-name><initials>G.</initials><afid>60006646</afid><afid>60024053</afid></author><authkeywords>Facebook | Mobile social networking | Psychological stress | Psychometric modeling | Psychophysiology | Social network sites</authkeywords><intid>1785454622</intid><source-id>19419</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929658134"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929658134?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929658134&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929658134&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1075996415300135"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929658134</prism:url><dc:identifier>SCOPUS_ID:84929658134</dc:identifier><eid>2-s2.0-84929658134</eid><dc:title>Recurrent clostridium difficile infection: From colonization to cure</dc:title><dc:creator>Shields K.</dc:creator><prism:publicationName>Anaerobe</prism:publicationName><prism:issn>10759964</prism:issn><prism:eIssn>10958274</prism:eIssn><prism:volume>34</prism:volume><prism:pageRange>59-73</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.anaerobe.2015.04.012</prism:doi><pii>S1075996415300135</pii><dc:description>© 2015 Elsevier Ltd. Clostridium difficile infection (CDI) is increasingly prevalent, dangerous and challenging to prevent and manage. Despite intense national and international attention the incidence of primary and of recurrent CDI (PCDI and RCDI, respectively) have risen rapidly throughout the past decade. Of major concern is the increase in cases of RCDI resulting in substantial morbidity, morality and economic burden. RCDI management remains challenging as there is no uniformly effective therapy, no firm consensus on optimal treatment, and reliable data regarding RCDI-specific treatment options is scant. Novel therapeutic strategies are critically needed to rapidly, accurately, and effectively identify and treat patients with, or at-risk for, RCDI. In this review we consider the factors implicated in the epidemiology, pathogenesis and clinical presentation of RCDI, evaluate current management options for RCDI and explore novel and emerging therapies.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002746</affiliation-url><afid>60002746</afid><affilname>Harvard Medical School</affilname><name-variant>Harvard Medical School</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002746</affiliation-url><afid>60002746</afid><affilname>Harvard Medical School</affilname><name-variant>Harvard Medical School</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55586496200</author-url><authid>55586496200</authid><authname>Shields K.</authname><surname>Shields</surname><given-name>Kelsey</given-name><initials>K.</initials><afid>60002746</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8406621000</author-url><authid>8406621000</authid><authname>Araujo-Castillo R.</authname><surname>Araujo-Castillo</surname><given-name>Roger V.</given-name><initials>R.V.</initials><afid>60002746</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:25925495300</author-url><authid>25925495300</authid><authname>Theethira T.</authname><surname>Theethira</surname><given-name>Thimmaiah G.</given-name><initials>T.G.</initials><afid>60002746</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:38662205700</author-url><authid>38662205700</authid><authname>Alonso C.</authname><surname>Alonso</surname><given-name>Carolyn D.</given-name><initials>C.D.</initials><afid>60002746</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7401583787</author-url><authid>7401583787</authid><authname>Kelly C.</authname><surname>Kelly</surname><given-name>Ciaran P.</given-name><initials>C.P.</initials><afid>60002746</afid></author><authkeywords>Antibiotic | Fecal microbiota therapy | Infection control | Infectious diarrhea | Nosocomial infection | Toxin</authkeywords><intid>2035986309</intid><source-id>19607</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929324278"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929324278?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929324278&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929324278&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006774"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929324278</prism:url><dc:identifier>SCOPUS_ID:84929324278</dc:identifier><eid>2-s2.0-84929324278</eid><dc:title>Ticagrelor increases endothelial progenitor cell level compared to clopidogrel in acute coronary syndromes: A prospective randomized study</dc:title><dc:creator>Bonello L.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>502-507</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.414</prism:doi><dc:description>© 2015 Published by Elsevier Ireland Ltd. Background: The clinical benefit of ticagrelor compared to clopidogrel in ACS patients suggested off-target property. Such pleiotropic effect could be mediated by circulating endothelial progenitor cells (EPC) which are critical for vascular healing. We aimed to investigate the impact of ticagrelor on EPC in acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI). Methods: We prospectively randomized 106 ACS patients to ticagrelor or clopidogrel. Sub-populations of CD34+ circulating progenitor cells (PC) were analyzed by flow cytometry allowing one to determine the levels of CD34+ PC, CD34+CD45+ Hematopoietic PC, CD34+133+ immature PC and CD34+KDR+ EPC on admission and at 1 month. Changes in PC level were calculated as the difference between 1 month and baseline value. Results: The 2 groups were similar regarding baseline characteristics including PC numbers on admission. The 2 groups had similar change in overall CD34+ PC and hematopoietic CD34+45+ PC level (p = 0.2). On the contrary, when considering CD34+133+ PC and CD34+KDR+ EPC, we observed that patients treated by ticagrelor had a significantly higher increase in levels of these PC subtypes compared to those treated by clopidogrel (0.23 (-0.33; 0.79) vs 0.00 (-0.5; 0.34); p = 0.04 and 0.01 (-0.04; 0.05) vs -0.01 (-0.06; 0.03); p = 0.02). Changes in the level of CD34+CD133+ PC correlated with platelet activity measured by the VASP index (r = -0.30; p = 0.008). By contrast the increase in the level of CD34+KDR+ EPC in the ticagrelor group was independent of platelet activity. Conclusions: Ticagrelor increases the number of EPC in ACS patients suggesting a benefit on endothelial regeneration that may participate in the pleiotropic property of the drug.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60102127</affiliation-url><afid>60102127</afid><affilname>Aix Marseille Universite</affilname><name-variant>Aix-Marseille University</name-variant><affiliation-city>Marseille</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60102127</affiliation-url><afid>60102127</afid><affilname>Aix Marseille Universite</affilname><name-variant>Aix-Marseille University</name-variant><affiliation-city>Marseille</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024144</affiliation-url><afid>60024144</afid><affilname>Hopital La Timone</affilname><name-variant>CHU Timone</name-variant><affiliation-city>Marseille</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60102127</affiliation-url><afid>60102127</afid><affilname>Aix Marseille Universite</affilname><name-variant>Aix-Marseille University</name-variant><affiliation-city>Marseille</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60102127</affiliation-url><afid>60102127</afid><affilname>Aix Marseille Universite</affilname><name-variant>Aix-Marseille University</name-variant><affiliation-city>Marseille</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004797</affiliation-url><afid>60004797</afid><affilname>AP-HM Assistance Publique - Hopitaux de Marseille</affilname><name-variant>CHU</name-variant><affiliation-city>Marseille</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017724</affiliation-url><afid>60017724</afid><affilname>Centre Hospitalier Regional Universitaire de Lille</affilname><name-variant>CHU</name-variant><affiliation-city>Lille</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033039</affiliation-url><afid>60033039</afid><affilname>Hopital de La Conception</affilname><name-variant>Hôpital de la Conception</name-variant><affiliation-city>Marseille</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">19</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:12808957200</author-url><authid>12808957200</authid><authname>Bonello L.</authname><surname>Bonello</surname><given-name>Laurent</given-name><initials>L.</initials><afid>60102127</afid><afid>60102127</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:12808957200</author-url><authid>12808957200</authid><authname>Bonello L.</authname><surname>Bonello</surname><given-name>Laurent</given-name><initials>L.</initials><afid>60102127</afid><afid>60102127</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603836206</author-url><authid>6603836206</authid><authname>Frere C.</authname><surname>Frere</surname><given-name>Corinne</given-name><initials>C.</initials><afid>60102127</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:37121838800</author-url><authid>37121838800</authid><authname>Cointe S.</authname><surname>Cointe</surname><given-name>Sylvie</given-name><initials>S.</initials><afid>60102127</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:50061436700</author-url><authid>50061436700</authid><authname>Laine M.</authname><surname>Laine</surname><given-name>Marc</given-name><initials>M.</initials><afid>60102127</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55642224600</author-url><authid>55642224600</authid><authname>Mancini J.</authname><surname>Mancini</surname><given-name>Julien</given-name><initials>J.</initials><afid>60024144</afid><afid>60102127</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55642224600</author-url><authid>55642224600</authid><authname>Mancini J.</authname><surname>Mancini</surname><given-name>Julien</given-name><initials>J.</initials><afid>60024144</afid><afid>60102127</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7801421244</author-url><authid>7801421244</authid><authname>Thuny F.</authname><surname>Thuny</surname><given-name>Franck</given-name><initials>F.</initials><afid>60102127</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6602856874</author-url><authid>6602856874</authid><authname>Kerbaul F.</authname><surname>Kerbaul</surname><given-name>François</given-name><initials>F.</initials><afid>60102127</afid><afid>60004797</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6602856874</author-url><authid>6602856874</authid><authname>Kerbaul F.</authname><surname>Kerbaul</surname><given-name>François</given-name><initials>F.</initials><afid>60102127</afid><afid>60004797</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:25623579600</author-url><authid>25623579600</authid><authname>Lemesle G.</authname><surname>Lemesle</surname><given-name>Gilles</given-name><initials>G.</initials><afid>60017724</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7006142668</author-url><authid>7006142668</authid><authname>Paganelli F.</authname><surname>Paganelli</surname><given-name>Franck</given-name><initials>F.</initials><afid>60102127</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:55497247400</author-url><authid>55497247400</authid><authname>Guieu R.</authname><surname>Guieu</surname><given-name>Regis</given-name><initials>R.</initials><afid>60102127</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:35316932300</author-url><authid>35316932300</authid><authname>Arnaud L.</authname><surname>Arnaud</surname><given-name>Laurent</given-name><initials>L.</initials><afid>60102127</afid><afid>60033039</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:35316932300</author-url><authid>35316932300</authid><authname>Arnaud L.</authname><surname>Arnaud</surname><given-name>Laurent</given-name><initials>L.</initials><afid>60102127</afid><afid>60033039</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7003860579</author-url><authid>7003860579</authid><authname>Dignat-George F.</authname><surname>Dignat-George</surname><given-name>Françoise</given-name><initials>F.</initials><afid>60102127</afid><afid>60033039</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7003860579</author-url><authid>7003860579</authid><authname>Dignat-George F.</authname><surname>Dignat-George</surname><given-name>Françoise</given-name><initials>F.</initials><afid>60102127</afid><afid>60033039</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:55881156700</author-url><authid>55881156700</authid><authname>Sabatier F.</authname><surname>Sabatier</surname><given-name>Florence</given-name><initials>F.</initials><afid>60102127</afid><afid>60033039</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:55881156700</author-url><authid>55881156700</authid><authname>Sabatier F.</authname><surname>Sabatier</surname><given-name>Florence</given-name><initials>F.</initials><afid>60102127</afid><afid>60033039</afid></author><authkeywords>Endothelial | P2y12-adp receptor | Pleiotropic | Progenitor cells | Vascular healing</authkeywords><intid>1535943725</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84921466994"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84921466994?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84921466994&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84921466994&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2352154615000157"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84921466994</prism:url><dc:identifier>SCOPUS_ID:84921466994</dc:identifier><eid>2-s2.0-84921466994</eid><dc:title>Physical activity, brain, and cognition</dc:title><dc:creator>Erickson K.</dc:creator><prism:publicationName>Current Opinion in Behavioral Sciences</prism:publicationName><prism:eIssn>23521546</prism:eIssn><prism:volume>4</prism:volume><prism:pageRange>27-32</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cobeha.2015.01.005</prism:doi><pii>S2352154615000157</pii><dc:description>© 2015 Elsevier Ltd. In this brief review we summarize the promising effects of physical activity and fitness on brain and cognition in children and older adults. Research in children finds that higher fit and more active preadolescent children show greater hippocampal and basal ganglia volume, greater white matter integrity, elevated and more efficient patterns of brain activity, and superior cognitive performance and scholastic achievement. Higher fit and more physically active older adults show greater hippocampal, prefrontal cortex, and basal ganglia volume, greater functional brain connectivity, greater white matter integrity, more efficient brain activity, and superior executive and memory function. Despite these promising results, more randomized trials are needed to understand heterogeneity in response to physical activity, mechanisms, and translation to public policy.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015543</affiliation-url><afid>60015543</afid><affilname>University of Pittsburgh</affilname><name-variant>University of Pittsburgh</name-variant><affiliation-city>Pittsburgh</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005290</affiliation-url><afid>60005290</afid><affilname>University of Illinois</affilname><name-variant>University of Illinois</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000745</affiliation-url><afid>60000745</afid><affilname>University of Illinois at Urbana-Champaign</affilname><name-variant>University of Illinois</name-variant><affiliation-city>Urbana</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7101770339</author-url><authid>7101770339</authid><authname>Erickson K.</authname><surname>Erickson</surname><given-name>Kirk I.</given-name><initials>K.I.</initials><afid>60015543</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003999862</author-url><authid>7003999862</authid><authname>Hillman C.</authname><surname>Hillman</surname><given-name>Charles H.</given-name><initials>C.H.</initials><afid>60005290</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7401931929</author-url><authid>7401931929</authid><authname>Kramer A.</authname><surname>Kramer</surname><given-name>Arthur F.</given-name><initials>A.F.</initials><afid>60000745</afid></author><intid>1534650559</intid><source-id>21100363813</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929317589"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929317589?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929317589&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929317589&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007202"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929317589</prism:url><dc:identifier>SCOPUS_ID:84929317589</dc:identifier><eid>2-s2.0-84929317589</eid><dc:title>Percutaneous coronary intervention driven by combined use of intracoronary anatomy and physiology towards a tailored therapy for coronary artery disease</dc:title><dc:creator>Vizzari G.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>562-564</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.010</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012753</affiliation-url><afid>60012753</afid><affilname>Universita degli Studi di Messina, Facolta di Medicina e Chirurgia</affilname><name-variant>Policlinico Universitario</name-variant><affiliation-city>Messina</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100363518</affiliation-url><afid>100363518</afid><affilname>Ospedale A. Cardarelli</affilname><name-variant>Oncologia Medica Ospedale A Cardarelli</name-variant><affiliation-city>Campobasso</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113137699</affiliation-url><afid>113137699</afid><affilname>Ospedale F. Veneziale</affilname><name-variant>Ospedale Veneziale</name-variant><affiliation-city>Isernia</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56275509500</author-url><authid>56275509500</authid><authname>Vizzari G.</authname><surname>Vizzari</surname><given-name>Giampiero</given-name><initials>G.</initials><afid>60012753</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36961128000</author-url><authid>36961128000</authid><authname>Di Giorgio A.</authname><surname>Di Giorgio</surname><given-name>Alessandro</given-name><initials>A.</initials><afid>60012753</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602789507</author-url><authid>6602789507</authid><authname>Saporito F.</authname><surname>Saporito</surname><given-name>Francesco</given-name><initials>F.</initials><afid>60012753</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:23981663200</author-url><authid>23981663200</authid><authname>Trio O.</authname><surname>Trio</surname><given-name>Olimpia</given-name><initials>O.</initials><afid>60012753</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56249861000</author-url><authid>56249861000</authid><authname>Versaci F.</authname><surname>Versaci</surname><given-name>Francesco</given-name><initials>F.</initials><afid>100363518</afid><afid>113137699</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56249861000</author-url><authid>56249861000</authid><authname>Versaci F.</authname><surname>Versaci</surname><given-name>Francesco</given-name><initials>F.</initials><afid>100363518</afid><afid>113137699</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56598610200</author-url><authid>56598610200</authid><authname>Andò G.</authname><surname>Andò</surname><given-name>Giuseppe</given-name><initials>G.</initials><afid>60012753</afid></author><authkeywords>Fractional flow reserve (ffr) | Multimodality coronary imaging | Optical coherence tomography (oct) | PCI | Percutaneous coronary revascularization</authkeywords><intid>1535945079</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84908648821"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84908648821?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84908648821&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84908648821&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915014011885"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84908648821</prism:url><dc:identifier>SCOPUS_ID:84908648821</dc:identifier><eid>2-s2.0-84908648821</eid><dc:title>The inverse association of incident cardiovascular disease with plasma bilirubin is unaffected by adiponectin</dc:title><dc:creator>Dullaart R.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>380-383</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2014.05.938</prism:doi><pii>S0021915014011885</pii><dc:description>© 2014 Elsevier Ireland Ltd. Objective: Bilirubin may protect against atherosclerotic cardiovascular disease (CVD). The heme oxygenase pathway is crucial for bilirubin generation, and is stimulated by adiponectin. We tested the relationship of plasma bilirubin with adiponectin, and determined whether the association of incident CVD with bilirubin is modified by adiponectin. Methods: A community-based prospective nested case-control study (PREVEND cohort) was carried out in 87 non-diabetic men who developed a first cardiovascular event (cases) and 94 controls during a median follow-up of 6.1 (2.8-10.6) years. Results: In all subjects combined, bilirubin was positively related to adiponectin (. r=0.205, P=0.006). Age-adjusted incident CVD was inversely associated with bilirubin (hazard ratio (HR): 0.80 (95% CI 0.65-0.99), P=0.048), independently of adiponectin (HR: 0.78 (95% CI 0.63-0.97), P=0.027). Adiponectin did not modify the association of CVD with bilirubin (interaction term: P=0.65). After additional adjustment for CVD risk factors, neither the association of incident CVD with bilirubin nor with adiponectin remained significant (P&gt;0.20 for both), and there was again no interaction between bilirubin and adiponectin on CVD risk (. P=0.67). Conclusion: Bilirubin is related to adiponectin, but the association of bilirubin with CVD risk is largely unaffected by adiponectin.</dc:description><citedby-count>2</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006027</affiliation-url><afid>60006027</afid><affilname>Universitair Medisch Centrum Groningen</affilname><name-variant>University Medical Center Groningen</name-variant><affiliation-city>Groningen</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006027</affiliation-url><afid>60006027</afid><affilname>Universitair Medisch Centrum Groningen</affilname><name-variant>University Medical Center Groningen</name-variant><affiliation-city>Groningen</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006027</affiliation-url><afid>60006027</afid><affilname>Universitair Medisch Centrum Groningen</affilname><name-variant>University Medical Center Groningen</name-variant><affiliation-city>Groningen</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><pubmed-id>24929286</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56233750500</author-url><authid>56233750500</authid><authname>Dullaart R.</authname><surname>Dullaart</surname><given-name>Robin P F</given-name><initials>R.P.F.</initials><afid>60006027</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56490361400</author-url><authid>56490361400</authid><authname>Boersema J.</authname><surname>Boersema</surname><given-name>Jeltje</given-name><initials>J.</initials><afid>60006027</afid><afid>60006027</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56490361400</author-url><authid>56490361400</authid><authname>Boersema J.</authname><surname>Boersema</surname><given-name>Jeltje</given-name><initials>J.</initials><afid>60006027</afid><afid>60006027</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35565576000</author-url><authid>35565576000</authid><authname>Lefrandt J.</authname><surname>Lefrandt</surname><given-name>Joop D.</given-name><initials>J.D.</initials><afid>60006027</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7005975255</author-url><authid>7005975255</authid><authname>Wolffenbuttel B.</authname><surname>Wolffenbuttel</surname><given-name>Bruce H R</given-name><initials>B.H.R.</initials><afid>60006027</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7006070107</author-url><authid>7006070107</authid><authname>Bakker S.</authname><surname>Bakker</surname><given-name>Stephan J L</given-name><initials>S.J.L.</initials><afid>60006027</afid></author><authkeywords>Adiponectin | Bilirubin | Cardiovascular disease | Prospective nested case-control study</authkeywords><intid>1032499672</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929456122"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929456122?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929456122&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929456122&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0278691515001581"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929456122</prism:url><dc:identifier>SCOPUS_ID:84929456122</dc:identifier><eid>2-s2.0-84929456122</eid><dc:title>In vivo protective effect of Uridine, a pyrimidine nucleoside, on genotoxicity induced by Levodopa/Carbidopa in mice</dc:title><dc:creator>Orenlili Yaylagul E.</dc:creator><prism:publicationName>Food and Chemical Toxicology</prism:publicationName><prism:issn>02786915</prism:issn><prism:eIssn>18736351</prism:eIssn><prism:volume>82</prism:volume><prism:pageRange>36-41</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.fct.2015.05.002</prism:doi><pii>S0278691515001581</pii><dc:description>© 2015. Parkinson's disease (PD) is a common neurodegenerative disorder that affects millions of people all over the world. Motor symptoms of PD are most commonly controlled by L-3,4-dihydroxyphenylalanine (Levodopa, L-DOPA), a precursor of dopamine, plus a peripherally-acting aromatic-L-amino-acid decarboxylase (dopa decarboxylase) inhibitor, such as carbidopa. However, chronic treatment with a combination of Levodopa plus carbidopa has been demonstrated to cause a major complication, namely abnormal involuntary movements. On the other hand, the effect of this treatment on bone marrow cells is unknown. Therefore, in this study, we aimed to investigate possible genotoxic effects of Levodopa and Carbidopa using male Balb/C mice. Our results showed that Levodopa alone or in combination with carbidopa caused genotoxicity in in vivo micronucleus test (mouse bone marrow) and Comet assay (blood cells). Furthermore, we showed that simultaneous administration of uridine, a pyrimidine nucleoside, reversed the genotoxic effect of Levodopa and Carbidopa in both assays. Our data show for the first time that Levodopa plus carbidopa combination causes genotoxicity which is reversed by uridine treatment. These findings might enhance our understanding for the complications of a common Parkinson's treatment and confer benefit in terms of reducing a possible genotoxic effect of this treatment.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023033</affiliation-url><afid>60023033</afid><affilname>Adnan Menderes Universitesi</affilname><name-variant>Adnan Menderes University</name-variant><affiliation-city>Aydin</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009425</affiliation-url><afid>60009425</afid><affilname>Uludag Universitesi</affilname><name-variant>Uludag University</name-variant><affiliation-city>Bursa</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009425</affiliation-url><afid>60009425</afid><affilname>Uludag Universitesi</affilname><name-variant>Uludag University</name-variant><affiliation-city>Bursa</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56648094100</author-url><authid>56648094100</authid><authname>Orenlili Yaylagul E.</authname><surname>Orenlili Yaylagul</surname><given-name>Esra</given-name><initials>E.</initials><afid>60023033</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8872816100</author-url><authid>8872816100</authid><authname>Cansev M.</authname><surname>Cansev</surname><given-name>Mehmet</given-name><initials>M.</initials><afid>60009425</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56422264200</author-url><authid>56422264200</authid><authname>Celikler Kasimogullari S.</authname><surname>Celikler Kasimogullari</surname><given-name>Serap</given-name><initials>S.</initials><afid>60009425</afid></author><authkeywords>Carbidopa | Comet | Genotoxicity | Levodopa | Micronuclei | Uridine</authkeywords><intid>535965074</intid><source-id>25096</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929399677"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929399677?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929399677&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929399677&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0963996915002082"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929399677</prism:url><dc:identifier>SCOPUS_ID:84929399677</dc:identifier><eid>2-s2.0-84929399677</eid><dc:title>Factors affecting the rheological properties of a structured cellular solid used as a fat mimetic</dc:title><dc:creator>Blake A.</dc:creator><prism:publicationName>Food Research International</prism:publicationName><prism:issn>09639969</prism:issn><prism:volume>74</prism:volume><prism:pageRange>284-293</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.foodres.2015.04.045</prism:doi><pii>S0963996915002082</pii><dc:description>© 2015 Elsevier Ltd. The effects of water content, monoglyceride chain length and concentration, oil type, and the addition of oil-phase and water-phase additives on the elastic modulus and yield stress of a structured oil in water were evaluated. The goal was to increase the elastic modulus of the original emulsion from 8.42×10&lt;sup&gt;3&lt;/sup&gt;±11.3Pa to 1.55×10&lt;sup&gt;6&lt;/sup&gt;±2.1×10&lt;sup&gt;5&lt;/sup&gt;Pa, and the yield stress from 112±2.31Pa to 835±227Pa. The addition of wax at greater than 10% (w/w), the use of palm oil or the gelation of the liquid oil phase with 5-7.5% rice bran wax, the use of C-18 saturated monoglyceride at 6%(w/w), and 4% (w/w) for C-22 saturated monoglyceride molecules were effective modifications capable of improving the mechanical behavior of the emulsion so that it can be used as a zero trans and reduced saturated fat laminating shortening substitute for puff pastry products.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015881</affiliation-url><afid>60015881</afid><affilname>University of Guelph</affilname><name-variant>University of Guelph</name-variant><affiliation-city>Guelph</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56029241900</author-url><authid>56029241900</authid><authname>Blake A.</authname><surname>Blake</surname><given-name>Alexia I.</given-name><initials>A.I.</initials><afid>60015881</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7005543720</author-url><authid>7005543720</authid><authname>Marangoni A.</authname><surname>Marangoni</surname><given-name>Alejandro G.</given-name><initials>A.G.</initials><afid>60015881</afid></author><authkeywords>Cellular solid | Laminate fat | Monoglyceride | Oleogel | Rheology | Shortening</authkeywords><intid>1535955648</intid><source-id>23180</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928396841"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928396841?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928396841&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928396841&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0028390815001264"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928396841</prism:url><dc:identifier>SCOPUS_ID:84928396841</dc:identifier><eid>2-s2.0-84928396841</eid><dc:title>Possible inhibitory role of endogenous 2-arachidonoylglycerol as an endocannabinoid in (±)-epibatidine-induced activation of central adrenomedullary outflow in the rat</dc:title><dc:creator>Shimizu T.</dc:creator><prism:publicationName>Neuropharmacology</prism:publicationName><prism:issn>00283908</prism:issn><prism:eIssn>18737064</prism:eIssn><prism:volume>95</prism:volume><prism:pageRange>278-289</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.neuropharm.2015.03.034</prism:doi><pii>S0028390815001264</pii><dc:description>© 2015 Elsevier Ltd. All rights reserved. We previously reported that intracerebroventricularly (i.c.v.) administered (±)-epibatidine (1, 5 or 10 nmol/animal), a nicotinic acetylcholine receptor agonist, dose-dependently induced secretion of noradrenaline and adrenaline (catecholamines) from the rat adrenal medulla by brain diacylglycerol lipase- (DGL), monoacylglycerol lipase- (MGL) and cyclooxygenase-mediated mechanisms. Diacylglycerol is hydrolyzed by DGL into 2-arachidonoylglycerol (2-AG), which is further hydrolyzed by MGL to arachidonic acid (AA), a cyclooxygenase substrate. These findings suggest that brain 2-AG-derived AA is involved in the (±)-epibatidine-induced response. This AA precursor 2-AG is also a major brain endocannabinoid, which inhibits synaptic transmission through presynaptic cannabinoid CB&lt;inf&gt;1&lt;/inf&gt; receptors. Released 2-AG into the synaptic cleft is rapidly inactivated by cellular uptake. Here, we examined a role of brain 2-AG as an endocannabinoid in the (±)-epibatidine-induced activation of central adrenomedullary outflow using anesthetized male Wistar rats. In central presence of AM251 (CB&lt;inf&gt;1&lt;/inf&gt; antagonist) (90 and 180 nmol/animal, i.c.v.), (±)-epibatidine elevated plasma catecholamines even at an ineffective dose (1 nmol/animal, i.c.v.). Central pretreatment with ACEA (CB&lt;inf&gt;1&lt;/inf&gt; agonist) (0.7 and 1.4 μmol/animal, i.c.v.), 2-AG ether (stable 2-AG analog for MGL) (0.5 and 1.0 μmol/animal, i.c.v.) or AM404 (endocannabinoid uptake inhibitor) (80 and 250 nmol/animal, i.c.v.) significantly reduced an effective dose of (±)-epibatidine- (5 nmol/animal, i.c.v.) induced elevation of plasma catecholamines, and AM251 (90 and 180 nmol/animal, i.c.v.) centrally abolished the reduction induced by 2-AG ether (1.0 μmol/animal, i.c.v.) or AM404 (250 nmol/animal, i.c.v.). Immunohistochemical studies demonstrated that (±)-epibatidine (10 nmol/animal, i.c.v.) activated DGLα-positive spinally projecting neurons in the hypothalamic paraventricular nucleus, a control center of central adrenomedullary system. These results suggest a possibility that a brain endocannabinoid, probably 2-AG, plays an inhibitory role in (±)-epibatidine-induced activation of central adrenomedullary outflow through brain CB&lt;inf&gt;1&lt;/inf&gt; receptors in the rat.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013623</affiliation-url><afid>60013623</afid><affilname>Kochi University</affilname><name-variant>Kochi University</name-variant><affiliation-city>Kochi</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013623</affiliation-url><afid>60013623</afid><affilname>Kochi University</affilname><name-variant>Kochi University</name-variant><affiliation-city>Kochi</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013623</affiliation-url><afid>60013623</afid><affilname>Kochi University</affilname><name-variant>Kochi University</name-variant><affiliation-city>Kochi</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013623</affiliation-url><afid>60013623</afid><affilname>Kochi University</affilname><name-variant>Kochi University</name-variant><affiliation-city>Kochi</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7408148894</author-url><authid>7408148894</authid><authname>Shimizu T.</authname><surname>Shimizu</surname><given-name>Takahiro</given-name><initials>T.</initials><afid>60013623</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55741459500</author-url><authid>55741459500</authid><authname>Tanaka K.</authname><surname>Tanaka</surname><given-name>Kenjiro</given-name><initials>K.</initials><afid>60013623</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56513053400</author-url><authid>56513053400</authid><authname>Shimizu S.</authname><surname>Shimizu</surname><given-name>Shogo</given-name><initials>S.</initials><afid>60013623</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56513305400</author-url><authid>56513305400</authid><authname>Higashi Y.</authname><surname>Higashi</surname><given-name>Youichirou</given-name><initials>Y.</initials><afid>60013623</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6603444893</author-url><authid>6603444893</authid><authname>Yawata T.</authname><surname>Yawata</surname><given-name>Toshio</given-name><initials>T.</initials><afid>60013623</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55964231400</author-url><authid>55964231400</authid><authname>Nakamura K.</authname><surname>Nakamura</surname><given-name>Kumiko</given-name><initials>K.</initials><afid>60013623</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7006829713</author-url><authid>7006829713</authid><authname>Taniuchi K.</authname><surname>Taniuchi</surname><given-name>Keisuke</given-name><initials>K.</initials><afid>60013623</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6602834255</author-url><authid>6602834255</authid><authname>Ueba T.</authname><surname>Ueba</surname><given-name>Tetsuya</given-name><initials>T.</initials><afid>60013623</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56265723300</author-url><authid>56265723300</authid><authname>Yuri K.</authname><surname>Yuri</surname><given-name>Kazunari</given-name><initials>K.</initials><afid>60013623</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56428312600</author-url><authid>56428312600</authid><authname>Saito M.</authname><surname>Saito</surname><given-name>Motoaki</given-name><initials>M.</initials><afid>60013623</afid></author><authkeywords>(±)-Epibatidine | 2-Arachidonoylglycerol | Brain | Cannabinoid CB&lt;inf&gt;1&lt;/inf&gt; receptor | Central adrenomedullary outflow | Endocannabinoid</authkeywords><intid>535780182</intid><source-id>20435</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929318149"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929318149?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929318149&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929318149&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0014480015000891"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929318149</prism:url><dc:identifier>SCOPUS_ID:84929318149</dc:identifier><eid>2-s2.0-84929318149</eid><dc:title>Association of mutations in the mitochondrial genome with the subclinical carotid atherosclerosis in women</dc:title><dc:creator>Sazonova M.</dc:creator><prism:publicationName>Experimental and Molecular Pathology</prism:publicationName><prism:issn>00144800</prism:issn><prism:eIssn>10960945</prism:eIssn><prism:volume>99</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>25-32</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yexmp.2015.04.003</prism:doi><pii>S0014480015000891</pii><dc:description>© 2015 Elsevier Inc. The importance of the study of an association of mitochondrial DNA mutations with asymptomatic atherosclerosis in women is undeniable. In the present study, a series of PCR with primers for mutation region and further amplificate pyrosequencing were carried out to identify point substitutions or microdeletions of the mitochondrial genome. The results obtained were processed using the original method of estimating the level of heteroplasmy. Five mutations in the mitochondrial genome, namely C3256T, G14709A, G12315A, G13513A and G14846A, in which the heteroplasmy level was associated with the degree of preclinical atherosclerosis in women, were identified. The data obtained in the study showed that C3256T, G14709A and G12315A mutations have a positive correlation with atherosclerosis while G13513A and G14846A mutations have a negative correlation with atherosclerotic lesions. Total mutational load of the mitochondrial genome for C3256T, G14709A, G12315A, G13513A and G14846A mutations explains 68% of the variability of thickness of the carotid intima-medial layer, while the complex of traditional risk factors for cardiovascular diseases explains only 8% of the IMT variability. Data on the correlation between heteroplasmy levels of C3256T, G14709A, G12315A, G13513A and G14846A mutations prompt a suggestion that these mutations may be present on the same haplotypes of mitochondrial genome, associated with atherosclerosis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101042998</affiliation-url><afid>101042998</afid><affilname>Russian Cardiology Research and Production Complex</affilname><name-variant>Russian Cardiology Research-and-Production Complex</name-variant><affiliation-city>Moscow</affiliation-city><affiliation-country>Russian Federation</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100314332</affiliation-url><afid>100314332</afid><affilname>Institute of General Pathology and Pathophysiology</affilname><name-variant>Institute of General Pathology and Pathophysiology</name-variant><affiliation-city>Moscow</affiliation-city><affiliation-country>Russian Federation</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028333</affiliation-url><afid>60028333</afid><affilname>University of New South Wales (UNSW) Australia</affilname><name-variant>University of New South Wales</name-variant><affiliation-city>Sydney</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017803</affiliation-url><afid>60017803</afid><affilname>University of Western Sydney</affilname><name-variant>University of Western Sydney</name-variant><affiliation-city>Penrith</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112627862</affiliation-url><afid>112627862</afid><affilname>Skolkovo Innovative Centre</affilname><name-variant>Skolkovo Innovative Centre</name-variant><affiliation-city>Moscow</affiliation-city><affiliation-country>Russian Federation</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007457</affiliation-url><afid>60007457</afid><affilname>Lomonosov Moscow State University</affilname><name-variant>Moscow State University</name-variant><affiliation-city>Moscow</affiliation-city><affiliation-country>Russian Federation</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602397114</author-url><authid>6602397114</authid><authname>Sazonova M.</authname><surname>Sazonova</surname><given-name>Margarita A.</given-name><initials>M.A.</initials><afid>101042998</afid><afid>100314332</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602397114</author-url><authid>6602397114</authid><authname>Sazonova M.</authname><surname>Sazonova</surname><given-name>Margarita A.</given-name><initials>M.A.</initials><afid>101042998</afid><afid>100314332</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644655300</author-url><authid>56644655300</authid><authname>Chicheva M.</authname><surname>Chicheva</surname><given-name>Mariya M.</given-name><initials>M.M.</initials><afid>101042998</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55372083100</author-url><authid>55372083100</authid><authname>Zhelankin A.</authname><surname>Zhelankin</surname><given-name>Andrey V.</given-name><initials>A.V.</initials><afid>101042998</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7004029063</author-url><authid>7004029063</authid><authname>Sobenin I.</authname><surname>Sobenin</surname><given-name>Igor A.</given-name><initials>I.A.</initials><afid>101042998</afid><afid>100314332</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7004029063</author-url><authid>7004029063</authid><authname>Sobenin I.</authname><surname>Sobenin</surname><given-name>Igor A.</given-name><initials>I.A.</initials><afid>101042998</afid><afid>100314332</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7006463929</author-url><authid>7006463929</authid><authname>Bobryshev Y.</authname><surname>Bobryshev</surname><given-name>Yuri V.</given-name><initials>Y.V.</initials><afid>100314332</afid><afid>60028333</afid><afid>60017803</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7006463929</author-url><authid>7006463929</authid><authname>Bobryshev Y.</authname><surname>Bobryshev</surname><given-name>Yuri V.</given-name><initials>Y.V.</initials><afid>100314332</afid><afid>60028333</afid><afid>60017803</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7006463929</author-url><authid>7006463929</authid><authname>Bobryshev Y.</authname><surname>Bobryshev</surname><given-name>Yuri V.</given-name><initials>Y.V.</initials><afid>100314332</afid><afid>60028333</afid><afid>60017803</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7102417184</author-url><authid>7102417184</authid><authname>Orekhov A.</authname><surname>Orekhov</surname><given-name>Alexander N.</given-name><initials>A.N.</initials><afid>100314332</afid><afid>112627862</afid><afid>60007457</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7102417184</author-url><authid>7102417184</authid><authname>Orekhov A.</authname><surname>Orekhov</surname><given-name>Alexander N.</given-name><initials>A.N.</initials><afid>100314332</afid><afid>112627862</afid><afid>60007457</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7102417184</author-url><authid>7102417184</authid><authname>Orekhov A.</authname><surname>Orekhov</surname><given-name>Alexander N.</given-name><initials>A.N.</initials><afid>100314332</afid><afid>112627862</afid><afid>60007457</afid></author><authkeywords>Atherosclerosis | Heteroplasmy level | Mitochondria | Mitochondrial genome | Mutations</authkeywords><intid>1035940179</intid><source-id>13247</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84921488499"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84921488499?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84921488499&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84921488499&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915014011629"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84921488499</prism:url><dc:identifier>SCOPUS_ID:84921488499</dc:identifier><eid>2-s2.0-84921488499</eid><dc:title>Low dose aspirin is associated with plasma chemerin levels and may reduce adipose tissue inflammation</dc:title><dc:creator>Herová M.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>256-262</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2014.05.912</prism:doi><pii>S0021915014011629</pii><dc:description>© 2014 Elsevier Ireland Ltd. Chemerin is a peptide chemoattractant for macrophages and an adipokine regulating adipocyte differentiation and metabolism. Plasma chemerin is increased in chronic inflammatory diseases and in obesity. As inflammation and obesity are risk factors for coronary artery disease (CAD), we investigated possible associations of plasma chemerin with inflammatory markers and atherosclerosis in a CAD case-control study (. n=. 470). Chemerin levels were associated with C-reactive protein, BMI and LDL levels, and negatively associated with HDL levels. Mean plasma chemerin levels were similar in controls and CAD patients but significantly higher in CAD patients not taking low dose aspirin. To investigate the mechanism of chemerin reduction by aspirin, we analyzed chemerin expression in hepatocytes and adipocytes treated with aspirin in the presence and absence of inflammatory cytokines. Chemerin expression was upregulated by pro-inflammatory stimuli in adipocytes but not in hepatocytes. Treatment of stimulated hepatocytes and adipocytes with aspirin did not affect chemerin expression. However, treatment of inflammatory M1 macrophages with aspirin reduced secretion of the pro-inflammatory cytokines IL-1β and IL-6, and increased secretion of the anti-inflammatory IL-10. In summary, we show that plasma chemerin levels are associated with markers of inflammation and that they are significantly higher in CAD patients not treated with low dose aspirin. In addition, we show that low dose aspirin treatment reduces pro-inflammatory cytokine secretion by macrophages, which may lead to reduced chemerin secretion by adipocytes and may be a reason for the lower chemerin levels in the circulation of CAD patients on low dose aspirin.</dc:description><citedby-count>3</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002695</affiliation-url><afid>60002695</afid><affilname>Kinderspital Zurich</affilname><name-variant>University Children's Hospital</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002695</affiliation-url><afid>60002695</afid><affilname>Kinderspital Zurich</affilname><name-variant>University Children's Hospital</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012614</affiliation-url><afid>60012614</afid><affilname>Universitat Zurich</affilname><name-variant>University of Zurich</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><pubmed-id>24880897</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16679028200</author-url><authid>16679028200</authid><authname>Herová M.</authname><surname>Herová</surname><given-name>Magdalena</given-name><initials>M.</initials><afid>60002695</afid><afid>60002695</afid><afid>60012614</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16679028200</author-url><authid>16679028200</authid><authname>Herová M.</authname><surname>Herová</surname><given-name>Magdalena</given-name><initials>M.</initials><afid>60002695</afid><afid>60002695</afid><afid>60012614</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16679028200</author-url><authid>16679028200</authid><authname>Herová M.</authname><surname>Herová</surname><given-name>Magdalena</given-name><initials>M.</initials><afid>60002695</afid><afid>60002695</afid><afid>60012614</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:54977074100</author-url><authid>54977074100</authid><authname>Schmid M.</authname><surname>Schmid</surname><given-name>Mattia</given-name><initials>M.</initials><afid>60002695</afid><afid>60002695</afid><afid>60012614</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:54977074100</author-url><authid>54977074100</authid><authname>Schmid M.</authname><surname>Schmid</surname><given-name>Mattia</given-name><initials>M.</initials><afid>60002695</afid><afid>60002695</afid><afid>60012614</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:54977074100</author-url><authid>54977074100</authid><authname>Schmid M.</authname><surname>Schmid</surname><given-name>Mattia</given-name><initials>M.</initials><afid>60002695</afid><afid>60002695</afid><afid>60012614</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:54978361700</author-url><authid>54978361700</authid><authname>Gemperle C.</authname><surname>Gemperle</surname><given-name>Claudio</given-name><initials>C.</initials><afid>60002695</afid><afid>60002695</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:54978361700</author-url><authid>54978361700</authid><authname>Gemperle C.</authname><surname>Gemperle</surname><given-name>Claudio</given-name><initials>C.</initials><afid>60002695</afid><afid>60002695</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55352881900</author-url><authid>55352881900</authid><authname>Loretz C.</authname><surname>Loretz</surname><given-name>Christa</given-name><initials>C.</initials><afid>60002695</afid><afid>60002695</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55352881900</author-url><authid>55352881900</authid><authname>Loretz C.</authname><surname>Loretz</surname><given-name>Christa</given-name><initials>C.</initials><afid>60002695</afid><afid>60002695</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6701764926</author-url><authid>6701764926</authid><authname>Hersberger M.</authname><surname>Hersberger</surname><given-name>Martin</given-name><initials>M.</initials><afid>60002695</afid><afid>60002695</afid><afid>60012614</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6701764926</author-url><authid>6701764926</authid><authname>Hersberger M.</authname><surname>Hersberger</surname><given-name>Martin</given-name><initials>M.</initials><afid>60002695</afid><afid>60002695</afid><afid>60012614</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6701764926</author-url><authid>6701764926</authid><authname>Hersberger M.</authname><surname>Hersberger</surname><given-name>Martin</given-name><initials>M.</initials><afid>60002695</afid><afid>60002695</afid><afid>60012614</afid></author><authkeywords>Adipose tissue inflammation | Chemerin | Coronary artery disease | Obesity</authkeywords><intid>1034649072</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929177875"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929177875?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929177875&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929177875&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0014480015000969"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929177875</prism:url><dc:identifier>SCOPUS_ID:84929177875</dc:identifier><eid>2-s2.0-84929177875</eid><dc:title>Plancitoxin I from the venom of crown-of-thorns starfish (Acanthaster planci) induces oxidative and endoplasmic reticulum stress associated cytotoxicity in A375.S2 cells</dc:title><dc:creator>Lee C.</dc:creator><prism:publicationName>Experimental and Molecular Pathology</prism:publicationName><prism:issn>00144800</prism:issn><prism:eIssn>10960945</prism:eIssn><prism:volume>99</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>7-15</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yexmp.2015.05.001</prism:doi><pii>S0014480015000969</pii><dc:description>© 2015 Elsevier Inc. The crown-of-thorns starfish Acanthaster planci is a venomous starfish whose venom provokes strong cytotoxicity. In the present study, the purified cytotoxic toxin of A. planci venom (CAV) was identified as plancitoxin I protein by mass spectrum analyses. This study aims to investigate the molecular mechanism underlying the cytotoxicity function of plancitoxin I by focusing on the oxidative stress, mitochondrial dysfunction and endoplasmic reticulum (ER) stress pathway in human melanoma A375.S2 cells. The results indicated that after being treated with CAV toxin, A375.S2 cells significantly decreased viability in a dose-dependent manner. The CAV was found to reduce the cellular antioxidant enzymes such as SOD and CAT, and there was a significant decrease in total thiol level and mtDNA integrity, and it enhanced the lipid peroxidation. In addition, CAV increased cytosolic Ca&lt;sup&gt;2+&lt;/sup&gt; concentration, and enhanced the expression of the ER molecular chaperones GRP78 and CHOP in a dose-dependent manner. CAV significantly elevated the activity of caspase-3, -8 and -9, and reduced the ratio of Bcl-2/Bax. The cells exhibited apoptosis were determined by using propidium iodide (PI) staining of DNA fragmentation (sub-G1 peak). In summary, the results demonstrated that plancitoxin I inhibits the proliferation of A375.S2 cells through induction of oxidative stress, mitochondrial dysfunction and ER stress associated apoptosis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023529</affiliation-url><afid>60023529</afid><affilname>National Taiwan Ocean University</affilname><name-variant>National Taiwan Ocean University</name-variant><affiliation-city>Keelung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60075699</affiliation-url><afid>60075699</afid><affilname>Council of Agriculture Taiwan</affilname><name-variant>Council of Agriculture</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60072429</affiliation-url><afid>60072429</afid><affilname>Asia University Taiwan</affilname><name-variant>Asia University</name-variant><affiliation-city>Wufong</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55807020300</author-url><authid>55807020300</authid><authname>Lee C.</authname><surname>Lee</surname><given-name>Chi Chiu</given-name><initials>C.C.</initials><afid>60023529</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:17340625000</author-url><authid>17340625000</authid><authname>Hsieh H.</authname><surname>Hsieh</surname><given-name>Hernyi Justin</given-name><initials>H.J.</initials><afid>60075699</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56424656900</author-url><authid>56424656900</authid><authname>Hsieh C.</authname><surname>Hsieh</surname><given-name>Cheng Hong</given-name><initials>C.H.</initials><afid>60072429</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35233469400</author-url><authid>35233469400</authid><authname>Hwang D.</authname><surname>Hwang</surname><given-name>Deng Fwu</given-name><initials>D.F.</initials><afid>60023529</afid><afid>60072429</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35233469400</author-url><authid>35233469400</authid><authname>Hwang D.</authname><surname>Hwang</surname><given-name>Deng Fwu</given-name><initials>D.F.</initials><afid>60023529</afid><afid>60072429</afid></author><authkeywords>A375.S2 cell | Crown-of-thorns starfish Acanthaster planci | Endoplasmic reticulum (ER) stress | Oxidative stress | Plancitoxin I</authkeywords><intid>1785918548</intid><source-id>13247</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926469800"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926469800?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926469800&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926469800&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0304389415002691"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926469800</prism:url><dc:identifier>SCOPUS_ID:84926469800</dc:identifier><eid>2-s2.0-84926469800</eid><dc:title>Toxicity assessment due to sub-chronic exposure to individual and mixtures of four toxic heavy metals</dc:title><dc:creator>Cobbina S.</dc:creator><prism:publicationName>Journal of Hazardous Materials</prism:publicationName><prism:issn>03043894</prism:issn><prism:eIssn>18733336</prism:eIssn><prism:volume>294</prism:volume><prism:pageRange>109-120</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jhazmat.2015.03.057</prism:doi><pii>S0304389415002691</pii><dc:description>© 2015 Elsevier B.V. Humans are exposed to a cocktail of heavy metal toxicants in the environment. Though heavy metals are deleterious, there is a paucity of information on toxicity of low dose mixtures. In this study, lead (Pb) (0.01. mg/L), mercury (Hg) (0.001. mg/L), cadmium (Cd) (0.005. mg/L) and arsenic (As) (0.01. mg/L) were administered individually and as mixtures to 10 groups of 40 three-week old mice (20 males and 20 females), for 120 days. The study established that low dose exposures induced toxicity to the brain, liver, and kidney of mice. Metal mixtures showed higher toxicities compared to individual metals, as exposure to low dose Pb. +. Hg. +. Cd reduced brain weight and induced structural lesions, such as neuronal degeneration in 30-days. Pb. +. Hg. +. Cd and Pb. +. Hg. +. As. +. Cd exposure induced hepatocellular injury to mice evidenced by decreased antioxidant activities with marginal increases in MDA. These were accentuated by increases in ALT, AST and ALP. Interactions in metal mixtures were basically synergistic in nature and exposure to Pb. +. Hg. +. As. +. Cd induced renal tubular necrosis in kidneys of mice. This study underlines the importance of elucidating the toxicity of low dose metal mixtures so as to protect public health.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017482</affiliation-url><afid>60017482</afid><affilname>Jiangsu University</affilname><name-variant>Jiangsu University</name-variant><affiliation-city>Zhenjiang</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017482</affiliation-url><afid>60017482</afid><affilname>Jiangsu University</affilname><name-variant>Jiangsu University</name-variant><affiliation-city>Zhenjiang</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017482</affiliation-url><afid>60017482</afid><affilname>Jiangsu University</affilname><name-variant>Jiangsu University</name-variant><affiliation-city>Zhenjiang</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017482</affiliation-url><afid>60017482</afid><affilname>Jiangsu University</affilname><name-variant>Jiangsu University</name-variant><affiliation-city>Zhenjiang</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:26654761400</author-url><authid>26654761400</authid><authname>Cobbina S.</authname><surname>Cobbina</surname><given-name>Samuel J.</given-name><initials>S.J.</initials><afid>60017482</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56377426200</author-url><authid>56377426200</authid><authname>Chen Y.</authname><surname>Chen</surname><given-name>Yao</given-name><initials>Y.</initials><afid>60017482</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56047776700</author-url><authid>56047776700</authid><authname>Zhou Z.</authname><surname>Zhou</surname><given-name>Zhaoxiang</given-name><initials>Z.</initials><afid>60017482</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55877425800</author-url><authid>55877425800</authid><authname>Wu X.</authname><surname>Wu</surname><given-name>Xueshan</given-name><initials>X.</initials><afid>60017482</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56430322200</author-url><authid>56430322200</authid><authname>Zhao T.</authname><surname>Zhao</surname><given-name>Ting</given-name><initials>T.</initials><afid>60017482</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56229875400</author-url><authid>56229875400</authid><authname>Zhang Z.</authname><surname>Zhang</surname><given-name>Zhen</given-name><initials>Z.</initials><afid>60017482</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56460707700</author-url><authid>56460707700</authid><authname>Feng W.</authname><surname>Feng</surname><given-name>Weiwei</given-name><initials>W.</initials><afid>60017482</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56460796100</author-url><authid>56460796100</authid><authname>Wang W.</authname><surname>Wang</surname><given-name>Wei</given-name><initials>W.</initials><afid>60017482</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56460509600</author-url><authid>56460509600</authid><authname>Li Q.</authname><surname>Li</surname><given-name>Qian</given-name><initials>Q.</initials><afid>60017482</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7407063569</author-url><authid>7407063569</authid><authname>Wu X.</authname><surname>Wu</surname><given-name>Xiangyang</given-name><initials>X.</initials><afid>60017482</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:55732912600</author-url><authid>55732912600</authid><authname>Yang L.</authname><surname>Yang</surname><given-name>Liuqing</given-name><initials>L.</initials><afid>60017482</afid></author><authkeywords>Low dose | Metal mixture | Multivariate | Oxidative stress | Toxicity</authkeywords><intid>535455137</intid><source-id>25858</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84920268667"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84920268667?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84920268667&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84920268667&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0958166914002225"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84920268667</prism:url><dc:identifier>SCOPUS_ID:84920268667</dc:identifier><eid>2-s2.0-84920268667</eid><dc:title>A nexus for cellular homeostasis: The interplay between metabolic and signal transduction pathways</dc:title><dc:creator>Gomes A.</dc:creator><prism:publicationName>Current Opinion in Biotechnology</prism:publicationName><prism:issn>09581669</prism:issn><prism:eIssn>18790429</prism:eIssn><prism:volume>34</prism:volume><prism:pageRange>110-117</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.copbio.2014.12.007</prism:doi><pii>S0958166914002225</pii><dc:description>© 2014 Elsevier Ltd. In multicellular organisms, individual cells have evolved to sense external and internal cues in order to maintain cellular homeostasis and survive under different environmental conditions. Cells efficiently adjust their metabolism to reflect the abundance of nutrients, energy and growth factors. The ability to rewire cellular metabolism between anabolic and catabolic processes is crucial for cells to thrive. Thus, cells have developed, through evolution, metabolic networks that are highly plastic and tightly regulated to meet the requirements necessary to maintain cellular homeostasis. The plasticity of these cellular systems is tightly regulated by complex signaling networks that integrate the intracellular and extracellular information. The coordination of signal transduction and metabolic pathways is essential in maintaining a healthy and rapidly responsive cellular state.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007997</affiliation-url><afid>60007997</afid><affilname>Weill Cornell Medical College</affilname><name-variant>Cornell University Medical College</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007997</affiliation-url><afid>60007997</afid><affilname>Weill Cornell Medical College</affilname><name-variant>Cornell University Medical College</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002746</affiliation-url><afid>60002746</afid><affilname>Harvard Medical School</affilname><name-variant>Harvard Medical School</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:25929167300</author-url><authid>25929167300</authid><authname>Gomes A.</authname><surname>Gomes</surname><given-name>Ana P.</given-name><initials>A.P.</initials><afid>60007997</afid><afid>60007997</afid><afid>60002746</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:25929167300</author-url><authid>25929167300</authid><authname>Gomes A.</authname><surname>Gomes</surname><given-name>Ana P.</given-name><initials>A.P.</initials><afid>60007997</afid><afid>60007997</afid><afid>60002746</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:25929167300</author-url><authid>25929167300</authid><authname>Gomes A.</authname><surname>Gomes</surname><given-name>Ana P.</given-name><initials>A.P.</initials><afid>60007997</afid><afid>60007997</afid><afid>60002746</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7005290821</author-url><authid>7005290821</authid><authname>Blenis J.</authname><surname>Blenis</surname><given-name>John</given-name><initials>J.</initials><afid>60007997</afid><afid>60007997</afid><afid>60002746</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7005290821</author-url><authid>7005290821</authid><authname>Blenis J.</authname><surname>Blenis</surname><given-name>John</given-name><initials>J.</initials><afid>60007997</afid><afid>60007997</afid><afid>60002746</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7005290821</author-url><authid>7005290821</authid><authname>Blenis J.</authname><surname>Blenis</surname><given-name>John</given-name><initials>J.</initials><afid>60007997</afid><afid>60007997</afid><afid>60002746</afid></author><intid>534451222</intid><source-id>15579</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929340079"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929340079?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929340079&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929340079&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006725"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929340079</prism:url><dc:identifier>SCOPUS_ID:84929340079</dc:identifier><eid>2-s2.0-84929340079</eid><dc:title>Author's reply to digoxin and risk of acute pancreatitis</dc:title><dc:creator>Lai S.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>36</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.409</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006988</affiliation-url><afid>60006988</afid><affilname>China Medical University Taichung</affilname><name-variant>China Medical University</name-variant><affiliation-city>Taichung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031941</affiliation-url><afid>60031941</afid><affilname>China Medical University Hospital Taichung</affilname><name-variant>China Medical University Hospital</name-variant><affiliation-city>Taichung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031941</affiliation-url><afid>60031941</afid><affilname>China Medical University Hospital Taichung</affilname><name-variant>China Medical University Hospital</name-variant><affiliation-city>Taichung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006988</affiliation-url><afid>60006988</afid><affilname>China Medical University Taichung</affilname><name-variant>China Medical University</name-variant><affiliation-city>Taichung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021326</affiliation-url><afid>60021326</afid><affilname>Buddhist Tzu-Chi General Hospital Taiwan</affilname><name-variant>Buddhist Dalin Tzu Chi General Hospital</name-variant><affiliation-city>Hualien</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7402935881</author-url><authid>7402935881</authid><authname>Lai S.</authname><surname>Lai</surname><given-name>Shih Wei</given-name><initials>S.W.</initials><afid>60006988</afid><afid>60031941</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7402935881</author-url><authid>7402935881</authid><authname>Lai S.</authname><surname>Lai</surname><given-name>Shih Wei</given-name><initials>S.W.</initials><afid>60006988</afid><afid>60031941</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56180975900</author-url><authid>56180975900</authid><authname>Lin C.</authname><surname>Lin</surname><given-name>Cheng Li</given-name><initials>C.L.</initials><afid>60006988</afid><afid>60031941</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56180975900</author-url><authid>56180975900</authid><authname>Lin C.</authname><surname>Lin</surname><given-name>Cheng Li</given-name><initials>C.L.</initials><afid>60006988</afid><afid>60031941</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:8203700400</author-url><authid>8203700400</authid><authname>Liao K.</authname><surname>Liao</surname><given-name>Kuan Fu</given-name><initials>K.F.</initials><afid>60006988</afid><afid>60021326</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:8203700400</author-url><authid>8203700400</authid><authname>Liao K.</authname><surname>Liao</surname><given-name>Kuan Fu</given-name><initials>K.F.</initials><afid>60006988</afid><afid>60021326</afid></author><authkeywords>Acute pancreatitis | Digoxin</authkeywords><intid>1785944932</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929340080"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929340080?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929340080&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929340080&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008013"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929340080</prism:url><dc:identifier>SCOPUS_ID:84929340080</dc:identifier><eid>2-s2.0-84929340080</eid><dc:title>Association of an inter-arm systolic blood pressure difference with all-cause and cardiovascular mortality: An updated meta-analysis of cohort studies</dc:title><dc:creator>Cao K.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>211-219</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.079</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Objective: To evaluate whether an association exists between an inter-arm systolic blood pressure difference (sIAD) and all-cause and cardiovascular mortality. Methods: We searched for cohort studies that evaluated the association of a sIAD and all-cause or cardiovascular mortality in the electronic databases Medline/PubMed and Embase (August 2014). Random effects models were used to calculate pooled hazard ratios (HRs) and 95% confidence intervals (CIs). Results: Nine cohort studies (4 prospective and 5 retrospective) enrolling 15,617 participants were included. The pooled HR of all-cause mortality for a sIAD of ≥ 10 mm Hg was 1.53 (95% CI 1.14-2.06), and that for a sIAD of ≥ 15 mm Hg was 1.46 (1.13-1.88). Pooled HRs of cardiovascular mortality were 2.21 (95% CI 1.52-3.21) for a sIAD of ≥ 10 mm Hg, and 1.89 (1.32-2.69) for a sIAD of ≥ 15 mm Hg. In the patient-based cohorts including hospital- and diabetes-based cohorts, both sIADs of ≥ 10 and ≥ 15 mm Hg were associated with increased all-cause (pooled HR 1.95, 95% CI 1.01-3.78 and 1.59, 1.06-2.38, respectively) and cardiovascular mortality (pooled HR 2.98, 95% CI 1.88-4.72 and 2.10, 1.07-4.13, respectively). In the community-based cohorts, however, only a sIAD of ≥ 15 mm Hg was associated with increased cardiovascular mortality (pooled HR 1.94, 95% CI 1.12-3.35). Conclusions: In the patient populations, a sIAD of ≥ 10 or of ≥ 15 mm Hg could be a useful indictor for increased all-cause and cardiovascular mortality, and a sIAD of ≥ 15 mm Hg might help to predict increased cardiovascular mortality in the community populations.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008332</affiliation-url><afid>60008332</afid><affilname>Nanchang University</affilname><name-variant>Nanchang University</name-variant><affiliation-city>Nanchang</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56010891200</author-url><authid>56010891200</authid><authname>Cao K.</authname><surname>Cao</surname><given-name>Kaiwu</given-name><initials>K.</initials><afid>60008332</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:50462531700</author-url><authid>50462531700</authid><authname>Xu J.</authname><surname>Xu</surname><given-name>Jingsong</given-name><initials>J.</initials><afid>60008332</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644613400</author-url><authid>56644613400</authid><authname>Shangguan Q.</authname><surname>Shangguan</surname><given-name>Qing</given-name><initials>Q.</initials><afid>60008332</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55490595300</author-url><authid>55490595300</authid><authname>Hu W.</authname><surname>Hu</surname><given-name>Weitong</given-name><initials>W.</initials><afid>60008332</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36062619700</author-url><authid>36062619700</authid><authname>Li P.</authname><surname>Li</surname><given-name>Ping</given-name><initials>P.</initials><afid>60008332</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35749641900</author-url><authid>35749641900</authid><authname>Cheng X.</authname><surname>Cheng</surname><given-name>Xiaoshu</given-name><initials>X.</initials><afid>60008332</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:15763681900</author-url><authid>15763681900</authid><authname>Su H.</authname><surname>Su</surname><given-name>Hai</given-name><initials>H.</initials><afid>60008332</afid></author><authkeywords>All-cause mortality | Cardiovascular mortality | Inter-arm systolic blood pressure difference | Meta-analysis</authkeywords><intid>1535944543</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929577601"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929577601?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929577601&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929577601&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S014181301500183X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929577601</prism:url><dc:identifier>SCOPUS_ID:84929577601</dc:identifier><eid>2-s2.0-84929577601</eid><dc:title>Chronotherapeutic drug delivery of Tamarind gum, Chitosan and Okra gum controlled release colon targeted directly compressed Propranolol HCl matrix tablets and in-vitro evaluation</dc:title><dc:creator>Newton A.</dc:creator><prism:publicationName>International Journal of Biological Macromolecules</prism:publicationName><prism:issn>01418130</prism:issn><prism:eIssn>18790003</prism:eIssn><prism:volume>79</prism:volume><prism:pageRange>290-299</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijbiomac.2015.03.031</prism:doi><pii>S014181301500183X</pii><dc:description>© 2015 Elsevier B.V. The main objective of this investigation is to develop a chronotherapeutic drug delivery of various natural polymers based colon targeted drug delivery systems to treat early morning sign in BP. The polymers such as Tamarind gum, Okra gum and Chitosan were used in the formulation design. A model drug Propranolol HCl was incorporated in the formulation in order to assess the controlled release and time dependent release potential of various natural polymers. A novel polymer Tamarind gum was extracted and used as a prime polymer in this study to prove the superiority of this polymer over other leading natural polymer. Propranolol HCl was used as a model drug which undergoes hepatic metabolism and witnesses the poor bioavailability. The matrix tablets of Propranolol HCl were prepared by direct compression. The tablets were evaluated for various quality control parameters and found to be within the limits. Carbopol 940 was used as an auxiliary polymer to modify the drug release and physicochemical characteristics of the tablets. The in vitro release studies were performed in 0.1N HCl for 1.5. h, followed by pH 6.8 phosphate buffer for 2. h and pH 7.4 phosphate buffer till maximum amount of drug release. The in vitro release profile of the formulations were fitted with various pharmacokinetic mathematical models and analyzed for release profile. The formulations prepared with Tamarind gum prolonged the release for an extended period of time compared to other polymer based formulation and showed an excellent compression characteristic.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115259674</affiliation-url><afid>115259674</afid><affilname>Rayat Bahra University</affilname><name-variant>Rayat Bahra University</name-variant><affiliation-city/><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:110585725</affiliation-url><afid>110585725</afid><affilname>Nirmala College of Pharmacy</affilname><name-variant>Nirmala College of Pharmacy</name-variant><affiliation-city>Andhrapradesh</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021891</affiliation-url><afid>60021891</afid><affilname>Jawaharlal Nehru Technological University</affilname><name-variant>Jawaharlal Nehru Technological University</name-variant><affiliation-city>Hyderabad</affiliation-city><affiliation-country>India</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55545379500</author-url><authid>55545379500</authid><authname>Newton A.</authname><surname>Newton</surname><given-name>A. M J</given-name><initials>A.M.J.</initials><afid>115259674</afid><afid>60021891</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55545379500</author-url><authid>55545379500</authid><authname>Newton A.</authname><surname>Newton</surname><given-name>A. M J</given-name><initials>A.M.J.</initials><afid>115259674</afid><afid>60021891</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56650906900</author-url><authid>56650906900</authid><authname>Indana V.</authname><surname>Indana</surname><given-name>V. L.</given-name><initials>V.L.</initials><afid>110585725</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7201862609</author-url><authid>7201862609</authid><authname>Kumar J.</authname><surname>Kumar</surname><given-name>Jatinder</given-name><initials>J.</initials><afid>115259674</afid></author><authkeywords>Chitosan and Propranolol HCl | Colonic delivery | Okra gum | Tamarind gum</authkeywords><intid>1035977574</intid><source-id>17544</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929346662"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929346662?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929346662&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929346662&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007986"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929346662</prism:url><dc:identifier>SCOPUS_ID:84929346662</dc:identifier><eid>2-s2.0-84929346662</eid><dc:title>Impact of moderate preoperative chronic kidney disease on mortality after transcatheter aortic valve implantation</dc:title><dc:creator>Gargiulo G.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>77-78</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.077</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017293</affiliation-url><afid>60017293</afid><affilname>Universita degli Studi di Napoli Federico II</affilname><name-variant>University of Naples Federico II</name-variant><affiliation-city>Naples</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010146</affiliation-url><afid>60010146</afid><affilname>Universita degli Studi di Catania</affilname><name-variant>Università di Catania</name-variant><affiliation-city>Catania</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:108728475</affiliation-url><afid>108728475</afid><affilname>Excellence Through Newest Advances (ETNA) Foundation</affilname><name-variant>Excellence Through Newest Advances (ETNA) Foundation</name-variant><affiliation-city>Catania</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7005046522</author-url><authid>7005046522</authid><authname>Gargiulo G.</authname><surname>Gargiulo</surname><given-name>Giuseppe</given-name><initials>G.</initials><afid>60017293</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:25642544700</author-url><authid>25642544700</authid><authname>Capodanno D.</authname><surname>Capodanno</surname><given-name>Davide</given-name><initials>D.</initials><afid>60010146</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36749696000</author-url><authid>36749696000</authid><authname>Sannino A.</authname><surname>Sannino</surname><given-name>Anna</given-name><initials>A.</initials><afid>60017293</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35293528300</author-url><authid>35293528300</authid><authname>Perrino C.</authname><surname>Perrino</surname><given-name>Cinzia</given-name><initials>C.</initials><afid>60017293</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:24472888200</author-url><authid>24472888200</authid><authname>Capranzano P.</authname><surname>Capranzano</surname><given-name>Piera</given-name><initials>P.</initials><afid>60010146</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6701371251</author-url><authid>6701371251</authid><authname>Stabile E.</authname><surname>Stabile</surname><given-name>Eugenio</given-name><initials>E.</initials><afid>60017293</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7103084272</author-url><authid>7103084272</authid><authname>Trimarco B.</authname><surname>Trimarco</surname><given-name>Bruno</given-name><initials>B.</initials><afid>60017293</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7006304483</author-url><authid>7006304483</authid><authname>Tamburino C.</authname><surname>Tamburino</surname><given-name>Corrado</given-name><initials>C.</initials><afid>60010146</afid><afid>108728475</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7006304483</author-url><authid>7006304483</authid><authname>Tamburino C.</authname><surname>Tamburino</surname><given-name>Corrado</given-name><initials>C.</initials><afid>60010146</afid><afid>108728475</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:55482395100</author-url><authid>55482395100</authid><authname>Esposito G.</authname><surname>Esposito</surname><given-name>Giovanni</given-name><initials>G.</initials><afid>60017293</afid></author><authkeywords>Aortic stenosis | Chronic kidney disease | Prognosis | Transcatheter aortic valve implantation</authkeywords><intid>535947388</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925120349"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925120349?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925120349&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925120349&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0926669015001211"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925120349</prism:url><dc:identifier>SCOPUS_ID:84925120349</dc:identifier><eid>2-s2.0-84925120349</eid><dc:title>An application of response surface methodology for optimizing coagulation process of raw industrial effluent using Cassia obtusifolia seed gum together with alum</dc:title><dc:creator>Subramonian W.</dc:creator><prism:publicationName>Industrial Crops and Products</prism:publicationName><prism:issn>09266690</prism:issn><prism:volume>70</prism:volume><prism:pageRange>107-115</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.indcrop.2015.02.026</prism:doi><pii>S0926669015001211</pii><dc:description>© 2015 Elsevier B.V. Coagulation is effective, simple to operate, and widely used in treatment of industrial effluent. However, commonly used inorganic coagulants pose detrimental effects on human health and living organisms in long run, and generate large amount of toxic sludge. Thus, this study investigated the optimized use of Cassia obtusifolia alone or combination of alum with lower dosages in treatment of industrial effluent. In this study, raw pulp and paper mill effluent (PPME) was used as a model wastewater in confirming the potential use of C. obtusifolia seed gum as a plant-based coagulant or coagulant aid together with the alum. Response surface methodology (RSM) enabled the study of interactive effects between operating treatment conditions, and to determine the optimal treatment conditions. The analysis of variance results obtained in the present study reflected significant quadratic models and strong correlations between operating conditions and treatment performance. In addition, current findings suggested that the coagulation mechanisms using C. obtusifolia seed gum together with the alum were most likely based on adsorption with inter-particle bridging and charge neutralization. Floc characterization also showed distinctive results, indicating the presence of active functional groups and the thermal stability of floc formed using C. obtusifolia seed gum and alum. Using RSM, optimal dosages of 0.17 and 0.09. g/L of C. obtusifolia seed gum and alum, respectively were required to achieve maximum total suspended solids and chemical oxygen demand removals (89.6 and 55.4%, respectively) under natural pH of raw PPME and slow-mixing time of 3.40. min. By combining the use of both coagulants, coagulant dosages of C. obtusifolia seed gum and alum could be reduced up to 90.5 and 62.5%, respectively. The present study revealed C. obtusifolia seed gum could be used as a potential plant-based coagulant or coagulant aid in treatment of raw and complex industrial effluent together with reduced dosage of alum.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018894</affiliation-url><afid>60018894</afid><affilname>Monash University Malaysia</affilname><name-variant>Monash University</name-variant><affiliation-city>Bandar Sunway</affiliation-city><affiliation-country>Malaysia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56072276300</author-url><authid>56072276300</authid><authname>Subramonian W.</authname><surname>Subramonian</surname><given-name>Wennie</given-name><initials>W.</initials><afid>60018894</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35189784000</author-url><authid>35189784000</authid><authname>Wu T.</authname><surname>Wu</surname><given-name>Ta Yeong</given-name><initials>T.Y.</initials><afid>60018894</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:14033846200</author-url><authid>14033846200</authid><authname>Chai S.</authname><surname>Chai</surname><given-name>Siang Piao</given-name><initials>S.P.</initials><afid>60018894</afid></author><authkeywords>Coagulant aid | Floc | Natural coagulant | Primary treatment | Pulp and paper mill effluent | Wastewater treatment</authkeywords><intid>2035261599</intid><source-id>32791</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927550323"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927550323?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927550323&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927550323&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0042682215001804"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927550323</prism:url><dc:identifier>SCOPUS_ID:84927550323</dc:identifier><eid>2-s2.0-84927550323</eid><dc:title>Exosomes in human semen restrict HIV-1 transmission by vaginal cells and block intravaginal replication of LP-BM5 murine AIDS virus complex</dc:title><dc:creator>Madison M.</dc:creator><prism:publicationName>Virology</prism:publicationName><prism:issn>00426822</prism:issn><prism:eIssn>10960341</prism:eIssn><prism:volume>482</prism:volume><prism:pageRange>189-201</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.virol.2015.03.040</prism:doi><pii>S0042682215001804</pii><dc:description>© 2015 Elsevier Inc. Exosomes are membranous extracellular nanovesicles secreted by diverse cell types. Exosomes from healthy human semen have been shown to inhibit HIV-1 replication and to impair progeny virus infectivity. In this study, we examined the ability of healthy human semen exosomes to restrict HIV-1 and LP-BM5 murine AIDS virus transmission in three different model systems. We show that vaginal cells internalize exosomes with concomitant transfer of functional mRNA. Semen exosomes blocked the spread of HIV-1 from vaginal epithelial cells to target cells in our cell-to-cell infection model and suppressed transmission of HIV-1 across the vaginal epithelial barrier in our trans-well model. Our in vivo model shows that human semen exosomes restrict intravaginal transmission and propagation of murine AIDS virus. Our study highlights an antiretroviral role for semen exosomes that may be harnessed for the development of novel therapeutic strategies to combat HIV-1 transmission.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024324</affiliation-url><afid>60024324</afid><affilname>University of Iowa</affilname><name-variant>University of Iowa</name-variant><affiliation-city>Iowa City</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024324</affiliation-url><afid>60024324</afid><affilname>University of Iowa</affilname><name-variant>University of Iowa</name-variant><affiliation-city>Iowa City</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55582586100</author-url><authid>55582586100</authid><authname>Madison M.</authname><surname>Madison</surname><given-name>Marisa N.</given-name><initials>M.N.</initials><afid>60024324</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55574122696</author-url><authid>55574122696</authid><authname>Jones P.</authname><surname>Jones</surname><given-name>Philip H.</given-name><initials>P.H.</initials><afid>60024324</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7801368058</author-url><authid>7801368058</authid><authname>Okeoma C.</authname><surname>Okeoma</surname><given-name>Chioma M.</given-name><initials>C.M.</initials><afid>60024324</afid><afid>60024324</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7801368058</author-url><authid>7801368058</authid><authname>Okeoma C.</authname><surname>Okeoma</surname><given-name>Chioma M.</given-name><initials>C.M.</initials><afid>60024324</afid><afid>60024324</afid></author><authkeywords>Exosome | HIV | LP-BM5 virus | MAIDS | Murine AIDS | Semen | Vaginal epithelia</authkeywords><intid>35634323</intid><source-id>20886</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928343354"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928343354?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928343354&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928343354&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1751616115001198"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928343354</prism:url><dc:identifier>SCOPUS_ID:84928343354</dc:identifier><eid>2-s2.0-84928343354</eid><dc:title>Evaluation of polyvinyl alcohol composite membranes containing collagen and bone particles</dc:title><dc:creator>Hameed N.</dc:creator><prism:publicationName>Journal of the Mechanical Behavior of Biomedical Materials</prism:publicationName><prism:issn>17516161</prism:issn><prism:eIssn>18780180</prism:eIssn><prism:volume>48</prism:volume><prism:pageRange>38-45</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jmbbm.2015.04.005</prism:doi><pii>S1751616115001198</pii><dc:description>© 2015 Elsevier Ltd. Composite biomaterials provide alternative materials that improve on the properties of the individual components and can be used to replace or restore damaged or diseased tissues. Typically, a composite biomaterial consists of a matrix, often a polymer, with one or more fillers that can be made up of particles, sheets or fibres. The polymer matrix can be chosen from a wide range of compositions and can be fabricated easily and rapidly into complex shapes and structures. In the present study we have examined three size fractions of collagen-containing particles embedded at up to 60% w/w in a poly(vinyl alcohol) (PVA) matrix. The particles used were bone particles, which are a mineral-collagen composite and demineralised bone, which gives naturally cross-linked collagen particles. SEM showed well dispersed particles in the PVA matrix for all concentrations and sizes of particles, with FTIR suggesting collagen to PVA hydrogen bonding. T&lt;inf&gt;g&lt;/inf&gt; of membranes shifted to a slightly lower temperature with increasing collagen content, along with a minor amount of melting point depression. The modulus and tensile strength of membranes were improved with the addition of both particles up to 10wt%, and were clearly strengthened by the addition, although this effect decreased with higher collagen loadings. Elongation at break decreased with collagen content. Cell adhesion to the membranes was observed associated with the collagen particles, indicating a lack of cytotoxicity.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018805</affiliation-url><afid>60018805</afid><affilname>Deakin University</affilname><name-variant>Deakin University</name-variant><affiliation-city>Geelong</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60105161</affiliation-url><afid>60105161</afid><affilname>CSIRO Manufacturing Flagship, Brisbane</affilname><name-variant>CSIRO Manufacturing Flagship</name-variant><affiliation-city>Brisbane</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23467006700</author-url><authid>23467006700</authid><authname>Hameed N.</authname><surname>Hameed</surname><given-name>Nishar</given-name><initials>N.</initials><afid>60018805</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6602329306</author-url><authid>6602329306</authid><authname>Glattauer V.</authname><surname>Glattauer</surname><given-name>Veronica</given-name><initials>V.</initials><afid>60105161</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005923830</author-url><authid>7005923830</authid><authname>Ramshaw J.</authname><surname>Ramshaw</surname><given-name>John A M</given-name><initials>J.A.M.</initials><afid>60105161</afid></author><authkeywords>Bone | Cell culture | Demineralised bone | Mechanical properties | Polyvinyl alcohol | Thermal properties</authkeywords><intid>535768474</intid><source-id>8000153139</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930200195"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930200195?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930200195&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930200195&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0149763415001190"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930200195</prism:url><dc:identifier>SCOPUS_ID:84930200195</dc:identifier><eid>2-s2.0-84930200195</eid><dc:title>Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review</dc:title><dc:creator>Deepmala </dc:creator><prism:publicationName>Neuroscience and Biobehavioral Reviews</prism:publicationName><prism:issn>01497634</prism:issn><prism:eIssn>18737528</prism:eIssn><prism:volume>55</prism:volume><prism:pageRange>294-321</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.neubiorev.2015.04.015</prism:doi><pii>S0149763415001190</pii><dc:description>© 2015. N-acetylcysteine (NAC) is recognized for its role in acetaminophen overdose and as a mucolytic. Over the past decade, there has been growing evidence for the use of NAC in treating psychiatric and neurological disorders, considering its role in attenuating pathophysiological processes associated with these disorders, including oxidative stress, apoptosis, mitochondrial dysfunction, neuroinflammation and glutamate and dopamine dysregulation. In this systematic review we find favorable evidence for the use of NAC in several psychiatric and neurological disorders, particularly autism, Alzheimer's disease, cocaine and cannabis addiction, bipolar disorder, depression, trichotillomania, nail biting, skin picking, obsessive-compulsive disorder, schizophrenia, drug-induced neuropathy and progressive myoclonic epilepsy. Disorders such as anxiety, attention deficit hyperactivity disorder and mild traumatic brain injury have preliminary evidence and require larger confirmatory studies while current evidence does not support the use of NAC in gambling, methamphetamine and nicotine addictions and amyotrophic lateral sclerosis. Overall, NAC treatment appears to be safe and tolerable. Further well designed, larger controlled trials are needed for specific psychiatric and neurological disorders where the evidence is favorable.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003652</affiliation-url><afid>60003652</afid><affilname>Arkansas Children's Hospital</affilname><name-variant>Arkansas Children's Hospital</name-variant><affiliation-city>Little Rock</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024885</affiliation-url><afid>60024885</afid><affilname>University of Arkansas for Medical Sciences</affilname><name-variant>Univ. of Arkansas for Med. Sciences</name-variant><affiliation-city>Little Rock</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024885</affiliation-url><afid>60024885</afid><affilname>University of Arkansas for Medical Sciences</affilname><name-variant>Univ. of Arkansas for Med. Sciences</name-variant><affiliation-city>Little Rock</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026553</affiliation-url><afid>60026553</afid><affilname>University of Melbourne</affilname><name-variant>University of Melbourne</name-variant><affiliation-city>Parkville</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018805</affiliation-url><afid>60018805</afid><affilname>Deakin University</affilname><name-variant>Deakin University</name-variant><affiliation-city>Geelong</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:111745162</affiliation-url><afid>111745162</afid><affilname>BioPharma Services Inc.</affilname><name-variant>BioPharma Services Inc.</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">15</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56631423800</author-url><authid>56631423800</authid><authname>Deepmala </authname><surname>Deepmala</surname><given-name/><initials/><afid>60003652</afid><afid>60024885</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56631423800</author-url><authid>56631423800</authid><authname>Deepmala </authname><surname>Deepmala</surname><given-name/><initials/><afid>60003652</afid><afid>60024885</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55788805400</author-url><authid>55788805400</authid><authname>Slattery J.</authname><surname>Slattery</surname><given-name>John</given-name><initials>J.</initials><afid>60003652</afid><afid>60024885</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55788805400</author-url><authid>55788805400</authid><authname>Slattery J.</authname><surname>Slattery</surname><given-name>John</given-name><initials>J.</initials><afid>60003652</afid><afid>60024885</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56662660000</author-url><authid>56662660000</authid><authname>Kumar N.</authname><surname>Kumar</surname><given-name>Nihit</given-name><initials>N.</initials><afid>60003652</afid><afid>60024885</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56662660000</author-url><authid>56662660000</authid><authname>Kumar N.</authname><surname>Kumar</surname><given-name>Nihit</given-name><initials>N.</initials><afid>60003652</afid><afid>60024885</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55797727700</author-url><authid>55797727700</authid><authname>Delhey L.</authname><surname>Delhey</surname><given-name>Leanna</given-name><initials>L.</initials><afid>60003652</afid><afid>60024885</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55797727700</author-url><authid>55797727700</authid><authname>Delhey L.</authname><surname>Delhey</surname><given-name>Leanna</given-name><initials>L.</initials><afid>60003652</afid><afid>60024885</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7102183860</author-url><authid>7102183860</authid><authname>Berk M.</authname><surname>Berk</surname><given-name>Michael</given-name><initials>M.</initials><afid>60026553</afid><afid>60018805</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7102183860</author-url><authid>7102183860</authid><authname>Berk M.</authname><surname>Berk</surname><given-name>Michael</given-name><initials>M.</initials><afid>60026553</afid><afid>60018805</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:24334692300</author-url><authid>24334692300</authid><authname>Dean O.</authname><surname>Dean</surname><given-name>Olivia</given-name><initials>O.</initials><afid>60026553</afid><afid>60018805</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:24334692300</author-url><authid>24334692300</authid><authname>Dean O.</authname><surname>Dean</surname><given-name>Olivia</given-name><initials>O.</initials><afid>60026553</afid><afid>60018805</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56663138600</author-url><authid>56663138600</authid><authname>Spielholz C.</authname><surname>Spielholz</surname><given-name>Charles</given-name><initials>C.</initials><afid>111745162</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7101897929</author-url><authid>7101897929</authid><authname>Frye R.</authname><surname>Frye</surname><given-name>Richard</given-name><initials>R.</initials><afid>60003652</afid><afid>60024885</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7101897929</author-url><authid>7101897929</authid><authname>Frye R.</authname><surname>Frye</surname><given-name>Richard</given-name><initials>R.</initials><afid>60003652</afid><afid>60024885</afid></author><authkeywords>Mechanism of action | N-acetylcysteine (NAC) | Neurology | Psychiatry</authkeywords><intid>2036082240</intid><source-id>18045</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929093126"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929093126?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929093126&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929093126&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0195666315002111"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929093126</prism:url><dc:identifier>SCOPUS_ID:84929093126</dc:identifier><eid>2-s2.0-84929093126</eid><dc:title>Prevalence of picky eating behaviour in Chinese school-age children and associations with anthropometric parameters and intelligence quotient. A cross-sectional study</dc:title><dc:creator>Xue Y.</dc:creator><prism:publicationName>Appetite</prism:publicationName><prism:issn>01956663</prism:issn><prism:eIssn>10958304</prism:eIssn><prism:volume>91</prism:volume><prism:pageRange>248-255</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.appet.2015.04.065</prism:doi><pii>S0195666315002111</pii><dc:description>© 2015 The Authors. Previous studies have demonstrated the importance of eating behaviour regarding dietary variety and nutrient intake of children. However, the association between picky eating and growth of children is still a topic of debate. This study sought to estimate the prevalence of picky eating and to identify possible associations with the growth of school-age children in China. In this survey, 793 healthy children aged 7-12 years were recruited from nine cities and rural areas in China using a multi-stage cluster sampling method. Data collected included socio-demographic information and parents' perceptions of picky eating using a structured questionnaire, nutrient intake using 24-hour dietary recall, weight and height using body measurements, and intelligence using the Wechsler Intelligence Scale for Children. Blood samples were collected and analysed for minerals. The prevalence of picky eating reported by parents was 59.3% in children. Compared with non-picky eaters, picky eaters had a lower dietary intake of energy, protein, carbohydrates, most vitamins and minerals, and lower levels of magnesium, iron, and copper in the blood (p &lt; 0.05), and also had a 0.184 z-score lower in height for age (95% CI: -0.332, 0.036; p = 0.015), a 0.385 z-score lower in weight for age (95% CI: -0.533, -0.237; p &lt; 0.001), a 0.383 z-score lower in BMI for age (95% CI: -0.563, -0.203; p &lt; 0.001), and scored 2.726 points higher on the intelligence test (95% CI: 0.809, 4.643; p = 0.006) when adjusted for children's birth weight and food allergy, mothers' education, and family income. Picky eating behaviour towards meat, eggs and vegetables showed negative associations with growth. Picky eating behaviour is prevalent in school-age children in China and may have a negative effect on growth.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004573</affiliation-url><afid>60004573</afid><affilname>Peking University Health Science Center</affilname><name-variant>Peking University Health Science Center</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027550</affiliation-url><afid>60027550</afid><affilname>University of California, Los Angeles</affilname><name-variant>UCLA</name-variant><affiliation-city>Los Angeles</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004573</affiliation-url><afid>60004573</afid><affilname>Peking University Health Science Center</affilname><name-variant>Peking University Health Science Center</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026707</affiliation-url><afid>60026707</afid><affilname>Capital Medical University China</affilname><name-variant>Capital Medical University</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006876</affiliation-url><afid>60006876</afid><affilname>Turun yliopisto</affilname><name-variant>University of Turku</name-variant><affiliation-city>Abo (Turku)</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115228999</affiliation-url><afid>115228999</afid><affilname>Inner Mongolia Mengniu Dairy (Group) Co. Ltd</affilname><name-variant>Inner Mongolia Mengniu Dairy (Group) Co. Ltd</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56637491200</author-url><authid>56637491200</authid><authname>Xue Y.</authname><surname>Xue</surname><given-name>Yong</given-name><initials>Y.</initials><afid>60004573</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56637352000</author-url><authid>56637352000</authid><authname>Lee E.</authname><surname>Lee</surname><given-name>Eva</given-name><initials>E.</initials><afid>60027550</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56637965800</author-url><authid>56637965800</authid><authname>Ning K.</authname><surname>Ning</surname><given-name>Ke</given-name><initials>K.</initials><afid>60004573</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56146541200</author-url><authid>56146541200</authid><authname>Zheng Y.</authname><surname>Zheng</surname><given-name>Yingdong</given-name><initials>Y.</initials><afid>60004573</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:16307531200</author-url><authid>16307531200</authid><authname>Ma D.</authname><surname>Ma</surname><given-name>Defu</given-name><initials>D.</initials><afid>60004573</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56637443100</author-url><authid>56637443100</authid><authname>Gao H.</authname><surname>Gao</surname><given-name>Hongchong</given-name><initials>H.</initials><afid>60026707</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56637393100</author-url><authid>56637393100</authid><authname>Yang B.</authname><surname>Yang</surname><given-name>Baoru</given-name><initials>B.</initials><afid>60004573</afid><afid>60006876</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56637393100</author-url><authid>56637393100</authid><authname>Yang B.</authname><surname>Yang</surname><given-name>Baoru</given-name><initials>B.</initials><afid>60004573</afid><afid>60006876</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56637463000</author-url><authid>56637463000</authid><authname>Bai Y.</authname><surname>Bai</surname><given-name>Ying</given-name><initials>Y.</initials><afid>115228999</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56148132500</author-url><authid>56148132500</authid><authname>Wang P.</authname><surname>Wang</surname><given-name>Peiyu</given-name><initials>P.</initials><afid>60004573</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:55739928300</author-url><authid>55739928300</authid><authname>Zhang Y.</authname><surname>Zhang</surname><given-name>Yumei</given-name><initials>Y.</initials><afid>60004573</afid></author><authkeywords>Chinese | Dietary intake | Growth and development | Intelligence | Picky eating</authkeywords><intid>1535901036</intid><source-id>29994</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929579036"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929579036?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929579036&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929579036&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1050464815001850"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929579036</prism:url><dc:identifier>SCOPUS_ID:84929579036</dc:identifier><eid>2-s2.0-84929579036</eid><dc:title>Changes in barrier health status of the gill for grass carp (Ctenopharyngodon idella) during valine deficiency: Regulation of tight junction protein transcript, antioxidant status and apoptosis-related gene expression</dc:title><dc:creator>Feng L.</dc:creator><prism:publicationName>Fish and Shellfish Immunology</prism:publicationName><prism:issn>10504648</prism:issn><prism:eIssn>10959947</prism:eIssn><prism:volume>45</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>239-249</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.fsi.2015.04.023</prism:doi><pii>S1050464815001850</pii><dc:description>© 2015 Elsevier Ltd. This study investigated the effects of dietary valine on tight junction protein transcription, antioxidant status and apoptosis on grass carp gills (Ctenopharyngodon idella). Fish were fed six different experimental diets containing graded levels of valine (4.3, 8.0, 10.6, 13.1, 16.7, 19.1g/kg). The results indicated that valine deficiency decreased Claudin b, Claudin 3, Occludin and ZO-1 transcription and increased Claudin 15 expression in the fish gill (P&lt;0.05). These effects were partly due to the down-regulation of interleukin 10 (IL-10), transforming growth factor β1 (TGF-β1) and IκB α and the up-regulation of relative mRNA expression of interleukin 1β (IL-1β), interleukin 8 (IL-8), tumor necrosis factor-α (TNF-α) and nuclear factor κB P65 (NF-κB P65) (P&lt;0.05). However, valine deficiency and valine supplementation did not have a significant effect on Claudin c and Claudin 12 expression in grass carp gills (P&gt;0.05). Valine deficiency also disrupted antioxidant status in the gill by decreasing anti-superoxide radicals and hydroxyl radical capacity, glutathione contents and the activities and mRNA levels of Cu/Zn superoxide dismutase (SOD1), catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GR) and glutathione-S-transferase (GST) (P&lt;0.05). These results may be ascribed to the down-regulation of NF-E2-related factor 2 (Nrf2), target of rapamycin (TOR) and ribosomal protein S6 kinase 1 (S6K1) and the up-regulation of Kelch-like-ECH-associated protein 1 (Keap1) (P&lt;0.05). Additionally, valine deficiency induced DNA fragmentation via the up-regulation of Caspase 3, Caspase 8 and Caspase 9 expressions (P&lt;0.05). These results may be ascribed to the improvement in ROS levels in the fish gill (P&lt;0.05). Taken together, the results showed that valine deficiency impaired the structural integrity of fish gill by disrupted fish antioxidant defenses and regulating the expression of tight junction protein, cytokines, antioxidant enzymes, NF-κB p65, IκBα, TOR, Nrf2, Keap1 and apoptosis-related genes in the fish gill.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029885</affiliation-url><afid>60029885</afid><affilname>Sichuan Agricultural University</affilname><name-variant>Sichuan Agricultural University</name-variant><affiliation-city>Ya'an</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029885</affiliation-url><afid>60029885</afid><affilname>Sichuan Agricultural University</affilname><name-variant>Sichuan Agricultural University</name-variant><affiliation-city>Ya'an</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029885</affiliation-url><afid>60029885</afid><affilname>Sichuan Agricultural University</affilname><name-variant>Sichuan Agricultural University</name-variant><affiliation-city>Ya'an</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114577197</affiliation-url><afid>114577197</afid><affilname>Sichuan Academy of Animal Science</affilname><name-variant>Sichuan Academy of Animal Science</name-variant><affiliation-city>Chengdu</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021836</affiliation-url><afid>60021836</afid><affilname>Institute of Hydrobiology, Chinese Academy of Sciences</affilname><name-variant>Chinese Academy of Sciences</name-variant><affiliation-city>Wuhan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">22</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55507811300</author-url><authid>55507811300</authid><authname>Feng L.</authname><surname>Feng</surname><given-name>Lin</given-name><initials>L.</initials><afid>60029885</afid><afid>60029885</afid><afid>60029885</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55507811300</author-url><authid>55507811300</authid><authname>Feng L.</authname><surname>Feng</surname><given-name>Lin</given-name><initials>L.</initials><afid>60029885</afid><afid>60029885</afid><afid>60029885</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55507811300</author-url><authid>55507811300</authid><authname>Feng L.</authname><surname>Feng</surname><given-name>Lin</given-name><initials>L.</initials><afid>60029885</afid><afid>60029885</afid><afid>60029885</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56278303300</author-url><authid>56278303300</authid><authname>Luo J.</authname><surname>Luo</surname><given-name>Jian Bo</given-name><initials>J.B.</initials><afid>60029885</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36655984000</author-url><authid>36655984000</authid><authname>Jiang W.</authname><surname>Jiang</surname><given-name>Wei Dan</given-name><initials>W.D.</initials><afid>60029885</afid><afid>60029885</afid><afid>60029885</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36655984000</author-url><authid>36655984000</authid><authname>Jiang W.</authname><surname>Jiang</surname><given-name>Wei Dan</given-name><initials>W.D.</initials><afid>60029885</afid><afid>60029885</afid><afid>60029885</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36655984000</author-url><authid>36655984000</authid><authname>Jiang W.</authname><surname>Jiang</surname><given-name>Wei Dan</given-name><initials>W.D.</initials><afid>60029885</afid><afid>60029885</afid><afid>60029885</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55133104700</author-url><authid>55133104700</authid><authname>Liu Y.</authname><surname>Liu</surname><given-name>Yang</given-name><initials>Y.</initials><afid>60029885</afid><afid>60029885</afid><afid>60029885</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55133104700</author-url><authid>55133104700</authid><authname>Liu Y.</authname><surname>Liu</surname><given-name>Yang</given-name><initials>Y.</initials><afid>60029885</afid><afid>60029885</afid><afid>60029885</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55133104700</author-url><authid>55133104700</authid><authname>Liu Y.</authname><surname>Liu</surname><given-name>Yang</given-name><initials>Y.</initials><afid>60029885</afid><afid>60029885</afid><afid>60029885</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:39062242600</author-url><authid>39062242600</authid><authname>Wu P.</authname><surname>Wu</surname><given-name>Pei</given-name><initials>P.</initials><afid>60029885</afid><afid>60029885</afid><afid>60029885</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:39062242600</author-url><authid>39062242600</authid><authname>Wu P.</authname><surname>Wu</surname><given-name>Pei</given-name><initials>P.</initials><afid>60029885</afid><afid>60029885</afid><afid>60029885</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:39062242600</author-url><authid>39062242600</authid><authname>Wu P.</authname><surname>Wu</surname><given-name>Pei</given-name><initials>P.</initials><afid>60029885</afid><afid>60029885</afid><afid>60029885</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:36637561200</author-url><authid>36637561200</authid><authname>Jiang J.</authname><surname>Jiang</surname><given-name>Jun</given-name><initials>J.</initials><afid>60029885</afid><afid>60029885</afid><afid>60029885</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:36637561200</author-url><authid>36637561200</authid><authname>Jiang J.</authname><surname>Jiang</surname><given-name>Jun</given-name><initials>J.</initials><afid>60029885</afid><afid>60029885</afid><afid>60029885</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:36637561200</author-url><authid>36637561200</authid><authname>Jiang J.</authname><surname>Jiang</surname><given-name>Jun</given-name><initials>J.</initials><afid>60029885</afid><afid>60029885</afid><afid>60029885</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35088423100</author-url><authid>35088423100</authid><authname>Kuang S.</authname><surname>Kuang</surname><given-name>Sheng Yao</given-name><initials>S.Y.</initials><afid>114577197</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:35089103600</author-url><authid>35089103600</authid><authname>Tang L.</authname><surname>Tang</surname><given-name>Ling</given-name><initials>L.</initials><afid>114577197</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56027289600</author-url><authid>56027289600</authid><authname>Zhang Y.</authname><surname>Zhang</surname><given-name>Yong An</given-name><initials>Y.A.</initials><afid>60021836</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56168383500</author-url><authid>56168383500</authid><authname>Zhou X.</authname><surname>Zhou</surname><given-name>Xiao Qiu</given-name><initials>X.Q.</initials><afid>60029885</afid><afid>60029885</afid><afid>60029885</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56168383500</author-url><authid>56168383500</authid><authname>Zhou X.</authname><surname>Zhou</surname><given-name>Xiao Qiu</given-name><initials>X.Q.</initials><afid>60029885</afid><afid>60029885</afid><afid>60029885</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56168383500</author-url><authid>56168383500</authid><authname>Zhou X.</authname><surname>Zhou</surname><given-name>Xiao Qiu</given-name><initials>X.Q.</initials><afid>60029885</afid><afid>60029885</afid><afid>60029885</afid></author><authkeywords>Antioxidant defense | Apoptosis | Signaling molecule | Tight junction protein | Valine deficiency</authkeywords><intid>2035976356</intid><source-id>15066</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928408416"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928408416?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928408416&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928408416&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0165032715002220"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928408416</prism:url><dc:identifier>SCOPUS_ID:84928408416</dc:identifier><eid>2-s2.0-84928408416</eid><dc:title>Mental health self-management questionnaire: Development and psychometric properties</dc:title><dc:creator>Coulombe S.</dc:creator><prism:publicationName>Journal of Affective Disorders</prism:publicationName><prism:issn>01650327</prism:issn><prism:eIssn>15732517</prism:eIssn><prism:volume>181</prism:volume><prism:pageRange>41-49</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jad.2015.04.007</prism:doi><pii>S0165032715002220</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. Background Through self-management, people living with depression, anxiety or bipolar disorders can play an active role in their recovery. However, absence of a validated questionnaire limits empirical research on self-management. The study aimed to develop a French instrument, the Mental Health Self-Management Questionnaire (MHSQ), and to investigate its psychometric properties Methods A pool of 86 items was created based on a qualitative study with 50 people in recovery from depression, anxiety or bipolar disorders. The 64 most pertinent items were identified following ratings from 14 experts. A sample of 149 people in recovery completed these items and criterion-related measures (specific aspects of self-management, clinical and personal recovery, social desirability), and 93 participants also completed MHSQ two weeks later Results Exploratory and confirmatory factor analyses show that MHSQ is composed of three subscales: Clinical (getting help and using resources), Empowerment (building upon strengths and positive self-concept to gain control) and Vitality (active and healthy lifestyle). These subscales had satisfying consistency and test-retest reliability, and were mostly unrelated to social desirability. Correlations with criterion variables support convergent and concurrent validity, especially for Empowerment and Vitality. Comparison of structural models provides evidence of the distinct nature of MHSQ in comparison to the constructs of clinical and personal recovery Limitations Longitudinal studies with larger samples are needed to explore the validity of MHSQ for predicting recovery over time Conclusion MHSQ is a psychometrically-sound instrument, useful for establishing the role of self-management in recovery and monitoring the efficacy of self-management support programs.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027863</affiliation-url><afid>60027863</afid><affilname>Universite du Quebec a Montreal</affilname><name-variant>Université du Québec à Montréal</name-variant><affiliation-city>Montreal</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032619</affiliation-url><afid>60032619</afid><affilname>Universite Laval</affilname><name-variant>Université Laval</name-variant><affiliation-city>Quebec</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011832</affiliation-url><afid>60011832</afid><affilname>Universite de Sherbrooke</affilname><name-variant>University of Sherbrooke</name-variant><affiliation-city>Sherbrooke</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032619</affiliation-url><afid>60032619</afid><affilname>Universite Laval</affilname><name-variant>Université Laval</name-variant><affiliation-city>Quebec</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56530413300</author-url><authid>56530413300</authid><authname>Coulombe S.</authname><surname>Coulombe</surname><given-name>Simon</given-name><initials>S.</initials><afid>60027863</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56605073500</author-url><authid>56605073500</authid><authname>Radziszewski S.</authname><surname>Radziszewski</surname><given-name>Stephanie</given-name><initials>S.</initials><afid>60027863</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55163830000</author-url><authid>55163830000</authid><authname>Trépanier S.</authname><surname>Trépanier</surname><given-name>Sarah Geneviève</given-name><initials>S.G.</initials><afid>60027863</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6602150907</author-url><authid>6602150907</authid><authname>Provencher H.</authname><surname>Provencher</surname><given-name>Hélène</given-name><initials>H.</initials><afid>60032619</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:12139779900</author-url><authid>12139779900</authid><authname>Roberge P.</authname><surname>Roberge</surname><given-name>Pasquale</given-name><initials>P.</initials><afid>60011832</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:8236134800</author-url><authid>8236134800</authid><authname>Hudon C.</authname><surname>Hudon</surname><given-name>Catherine</given-name><initials>C.</initials><afid>60011832</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56494522700</author-url><authid>56494522700</authid><authname>Meunier S.</authname><surname>Meunier</surname><given-name>Sophie</given-name><initials>S.</initials><afid>60027863</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6701663481</author-url><authid>6701663481</authid><authname>Provencher M.</authname><surname>Provencher</surname><given-name>Martin D.</given-name><initials>M.D.</initials><afid>60032619</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:8511162800</author-url><authid>8511162800</authid><authname>Houle J.</authname><surname>Houle</surname><given-name>Janie</given-name><initials>J.</initials><afid>60027863</afid></author><authkeywords>Common mental disorder | Personal recovery | Questionnaire | Self-management | Symptom severity | Well-being</authkeywords><intid>1785779011</intid><source-id>16245</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924675011"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924675011?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924675011&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924675011&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924675011</prism:url><dc:identifier>SCOPUS_ID:84924675011</dc:identifier><eid>2-s2.0-84924675011</eid><dc:title>Energy harvesting using an array of granules</dc:title><dc:creator>Li K.</dc:creator><prism:publicationName>Journal of Vibration and Acoustics, Transactions of the ASME</prism:publicationName><prism:issn>10489002</prism:issn><prism:eIssn>15288927</prism:eIssn><prism:volume>137</prism:volume><prism:issueIdentifier>4</prism:issueIdentifier><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1115/1.4029735</prism:doi><dc:description>© 2015 by ASME. In the last decade, there has been an increasing attention on the use of highly and weakly nonlinear solitary waves in engineering and physics. These waves can form and travel in nonlinear systems such as one-dimensional chains of particles. One engineering application of solitary waves is the fabrication of acoustic lenses, which are employed in a variety of fields ranging from biomedical imaging and surgery to defense systems and damage detection. In this paper, we propose to couple an acoustic lens to a wafer-type lead zirconate titanate (PZT) transducer to harvest energy from the vibration of an object tapping the lens. The lens consists of an ordered array of spherical particles in contact with a polycarbonate material where the nonlinear waves become linear and coalesce ideally into a focal point. The transducer located at the designed focal point converts the mechanical energy carried by the stress waves into electricity to power a load resistor. The performance of the designed harvester is compared to a conventional nonoptimized cantilever beam, and the experimental results show that the power generated with the nonlinear lens has the same order of magnitude of the beam.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015543</affiliation-url><afid>60015543</afid><affilname>University of Pittsburgh</affilname><name-variant>University of Pittsburgh</name-variant><affiliation-city>Pittsburgh</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55541417000</author-url><authid>55541417000</authid><authname>Li K.</authname><surname>Li</surname><given-name>Kaiyuan</given-name><initials>K.</initials><afid>60015543</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55880108000</author-url><authid>55880108000</authid><authname>Rizzo P.</authname><surname>Rizzo</surname><given-name>Piervincenzo</given-name><initials>P.</initials><afid>60015543</afid></author><authkeywords>acoustic lenses | discrete particle model | energy harvesting | granular arrays | highly nonlinear solitary waves | mechanical vibrations | nonlinear dynamics</authkeywords><intid>1035183594</intid><article-number>041002</article-number><source-id>120005</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927720405"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927720405?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927720405&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927720405&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S092540051500386X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927720405</prism:url><dc:identifier>SCOPUS_ID:84927720405</dc:identifier><eid>2-s2.0-84927720405</eid><dc:title>Recent advances in silicon-based neural microelectrodes and microsystems: A review</dc:title><dc:creator>Fekete Z.</dc:creator><prism:publicationName>Sensors and Actuators, B: Chemical</prism:publicationName><prism:issn>09254005</prism:issn><prism:volume>215</prism:volume><prism:pageRange>300-315</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.snb.2015.03.055</prism:doi><pii>S092540051500386X</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. Abstract Developments in neurotechnology are recently driven by newly national and international brain research initiatives worldwide. The challenging goal of understanding how the human brain works requires a vast amount of information gained by neural sensors. Microelectrodes implanted in the central nervous system are extensively used to record electric activity inside the brain tissue. More recently, deep-brain stimulation in Parkinson disease proved the feasibility of such electrodes in human medical treatments as well. To add novel sensor or even actuator functions to these microelectrodes, limitations of recent fabrication technologies have to be considered. To date, silicon microtechnology offered the highest potential to meet the demands of neural applications regarding multiple functions integrated on a single implantable microsystem. Besides reproducibility and low variability of silicon-based microelectrodes, combination of various functionalities like standard electrophysiology, integrated signal processing, local drug delivery, neurochemical detection and optogenetic stimulation is also possible using these microsystems. This ability makes silicon microelectrodes good candidates to provide high-resolution recording and stimulation in the electric, fluidic, chemical or optical domain in more complex neurophysiological experiments in the future. The aim of this review is to give an overview on various aspects of silicon-based implantable neural microelectrodes and microsystems developed in the last decade. Microfabrication approaches of 2-D and 3-D arrays are summarized. Features of the latest active microelectrodes including CMOS signal processing circuitry are compared. Integration methods of convection enhanced drug delivery functions for local administration of pharmacons are demonstrated. Performance of recent silicon-based chemical sensors for the detection of neurotransmitters is also studied. An analysis on the latest developments in silicon-based optrodes for optogenetic and thermogenetic stimulation is also included in this paper. Microelectrode-tissue interaction is described through the evaluation of recent experimental studies on in vitro and in vivo biocompatibility.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025641</affiliation-url><afid>60025641</afid><affilname>Universitat Freiburg im Breisgau</affilname><name-variant>Universität Freiburg</name-variant><affiliation-city>Freiburg im Breisgau</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027811</affiliation-url><afid>60027811</afid><affilname>Magyar Tudomanyos Akademia</affilname><name-variant>Hungarian Academy of Sciences</name-variant><affiliation-city>Budapest</affiliation-city><affiliation-country>Hungary</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56186617200</author-url><authid>56186617200</authid><authname>Fekete Z.</authname><surname>Fekete</surname><given-name>Zoltan</given-name><initials>Z.</initials><afid>60025641</afid><afid>60027811</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56186617200</author-url><authid>56186617200</authid><authname>Fekete Z.</authname><surname>Fekete</surname><given-name>Zoltan</given-name><initials>Z.</initials><afid>60025641</afid><afid>60027811</afid></author><authkeywords>brain-machine interfaces | Neural implants | Neural probes | neuroprosthetics | Silicon microelectrodes</authkeywords><intid>535667502</intid><article-number>18248</article-number><source-id>25236</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928019908"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928019908?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928019908&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928019908&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021999115002260"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928019908</prism:url><dc:identifier>SCOPUS_ID:84928019908</dc:identifier><eid>2-s2.0-84928019908</eid><dc:title>On the search of more stable second-order lattice-Boltzmann schemes in confined flows</dc:title><dc:creator>Golbert D.</dc:creator><prism:publicationName>Journal of Computational Physics</prism:publicationName><prism:issn>00219991</prism:issn><prism:eIssn>10902716</prism:eIssn><prism:volume>294</prism:volume><prism:pageRange>605-618</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jcp.2015.03.065</prism:doi><pii>S0021999115002260</pii><dc:description>© 2015 Elsevier Inc. The von Neumann linear analysis, restricted by a heuristic selection of wave-number vectors was applied to the search of explicit lattice Boltzmann schemes which exhibit more stability than existing methods. The relative stability of the family members of quasi-incompressible collision kernels, for the Navier-Stokes equations in confined flows, was analyzed. The linear stability analysis was simplified by assuming a uniform velocity level over the whole domain, where only the wave numbers of the first harmonic normal to the flow direction were permitted. A singular equilibrium function that maximizes the critical velocity level was identified, which was afterwards tested in particular cases of confined flows of interest, validating the resulting procedure.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60046283</affiliation-url><afid>60046283</afid><affilname>Laboratorio Nacional de Computacao Cientifica, Petropolis</affilname><name-variant>Laboratório Nacional de Computação Científica</name-variant><affiliation-city>Petropolis</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:110138758</affiliation-url><afid>110138758</afid><affilname>Instituto Nacional de Ciência e Tecnologia</affilname><name-variant>Instituto Nacional de Ciência e Tecnologia</name-variant><affiliation-city>Petropolis</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115168634</affiliation-url><afid>115168634</afid><affilname>CNEA-CONICET and Universidad Nacional del Centro</affilname><name-variant>CNEA-CONICET and Universidad Nacional del Centro</name-variant><affiliation-city/><affiliation-country>Argentina</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:48461366400</author-url><authid>48461366400</authid><authname>Golbert D.</authname><surname>Golbert</surname><given-name>D. R.</given-name><initials>D.R.</initials><afid>60046283</afid><afid>110138758</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:48461366400</author-url><authid>48461366400</authid><authname>Golbert D.</authname><surname>Golbert</surname><given-name>D. R.</given-name><initials>D.R.</initials><afid>60046283</afid><afid>110138758</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:13408462200</author-url><authid>13408462200</authid><authname>Blanco P.</authname><surname>Blanco</surname><given-name>P. J.</given-name><initials>P.J.</initials><afid>60046283</afid><afid>110138758</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:13408462200</author-url><authid>13408462200</authid><authname>Blanco P.</authname><surname>Blanco</surname><given-name>P. J.</given-name><initials>P.J.</initials><afid>60046283</afid><afid>110138758</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7004090070</author-url><authid>7004090070</authid><authname>Clausse A.</authname><surname>Clausse</surname><given-name>A.</given-name><initials>A.</initials><afid>115168634</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603761068</author-url><authid>6603761068</authid><authname>Feijóo R.</authname><surname>Feijóo</surname><given-name>R. A.</given-name><initials>R.A.</initials><afid>60046283</afid><afid>110138758</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603761068</author-url><authid>6603761068</authid><authname>Feijóo R.</authname><surname>Feijóo</surname><given-name>R. A.</given-name><initials>R.A.</initials><afid>60046283</afid><afid>110138758</afid></author><authkeywords>Incompressible flow | Linear stability | Von Neumann analysis</authkeywords><intid>2035711353</intid><source-id>13191</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929333937"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929333937?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929333937&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929333937&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315006245"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929333937</prism:url><dc:identifier>SCOPUS_ID:84929333937</dc:identifier><eid>2-s2.0-84929333937</eid><dc:title>A comparison of low versus standard heparin dose for prevention of forearm artery occlusion after 5 French coronary angiography</dc:title><dc:creator>Hahalis G.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>404-410</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.366</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Background: Radial artery occlusion (RAO) remains the Achilles' heel of transradial coronary procedures. Standard over lower systemic anticoagulation levels are believed to reduce RAO rates but this is ill-supported by scientific evidence. We compared whether standard in comparison with less intensive anticoagulation was superior in preventing vessel closure. Methods and results: The two arms of this analysis included 731 pooled patients with the same inclusion and exclusion criteria. We assessed forearm arterial access site occlusion rate by unfractionated heparin (UFH) dose in an individual participant data meta-analysis of this randomized study and of consecutive eligible patients from our previous trial. We randomized 308 consecutive patients undergoing transradial coronary angiography with 5 French (5Fr) catheters without need to crossover to receive 2500 or 5000 UFH units. The primary endpoint was the ultrasonographically determined vessel occlusion rate. Incident RAOs in the randomized arm were 15.9% vs. 14%, in the low and standard UFH dose, respectively (p = 0.7). Corresponding figures for forearm arterial occlusion rates in the pooled population were 13.0% vs. 9.9% (relative risk: 1.3, 95% confidence interval - CI: 0.88-1.98; p = 0.2). Procedural and fluoroscopy duration was less than 15 and 3 min, respectively. The mean UFH dose difference was 3.52 (95% CI: - 0.45 to 7.49) units per kilo body weight between occluded (n = 84) and patent forearm arteries (n = 647); (p = 0.053). Conclusions: Incident forearm arterial occlusions were high despite using 5Fr catheters for a short-lasting procedure. Systemic anticoagulation with standard over lower UFH dose did not reduce the frequency of RAOs after coronary angiography.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031155</affiliation-url><afid>60031155</afid><affilname>Panepistimion Patron</affilname><name-variant>University of Patras</name-variant><affiliation-city>Patra</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031193</affiliation-url><afid>60031193</afid><affilname>G. Gennimatas General Hospital</affilname><name-variant>G. Gennimatas Hospital</name-variant><affiliation-city>Athens</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">15</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602503595</author-url><authid>6602503595</authid><authname>Hahalis G.</authname><surname>Hahalis</surname><given-name>George</given-name><initials>G.</initials><afid>60031155</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644917800</author-url><authid>56644917800</authid><authname>Xathopoulou I.</authname><surname>Xathopoulou</surname><given-name>Ioanna</given-name><initials>I.</initials><afid>60031155</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:24538111900</author-url><authid>24538111900</authid><authname>Tsigkas G.</authname><surname>Tsigkas</surname><given-name>Grigorios</given-name><initials>G.</initials><afid>60031155</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:26025836500</author-url><authid>26025836500</authid><authname>Almpanis G.</authname><surname>Almpanis</surname><given-name>George</given-name><initials>G.</initials><afid>60031155</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56644603900</author-url><authid>56644603900</authid><authname>Christodoulou I.</authname><surname>Christodoulou</surname><given-name>Ioannis</given-name><initials>I.</initials><afid>60031155</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6506272045</author-url><authid>6506272045</authid><authname>Grapsas N.</authname><surname>Grapsas</surname><given-name>Nikolaos</given-name><initials>N.</initials><afid>60031155</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35518331600</author-url><authid>35518331600</authid><authname>Davlouros P.</authname><surname>Davlouros</surname><given-name>Periklis</given-name><initials>P.</initials><afid>60031155</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:24537655100</author-url><authid>24537655100</authid><authname>Koniari I.</authname><surname>Koniari</surname><given-name>Ioanna</given-name><initials>I.</initials><afid>60031155</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:55403166300</author-url><authid>55403166300</authid><authname>Deftereos S.</authname><surname>Deftereos</surname><given-name>Spyridon</given-name><initials>S.</initials><afid>60031193</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:24449653600</author-url><authid>24449653600</authid><authname>Raisakis K.</authname><surname>Raisakis</surname><given-name>Konstantinos</given-name><initials>K.</initials><afid>60031193</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:6504682143</author-url><authid>6504682143</authid><authname>Christopoulou G.</authname><surname>Christopoulou</surname><given-name>Georgia</given-name><initials>G.</initials><afid>60031155</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:15122092900</author-url><authid>15122092900</authid><authname>Giannopoulos G.</authname><surname>Giannopoulos</surname><given-name>George</given-name><initials>G.</initials><afid>60031193</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:56644344500</author-url><authid>56644344500</authid><authname>Kounis N.</authname><surname>Kounis</surname><given-name>Nikolaos</given-name><initials>N.</initials><afid>60031155</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:55395104200</author-url><authid>55395104200</authid><authname>Pyrgakis V.</authname><surname>Pyrgakis</surname><given-name>Vlassis</given-name><initials>V.</initials><afid>60031193</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:7006042805</author-url><authid>7006042805</authid><authname>Alexopoulos D.</authname><surname>Alexopoulos</surname><given-name>Dimitrios</given-name><initials>D.</initials><afid>60031155</afid></author><authkeywords>Anticoagulation | Arterial occlusion | Coronary angiography | Radial</authkeywords><intid>535945192</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925679903"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925679903?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925679903&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925679903&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0039914015001666"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925679903</prism:url><dc:identifier>SCOPUS_ID:84925679903</dc:identifier><eid>2-s2.0-84925679903</eid><dc:title>Development and validation of LC-MS/MS method for quantification of bisphenol A and estrogens in human plasma and seminal fluid</dc:title><dc:creator>Vitku J.</dc:creator><prism:publicationName>Talanta</prism:publicationName><prism:issn>00399140</prism:issn><prism:volume>140</prism:volume><prism:pageRange>62-67</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.talanta.2015.03.013</prism:doi><pii>S0039914015001666</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. Abstract Bisphenol A (BPA) is a widely known endocrine disruptor with estrogenic, antiestrogenic or antiandrogenic properties. BPA could interfere with estrogen metabolism as well with receptor-mediated estrogen actions. Both environmental BPA and estrogens may be traced in body fluids, of which, besides the blood plasma, the seminal fluid is of particular interest regarding their possible interactions in the testis. The method for simultaneously determining BPA and estrogens is then needed, taking into account that their concentrations in these body fluid may differ. Here the method was developed and validated for measurements of BPA, estrone (E1), estradiol (E2) and estriol (E3) in blood plasma and seminal plasma using liquid chromatography-tandem mass spectrometry. Due to the phenolic moiety of all compounds, dansyl chloride derivatization could be used. The analytical criteria of the method with respect to expected concentration of the analytes were satisfactory. The lower limits of quantifications (LLOQ) amounted to 43.5, 4.0, 12.7, 6.7 pg/mL for plasma BPA, E1, E2 and E3, and 28.9, 4.9, 4.5, 3.4 pg/mL for seminal BPA, E1, E2 and E3, respectively. The concentrations of individual steroids differed between body fluids. To the best of our knowledge, this is the first method that enabled the measurement of estrogens and BPA together in one run. The concentrations of E1, E2 and for the first time also of E3 in seminal plasma in normospermic men are reported.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027880</affiliation-url><afid>60027880</afid><affilname>Institute of Endocrinology</affilname><name-variant>Research Institute of Endocrinology</name-variant><affiliation-city>Prague</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016605</affiliation-url><afid>60016605</afid><affilname>Charles University in Prague</affilname><name-variant>Charles University in Prague</name-variant><affiliation-city>Prague</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011227</affiliation-url><afid>60011227</afid><affilname>Fakultni nemocnice Kralovske Vinohrady</affilname><name-variant>Charles University</name-variant><affiliation-city>Prague</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60039507</affiliation-url><afid>60039507</afid><affilname>Veobecna Fakultni Nemocnice V Praze</affilname><name-variant>General University Hospital</name-variant><affiliation-city>Prague</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56312800400</author-url><authid>56312800400</authid><authname>Vitku J.</authname><surname>Vitku</surname><given-name>Jana</given-name><initials>J.</initials><afid>60027880</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56534130400</author-url><authid>56534130400</authid><authname>Chlupacova T.</authname><surname>Chlupacova</surname><given-name>Tereza</given-name><initials>T.</initials><afid>60027880</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36609200000</author-url><authid>36609200000</authid><authname>Sosvorova L.</authname><surname>Sosvorova</surname><given-name>Lucie</given-name><initials>L.</initials><afid>60027880</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:13104534000</author-url><authid>13104534000</authid><authname>Hampl R.</authname><surname>Hampl</surname><given-name>Richard</given-name><initials>R.</initials><afid>60027880</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7404448132</author-url><authid>7404448132</authid><authname>Hill M.</authname><surname>Hill</surname><given-name>Martin</given-name><initials>M.</initials><afid>60027880</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7801477463</author-url><authid>7801477463</authid><authname>Heracek J.</authname><surname>Heracek</surname><given-name>Jiri</given-name><initials>J.</initials><afid>60016605</afid><afid>60011227</afid><afid>60039507</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7801477463</author-url><authid>7801477463</authid><authname>Heracek J.</authname><surname>Heracek</surname><given-name>Jiri</given-name><initials>J.</initials><afid>60016605</afid><afid>60011227</afid><afid>60039507</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7801477463</author-url><authid>7801477463</authid><authname>Heracek J.</authname><surname>Heracek</surname><given-name>Jiri</given-name><initials>J.</initials><afid>60016605</afid><afid>60011227</afid><afid>60039507</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55941954600</author-url><authid>55941954600</authid><authname>Bicikova M.</authname><surname>Bicikova</surname><given-name>Marie</given-name><initials>M.</initials><afid>60027880</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:8767592500</author-url><authid>8767592500</authid><authname>Starka L.</authname><surname>Starka</surname><given-name>Luboslav</given-name><initials>L.</initials><afid>60027880</afid></author><authkeywords>Bisphenol A | Estradiol | Estriol | Estrone | LC-MS | Semen</authkeywords><intid>2035323574</intid><article-number>15446</article-number><source-id>24555</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929376991"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929376991?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929376991&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929376991&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315005604"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929376991</prism:url><dc:identifier>SCOPUS_ID:84929376991</dc:identifier><eid>2-s2.0-84929376991</eid><dc:title>Impaired clopidogrel antiplatelet effects and age: Young patients at risk</dc:title><dc:creator>Polzin A.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>216-218</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.320</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60072305</affiliation-url><afid>60072305</afid><affilname>Uniklinik Dusseldorf</affilname><affiliation-city>Dusseldorf</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:50262667900</author-url><authid>50262667900</authid><authname>Polzin A.</authname><surname>Polzin</surname><given-name>Amin</given-name><initials>A.</initials><afid>60072305</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24794775000</author-url><authid>24794775000</authid><authname>Kelm M.</authname><surname>Kelm</surname><given-name>Malte</given-name><initials>M.</initials><afid>60072305</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6506371641</author-url><authid>6506371641</authid><authname>Zeus T.</authname><surname>Zeus</surname><given-name>Tobias</given-name><initials>T.</initials><afid>60072305</afid></author><authkeywords>Age | Clopidogrel | HPR | HTPR | PRI</authkeywords><intid>2035941287</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929340435"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929340435?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929340435&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929340435&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315005963"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929340435</prism:url><dc:identifier>SCOPUS_ID:84929340435</dc:identifier><eid>2-s2.0-84929340435</eid><dc:title>Effects of H. pylori infection on carotid intima-media thickness, serum glucose, serum uric acid, liver and kidney function in subjects with chronic alcohol ingestion</dc:title><dc:creator>Qu B.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>470-471</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.338</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114784084</affiliation-url><afid>114784084</afid><affilname>Taishan Hospital</affilname><name-variant>Taishan Hospital</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101672668</affiliation-url><afid>101672668</afid><affilname>Taishan Medical College</affilname><name-variant>Taishan Medical College</name-variant><affiliation-city>Tainan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644093700</author-url><authid>56644093700</authid><authname>Qu B.</authname><surname>Qu</surname><given-name>Baoge</given-name><initials>B.</initials><afid>114784084</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56645040200</author-url><authid>56645040200</authid><authname>Wang H.</authname><surname>Wang</surname><given-name>Hui</given-name><initials>H.</initials><afid>114784084</afid><afid>101672668</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56645040200</author-url><authid>56645040200</authid><authname>Wang H.</authname><surname>Wang</surname><given-name>Hui</given-name><initials>H.</initials><afid>114784084</afid><afid>101672668</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56645032100</author-url><authid>56645032100</authid><authname>Liu Y.</authname><surname>Liu</surname><given-name>Yuanxun</given-name><initials>Y.</initials><afid>114784084</afid><afid>101672668</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56645032100</author-url><authid>56645032100</authid><authname>Liu Y.</authname><surname>Liu</surname><given-name>Yuanxun</given-name><initials>Y.</initials><afid>114784084</afid><afid>101672668</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56643662000</author-url><authid>56643662000</authid><authname>Jia Y.</authname><surname>Jia</surname><given-name>Yiguo</given-name><initials>Y.</initials><afid>114784084</afid><afid>101672668</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56643662000</author-url><authid>56643662000</authid><authname>Jia Y.</authname><surname>Jia</surname><given-name>Yiguo</given-name><initials>Y.</initials><afid>114784084</afid><afid>101672668</afid></author><authkeywords>Chronic alcohol ingestion | H. Pylori infection</authkeywords><intid>1785947101</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928229447"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928229447?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928229447&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928229447&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2213231715000385"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928229447</prism:url><dc:identifier>SCOPUS_ID:84928229447</dc:identifier><eid>2-s2.0-84928229447</eid><dc:title>Fetal-maternal interface impedance parallels local NADPH oxidase related superoxide production</dc:title><dc:creator>Guedes-Martins L.</dc:creator><prism:publicationName>Redox Biology</prism:publicationName><prism:issn>22132317</prism:issn><prism:volume>5</prism:volume><prism:pageRange>114-123</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.redox.2015.04.007</prism:doi><pii>S2213231715000385</pii><dc:description>© 2015 The Authors. Blood flow assessment employing Doppler techniques is a useful procedure in pregnancy evaluation, as it may predict pregnancy disorders coursing with increased uterine vascular impedance, as pre-eclampsia. While the local causes are unknown, emphasis has been put on reactive oxygen species (ROS) excessive production. As NADPH oxidase (NOX) is a ROS generator, it is hypothesized that combining Doppler assessment with NOX activity might provide useful knowledge on placental bed disorders underlying mechanisms.A prospective longitudinal study was performed in 19 normal course, singleton pregnancies. Fetal aortic isthmus (AoI) and maternal uterine arteries (UtA) pulsatility index (PI) were recorded at two time points: 20-22 and 40-41 weeks, just before elective Cesarean section. In addition, placenta and placental bed biopsies were performed immediately after fetal extraction.NOX activity was evaluated using a dihydroethidium-based fluorescence method and associations to PI values were studied with Spearman correlations. A clustering of pregnancies coursing with higher and lower PI values was shown, which correlated strongly with placental bed NOX activity, but less consistently with placental tissue.The study provides evidence favoring that placental bed NOX activity parallels UtA PI enhancement and suggests that an excess in oxidation underlies the development of pregnancy disorders coursing with enhanced UtA impedance.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007249</affiliation-url><afid>60007249</afid><affilname>Universidade do Porto</affilname><name-variant>Universidade do Porto</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004346</affiliation-url><afid>60004346</afid><affilname>Instituto de Biologia Molecular e Celular</affilname><name-variant>Instituto de Biologia Molecular e Celular</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007249</affiliation-url><afid>60007249</afid><affilname>Universidade do Porto</affilname><name-variant>Universidade do Porto</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112391251</affiliation-url><afid>112391251</afid><affilname>Centro Hospitalar do Porto</affilname><name-variant>Centro Hospitalar Do Porto</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007249</affiliation-url><afid>60007249</afid><affilname>Universidade do Porto</affilname><name-variant>Universidade do Porto</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007249</affiliation-url><afid>60007249</afid><affilname>Universidade do Porto</affilname><name-variant>Universidade do Porto</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007249</affiliation-url><afid>60007249</afid><affilname>Universidade do Porto</affilname><name-variant>Universidade do Porto</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007249</affiliation-url><afid>60007249</afid><affilname>Universidade do Porto</affilname><name-variant>Universidade do Porto</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:105913316</affiliation-url><afid>105913316</afid><affilname>Hospital-CUF Porto</affilname><name-variant>Hospital CUF</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">22</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55509393300</author-url><authid>55509393300</authid><authname>Guedes-Martins L.</authname><surname>Guedes-Martins</surname><given-name>L.</given-name><initials>L.</initials><afid>60007249</afid><afid>60004346</afid><afid>60007249</afid><afid>112391251</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55509393300</author-url><authid>55509393300</authid><authname>Guedes-Martins L.</authname><surname>Guedes-Martins</surname><given-name>L.</given-name><initials>L.</initials><afid>60007249</afid><afid>60004346</afid><afid>60007249</afid><afid>112391251</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55509393300</author-url><authid>55509393300</authid><authname>Guedes-Martins L.</authname><surname>Guedes-Martins</surname><given-name>L.</given-name><initials>L.</initials><afid>60007249</afid><afid>60004346</afid><afid>60007249</afid><afid>112391251</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55509393300</author-url><authid>55509393300</authid><authname>Guedes-Martins L.</authname><surname>Guedes-Martins</surname><given-name>L.</given-name><initials>L.</initials><afid>60007249</afid><afid>60004346</afid><afid>60007249</afid><afid>112391251</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35555613900</author-url><authid>35555613900</authid><authname>Silva E.</authname><surname>Silva</surname><given-name>E.</given-name><initials>E.</initials><afid>60007249</afid><afid>60004346</afid><afid>60007249</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35555613900</author-url><authid>35555613900</authid><authname>Silva E.</authname><surname>Silva</surname><given-name>E.</given-name><initials>E.</initials><afid>60007249</afid><afid>60004346</afid><afid>60007249</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35555613900</author-url><authid>35555613900</authid><authname>Silva E.</authname><surname>Silva</surname><given-name>E.</given-name><initials>E.</initials><afid>60007249</afid><afid>60004346</afid><afid>60007249</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56538924500</author-url><authid>56538924500</authid><authname>Gaio A.</authname><surname>Gaio</surname><given-name>A. R.</given-name><initials>A.R.</initials><afid>60007249</afid><afid>60007249</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56538924500</author-url><authid>56538924500</authid><authname>Gaio A.</authname><surname>Gaio</surname><given-name>A. R.</given-name><initials>A.R.</initials><afid>60007249</afid><afid>60007249</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56012740500</author-url><authid>56012740500</authid><authname>Saraiva J.</authname><surname>Saraiva</surname><given-name>J.</given-name><initials>J.</initials><afid>60007249</afid><afid>60004346</afid><afid>60007249</afid><afid>112391251</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56012740500</author-url><authid>56012740500</authid><authname>Saraiva J.</authname><surname>Saraiva</surname><given-name>J.</given-name><initials>J.</initials><afid>60007249</afid><afid>60004346</afid><afid>60007249</afid><afid>112391251</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56012740500</author-url><authid>56012740500</authid><authname>Saraiva J.</authname><surname>Saraiva</surname><given-name>J.</given-name><initials>J.</initials><afid>60007249</afid><afid>60004346</afid><afid>60007249</afid><afid>112391251</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56012740500</author-url><authid>56012740500</authid><authname>Saraiva J.</authname><surname>Saraiva</surname><given-name>J.</given-name><initials>J.</initials><afid>60007249</afid><afid>60004346</afid><afid>60007249</afid><afid>112391251</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56602292800</author-url><authid>56602292800</authid><authname>Soares A.</authname><surname>Soares</surname><given-name>A. I.</given-name><initials>A.I.</initials><afid>60007249</afid><afid>60004346</afid><afid>60007249</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56602292800</author-url><authid>56602292800</authid><authname>Soares A.</authname><surname>Soares</surname><given-name>A. I.</given-name><initials>A.I.</initials><afid>60007249</afid><afid>60004346</afid><afid>60007249</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56602292800</author-url><authid>56602292800</authid><authname>Soares A.</authname><surname>Soares</surname><given-name>A. I.</given-name><initials>A.I.</initials><afid>60007249</afid><afid>60004346</afid><afid>60007249</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35338892800</author-url><authid>35338892800</authid><authname>Afonso J.</authname><surname>Afonso</surname><given-name>J.</given-name><initials>J.</initials><afid>60007249</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:16735937500</author-url><authid>16735937500</authid><authname>Macedo F.</authname><surname>Macedo</surname><given-name>F.</given-name><initials>F.</initials><afid>60007249</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:23017711100</author-url><authid>23017711100</authid><authname>Almeida H.</authname><surname>Almeida</surname><given-name>H.</given-name><initials>H.</initials><afid>60007249</afid><afid>60004346</afid><afid>60007249</afid><afid>105913316</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:23017711100</author-url><authid>23017711100</authid><authname>Almeida H.</authname><surname>Almeida</surname><given-name>H.</given-name><initials>H.</initials><afid>60007249</afid><afid>60004346</afid><afid>60007249</afid><afid>105913316</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:23017711100</author-url><authid>23017711100</authid><authname>Almeida H.</authname><surname>Almeida</surname><given-name>H.</given-name><initials>H.</initials><afid>60007249</afid><afid>60004346</afid><afid>60007249</afid><afid>105913316</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:23017711100</author-url><authid>23017711100</authid><authname>Almeida H.</authname><surname>Almeida</surname><given-name>H.</given-name><initials>H.</initials><afid>60007249</afid><afid>60004346</afid><afid>60007249</afid><afid>105913316</afid></author><authkeywords>Aortic isthmus | Doppler | NADPH oxidase | Oxidative stress | Pulsatility index | Uterine artery</authkeywords><intid>1785754040</intid><source-id>21100242403</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927592243"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927592243?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927592243&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927592243&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0925400515003652"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927592243</prism:url><dc:identifier>SCOPUS_ID:84927592243</dc:identifier><eid>2-s2.0-84927592243</eid><dc:title>Hydrogen peroxide biosensor utilizing a hybrid nano-interface of iron oxide nanoparticles and carbon nanotubes to assess the quality of milk</dc:title><dc:creator>Thandavan K.</dc:creator><prism:publicationName>Sensors and Actuators, B: Chemical</prism:publicationName><prism:issn>09254005</prism:issn><prism:volume>215</prism:volume><prism:pageRange>166-173</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.snb.2015.03.041</prism:doi><pii>S0925400515003652</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. A hybrid interface was developed using nano iron oxide and carbon nanotubes and this architecture offered an improved performance for the detection of hydrogen peroxide. Nano iron oxide was synthesized by a simple thermal co-precipitation technique and it was dispersed in nafionic solution. To this mixture added the catalase enzyme adsorbed multi-walled carbon nanotubes and this solution was used for the modification of the electrode. The morphology of the prepared nanocomposite was observed using FE-TEM and the electrochemical studies were carried out using cyclic voltammetry and amperometry. The linear range of the prepared amperometric sensor was found to be between 1.2 and 21.6 μM with a quick response time of less than 1 s. The interference, reproducibility and stability studies were carried out with satisfactory results. The limit of detection and limit of quantification were found to be 3.7 nM and 12.2 nM respectively. With the convincing results obtained in terms of the performance of the biosensor, this platform was successfully upgraded for the determination of hydrogen peroxide in the presence of milk samples.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>SASTRA University</affilname><name-variant>Centre for Nanotechnology and Advanced Biomaterials</name-variant><name-variant>School of Chemical and Biotechnology</name-variant><affiliation-city>Thanjavur, Tamil Nadu</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>SASTRA University</affilname><name-variant>Centre for Nanotechnology and Advanced Biomaterials</name-variant><name-variant>School of Electrical and Electronics Engineering</name-variant><affiliation-city>Thanjavur, Tamil Nadu</affiliation-city><affiliation-country>India</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:38863148500</author-url><authid>38863148500</authid><authname>Thandavan K.</authname><surname>Thandavan</surname><given-name>Kavitha</given-name><initials>K.</initials><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35795366300</author-url><authid>35795366300</authid><authname>Gandhi S.</authname><surname>Gandhi</surname><given-name>Sakthivel</given-name><initials>S.</initials><afid/></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55358367400</author-url><authid>55358367400</authid><authname>Nesakumar N.</authname><surname>Nesakumar</surname><given-name>Noel</given-name><initials>N.</initials><afid/></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8430496900</author-url><authid>8430496900</authid><authname>Sethuraman S.</authname><surname>Sethuraman</surname><given-name>Swaminathan</given-name><initials>S.</initials><afid/></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36523563700</author-url><authid>36523563700</authid><authname>Rayappan J.</authname><surname>Rayappan</surname><given-name>John Bosco Balaguru</given-name><initials>J.B.B.</initials><afid/><afid/></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36523563700</author-url><authid>36523563700</authid><authname>Rayappan J.</authname><surname>Rayappan</surname><given-name>John Bosco Balaguru</given-name><initials>J.B.B.</initials><afid/><afid/></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35409613500</author-url><authid>35409613500</authid><authname>Krishnan U.</authname><surname>Krishnan</surname><given-name>Uma Maheswari</given-name><initials>U.M.</initials><afid/></author><authkeywords>Carbon nanotubes | Catalase | Electrochemical bio-sensor | Hybrid interface | Iron oxide | Milk analysis</authkeywords><intid>535647946</intid><source-id>25236</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928157451"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928157451?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928157451&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928157451&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2352154615000534"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928157451</prism:url><dc:identifier>SCOPUS_ID:84928157451</dc:identifier><eid>2-s2.0-84928157451</eid><dc:title>Genetics of human memory functions in healthy cohorts</dc:title><dc:creator>Papassotiropoulos A.</dc:creator><prism:publicationName>Current Opinion in Behavioral Sciences</prism:publicationName><prism:eIssn>23521546</prism:eIssn><prism:volume>4</prism:volume><prism:pageRange>7380</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cobeha.2015.04.004</prism:doi><pii>S2352154615000534</pii><dc:description>© 2015 Elsevier Ltd. The study of the genetic underpinnings of human memory has important implications for the understanding of memory-related molecular processes. Here we show that human genetic research has contributed to such understanding. While candidate gene studies have partially confirmed animal-based hypotheses, genome-wide association studies (GWAS) have provided evidence for novel memory-related genes. In this article we review candidate gene and GWAS findings related to working memory, episodic memory and emotional memory in healthy cohorts. These memory types are disturbed in neuropsychiatric conditions, including schizophrenia and posttraumatic stress disorder (PTSD). Studies on the genetic underpinnings of memory functions in healthy cohorts are important for a better understanding of physiological processes and for the identification of novel drug targets related to such conditions.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023588</affiliation-url><afid>60023588</afid><affilname>Universitat Basel</affilname><name-variant>University of Basel</name-variant><affiliation-city>Basel</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023588</affiliation-url><afid>60023588</afid><affilname>Universitat Basel</affilname><name-variant>University of Basel</name-variant><affiliation-city>Basel</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015184</affiliation-url><afid>60015184</afid><affilname>Biozentrum University of Basel</affilname><name-variant>University of Basel</name-variant><affiliation-city>Basel</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023588</affiliation-url><afid>60023588</afid><affilname>Universitat Basel</affilname><name-variant>University of Basel</name-variant><affiliation-city>Basel</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023588</affiliation-url><afid>60023588</afid><affilname>Universitat Basel</affilname><name-variant>University of Basel</name-variant><affiliation-city>Basel</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56223193900</author-url><authid>56223193900</authid><authname>Papassotiropoulos A.</authname><surname>Papassotiropoulos</surname><given-name>Andreas</given-name><initials>A.</initials><afid>60023588</afid><afid>60023588</afid><afid>60015184</afid><afid>60023588</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56223193900</author-url><authid>56223193900</authid><authname>Papassotiropoulos A.</authname><surname>Papassotiropoulos</surname><given-name>Andreas</given-name><initials>A.</initials><afid>60023588</afid><afid>60023588</afid><afid>60015184</afid><afid>60023588</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56223193900</author-url><authid>56223193900</authid><authname>Papassotiropoulos A.</authname><surname>Papassotiropoulos</surname><given-name>Andreas</given-name><initials>A.</initials><afid>60023588</afid><afid>60023588</afid><afid>60015184</afid><afid>60023588</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56223193900</author-url><authid>56223193900</authid><authname>Papassotiropoulos A.</authname><surname>Papassotiropoulos</surname><given-name>Andreas</given-name><initials>A.</initials><afid>60023588</afid><afid>60023588</afid><afid>60015184</afid><afid>60023588</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603596748</author-url><authid>6603596748</authid><authname>de Quervain D.</authname><surname>de Quervain</surname><given-name>Dominique J F</given-name><initials>D.J.F.</initials><afid>60023588</afid><afid>60023588</afid><afid>60023588</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603596748</author-url><authid>6603596748</authid><authname>de Quervain D.</authname><surname>de Quervain</surname><given-name>Dominique J F</given-name><initials>D.J.F.</initials><afid>60023588</afid><afid>60023588</afid><afid>60023588</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603596748</author-url><authid>6603596748</authid><authname>de Quervain D.</authname><surname>de Quervain</surname><given-name>Dominique J F</given-name><initials>D.J.F.</initials><afid>60023588</afid><afid>60023588</afid><afid>60023588</afid></author><intid>1785733532</intid><source-id>21100363813</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84922631956"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84922631956?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84922631956&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84922631956&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2352154614000394"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84922631956</prism:url><dc:identifier>SCOPUS_ID:84922631956</dc:identifier><eid>2-s2.0-84922631956</eid><dc:title>Enhancing attention through training</dc:title><dc:creator>Posner M.</dc:creator><prism:publicationName>Current Opinion in Behavioral Sciences</prism:publicationName><prism:eIssn>23521546</prism:eIssn><prism:volume>4</prism:volume><prism:pageRange>1-5</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cobeha.2014.12.008</prism:doi><pii>S2352154614000394</pii><dc:description>© 2015 Elsevier Ltd. Attention can be improved by repetition of a specific task that involves an attention network (network training), or by exercise or meditation that changes the brain state (state training). We first review the concept of attention networks that link changes in orienting, alerting and executive control to brain networks. Network training through video games or computer exercises can improve aspects of attention. The extent of transfer beyond the trained task is a controversial issue. Mindfulness is a form of meditation that keeps attention focused on the current moment. Some forms of meditation have been shown to improve executive attention reduce stress and produce specific brain changes. Additional research is needed to understand the limits and mechanisms of these effects.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012317</affiliation-url><afid>60012317</afid><affilname>University of Oregon</affilname><name-variant>University of Oregon</name-variant><affiliation-city>Eugene</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021285</affiliation-url><afid>60021285</afid><affilname>Texas Tech University at Lubbock</affilname><name-variant>Texas Tech. University</name-variant><affiliation-city>Lubbock</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7201990629</author-url><authid>7201990629</authid><authname>Posner M.</authname><surname>Posner</surname><given-name>Michael I.</given-name><initials>M.I.</initials><afid>60012317</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004265324</author-url><authid>7004265324</authid><authname>Rothbart M.</authname><surname>Rothbart</surname><given-name>Mary K.</given-name><initials>M.K.</initials><afid>60012317</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7404591887</author-url><authid>7404591887</authid><authname>Tang Y.</authname><surname>Tang</surname><given-name>Yi Yuan</given-name><initials>Y.Y.</initials><afid>60021285</afid></author><intid>1784845082</intid><source-id>21100363813</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930198525"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930198525?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930198525&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930198525&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167945715000846"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930198525</prism:url><dc:identifier>SCOPUS_ID:84930198525</dc:identifier><eid>2-s2.0-84930198525</eid><dc:title>Effects of concurrent physical and cognitive demands on arm movement kinematics in a repetitive upper-extremity precision task</dc:title><dc:creator>Srinivasan D.</dc:creator><prism:publicationName>Human Movement Science</prism:publicationName><prism:issn>01679457</prism:issn><prism:eIssn>18727646</prism:eIssn><prism:volume>42</prism:volume><prism:pageRange>89-99</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.humov.2015.05.001</prism:doi><pii>S0167945715000846</pii><dc:description>© 2015 Elsevier B.V. The effect of concurrent physical and cognitive demands on arm motor control is poorly understood. This exploratory study compared movement kinematics in a repetitive high-precision pipetting task with and without additional concurrent cognitive demands in the form of instructions necessary to locate the correct target tube. Thirty-five healthy female subjects performed a standardized pipetting task, transferring liquid repeatedly from one pick-up tube to different target tubes. In the reference condition, lights indicated the target tube in each movement cycle, while the target tube had to be deciphered from a row and column number on a computer screen in the condition with additional cognitive demands. Kinematics of the dominant arm was assessed using the central tendency and variability of the pipette-tip end-point trajectory and joint kinematics properties of the shoulder and elbow. Movements slowed down (lower velocities and higher area under the movement curves) and trajectory variability increased in the condition with additional cognitive demands, but there were no changes in the kinematics properties such as joint range of motion, times of acceleration and deceleration (as indicated by the time to peak velocity), average angles, or phase relationships between angle and angular velocity of shoulder or elbow movements between the two conditions. Further, there were also no differences in the size or structure of variability of the shoulder and elbow joint angles, suggesting that subjects could maintain the motor repertoire unaltered in the presence of these specific additional cognitive demands. Further studies should address motor control at other levels of concurrent cognitive demands, and with motor tasks that are less automated than the pipetting task used in the present study, so as to gain an increased understanding of the effect of concurrent cognitive demands for other activities of relevance to daily life.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031052</affiliation-url><afid>60031052</afid><affilname>Hogskolan i Gavle</affilname><name-variant>University of Gävle</name-variant><affiliation-city>Gavle</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022134</affiliation-url><afid>60022134</afid><affilname>Aalborg Universitet</affilname><name-variant>Aalborg University</name-variant><affiliation-city>Aalborg</affiliation-city><affiliation-country>Denmark</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55190345500</author-url><authid>55190345500</authid><authname>Srinivasan D.</authname><surname>Srinivasan</surname><given-name>Divya</given-name><initials>D.</initials><afid>60031052</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003473142</author-url><authid>7003473142</authid><authname>Mathiassen S.</authname><surname>Mathiassen</surname><given-name>Svend Erik</given-name><initials>S.E.</initials><afid>60031052</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:25931713300</author-url><authid>25931713300</authid><authname>Samani A.</authname><surname>Samani</surname><given-name>Afshin</given-name><initials>A.</initials><afid>60022134</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6701448643</author-url><authid>6701448643</authid><authname>Madeleine P.</authname><surname>Madeleine</surname><given-name>Pascal</given-name><initials>P.</initials><afid>60022134</afid></author><authkeywords>Cyclic movements | Mental demands | Motor control | Movement variability | Pipetting</authkeywords><intid>1786087326</intid><source-id>14018</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930194047"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930194047?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930194047&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930194047&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167945715000901"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930194047</prism:url><dc:identifier>SCOPUS_ID:84930194047</dc:identifier><eid>2-s2.0-84930194047</eid><dc:title>Real-time MRI comparisons of brass players: A methodological pilot study</dc:title><dc:creator>Iltis P.</dc:creator><prism:publicationName>Human Movement Science</prism:publicationName><prism:issn>01679457</prism:issn><prism:eIssn>18727646</prism:eIssn><prism:volume>42</prism:volume><prism:pageRange>132-145</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.humov.2015.04.013</prism:doi><pii>S0167945715000901</pii><dc:description>© 2015 Elsevier B.V. This paper describes the use of real-time MRI at 30. frames/s in studying motor function within the oropharyngeal cavity of a trumpet, horn, trombone, and tuba player. Using Image J and customized MB-Ruler Pro software, analyses of discrete 33.3. ms snapshots of motion extracted from real-time MRI films obtained during an ascending five note sequence performed on a plastic practice device (B.E.R.P.) revealed inter-instrument differences in oropharyngeal cavity size and tongue conformation when moving from lower to higher notes. Tuba and trombone show a progressive decrease in oropharyngeal area featuring an upward and forward displacement of the tongue. Trumpet showed progressive increases in oropharyngeal area, with the posterior compartment showing the largest change, while horn essentially showed no change. A novel dynamic quantitative analysis method is also described utilizing Matlab. This method employs user-specified line profiles, aligned to the direction of the movement of interest. It takes advantage of time-varying pixel luminescence to derive spatial and temporal gradients. These gradients make possible the acquisition of kinematic data to describe movement in terms of slower position changes (spatial gradient) as well as fast, articulatory movements (temporal gradient). Spatial gradient analysis for the trumpet player demonstrates a progressive raising of the tongue during the ascending five note exercise. Temporal gradient analysis of double-tonguing revealed similarities in range of motion, anti-phase behavior, and frequency across instruments with respect to movements of the tongue tip and back of tongue. The paper concludes by making recommendations for extending these methods to studying musician's dystonia.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113487834</affiliation-url><afid>113487834</afid><affilname>Gordon College</affilname><name-variant>Gordon College</name-variant><affiliation-city>Athens</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112602384</affiliation-url><afid>112602384</afid><affilname>Hochschule für Musik</affilname><name-variant>Hochschule für Musik</name-variant><affiliation-city>Hannover</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032895</affiliation-url><afid>60032895</afid><affilname>Max Planck Institute for Biophysical Chemistry (Karl Friedrich Bonhoeffer Institute)</affilname><name-variant>Max Planck Institute for Biophysical Chemistry</name-variant><affiliation-city>Gottingen</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602353754</author-url><authid>6602353754</authid><authname>Iltis P.</authname><surname>Iltis</surname><given-name>Peter W.</given-name><initials>P.W.</initials><afid>113487834</afid><afid>112602384</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602353754</author-url><authid>6602353754</authid><authname>Iltis P.</authname><surname>Iltis</surname><given-name>Peter W.</given-name><initials>P.W.</initials><afid>113487834</afid><afid>112602384</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:14050955700</author-url><authid>14050955700</authid><authname>Schoonderwaldt E.</authname><surname>Schoonderwaldt</surname><given-name>Erwin</given-name><initials>E.</initials><afid>112602384</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35764170400</author-url><authid>35764170400</authid><authname>Zhang S.</authname><surname>Zhang</surname><given-name>Shuo</given-name><initials>S.</initials><afid>60032895</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56511371700</author-url><authid>56511371700</authid><authname>Frahm J.</authname><surname>Frahm</surname><given-name>Jens</given-name><initials>J.</initials><afid>60032895</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7004079354</author-url><authid>7004079354</authid><authname>Altenmüller E.</authname><surname>Altenmüller</surname><given-name>Eckart</given-name><initials>E.</initials><afid>112602384</afid></author><authkeywords>Brass players | Magnetic resonance imaging</authkeywords><intid>1536087742</intid><source-id>14018</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927632329"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927632329?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927632329&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927632329&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0309174015000856"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927632329</prism:url><dc:identifier>SCOPUS_ID:84927632329</dc:identifier><eid>2-s2.0-84927632329</eid><dc:title>Cholesterol and fatty acid composition of longissimus thoracis from water buffalo (Bubalus bubalis) and Brahman-influenced cattle raised under savannah conditions</dc:title><dc:creator>Giuffrida-Mendoza M.</dc:creator><prism:publicationName>Meat Science</prism:publicationName><prism:issn>03091740</prism:issn><prism:volume>106</prism:volume><prism:pageRange>44-49</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.meatsci.2015.03.024</prism:doi><pii>S0309174015000856</pii><dc:description>© 2015 Elsevier Ltd. Male (n. =. 66) water buffalo (Buffalo) and Brahman-influenced cattle (Brahman) were born, raised, weaned, fattened on grazing savannah and harvested at two different ages (19 and 24. months) to compare lipid composition of the longissimus thoracis muscle. Half of the animals were castrated at seven months of age (MOA) to examine the castration effects. At 24 MOA Brahman steers showed the highest content of total lipids (. P&lt;. 0.05). No significant variation was detected in cholesterol content for either the main or interaction effects in the age groups. Some individual fatty acids varied with the species (. P&lt;. 0.05), however, interspecific similarities were found in fatty acid ratios. For health-related indices, only atherogenic index (AI) showed lower values in favor of Buffalo meat (. P&lt;. 0.05) at both harvesting ages. Although, meat derived from both bovid groups was leaner and showed lower cholesterol level, AI indicates that Buffalo meat might be beneficial from a human health standpoint.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Universidad del Zulia</affilname><name-variant>Facultad de Medicina</name-variant><affiliation-city>Aptdo, Maracaibo</affiliation-city><affiliation-country>Venezuela</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Universidad del Zulia</affilname><name-variant>Facultad de Agronomía</name-variant><affiliation-city>Aptdo, Maracaibo</affiliation-city><affiliation-country>Venezuela</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Universidad del Zulia</affilname><name-variant>Facultad de Ciencias Veterinarias</name-variant><affiliation-city>Aptdo, Maracaibo</affiliation-city><affiliation-country>Venezuela</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>University of Manitoba</affilname><name-variant>Department of Animal Science</name-variant><affiliation-city>Winnipeg</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23980105000</author-url><authid>23980105000</authid><authname>Giuffrida-Mendoza M.</authname><surname>Giuffrida-Mendoza</surname><given-name>Maria</given-name><initials>M.</initials><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7801513612</author-url><authid>7801513612</authid><authname>de Moreno L.</authname><surname>de Moreno</surname><given-name>Lilia Arenas</given-name><initials>L.A.</initials><afid/></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003545531</author-url><authid>7003545531</authid><authname>Huerta-Leidenz N.</authname><surname>Huerta-Leidenz</surname><given-name>Nelson</given-name><initials>N.</initials><afid/></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6507323027</author-url><authid>6507323027</authid><authname>Uzcátegui-Bracho S.</authname><surname>Uzcátegui-Bracho</surname><given-name>Sojan</given-name><initials>S.</initials><afid/></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6508162177</author-url><authid>6508162177</authid><authname>Valero-Leal K.</authname><surname>Valero-Leal</surname><given-name>Kutchynskaya</given-name><initials>K.</initials><afid/></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56591978500</author-url><authid>56591978500</authid><authname>Romero S.</authname><surname>Romero</surname><given-name>Sonia</given-name><initials>S.</initials><afid/></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6506610374</author-url><authid>6506610374</authid><authname>Rodas-González A.</authname><surname>Rodas-González</surname><given-name>Argenis</given-name><initials>A.</initials><afid/></author><authkeywords>Beef cattle | Cholesterol | Fatty acid | Intramuscular fat | Water buffalo</authkeywords><intid>1035642539</intid><source-id>21219</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928344823"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928344823?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928344823&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928344823&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0378595515000842"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928344823</prism:url><dc:identifier>SCOPUS_ID:84928344823</dc:identifier><eid>2-s2.0-84928344823</eid><dc:title>Nicotinamide adenine dinucleotide: An essential factor in preserving hearing in cisplatin-induced ototoxicity</dc:title><dc:creator>Kim H.</dc:creator><prism:publicationName>Hearing Research</prism:publicationName><prism:issn>03785955</prism:issn><prism:eIssn>18785891</prism:eIssn><prism:volume>326</prism:volume><prism:pageRange>30-39</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.heares.2015.04.002</prism:doi><pii>S0378595515000842</pii><dc:description>© 2015 Elsevier B.V. Ototoxicity is an important issue in patients receiving cisplatin chemotherapy. Numerous studies have demonstrated that several mechanisms, including oxidative stress, DNA damage, and inflammatory responses, are closely associated with cisplatin-induced ototoxicity. Although much attention has been directed at identifying ways to protect the inner ear from cisplatin-induced damage, the precise underlying mechanisms have not yet been elucidated. The cofactor nicotinamide adenine dinucleotide (NAD&lt;sup&gt;+&lt;/sup&gt;) has emerged as an important regulator of cellular energy metabolism and homeostasis. NAD&lt;sup&gt;+&lt;/sup&gt; acts as a cofactor for various enzymes including sirtuins (SIRTs) and poly(ADP-ribose) polymerases (PARPs), and therefore, maintaining adequate NAD&lt;sup&gt;+&lt;/sup&gt; levels has therapeutic benefits because of its effect on NAD&lt;sup&gt;+&lt;/sup&gt;-dependent enzymes. Recent studies demonstrated that disturbance in intracellular NAD&lt;sup&gt;+&lt;/sup&gt; levels is critically involved in cisplatin-induced cochlear damage associated with oxidative stress, DNA damage, and inflammatory responses. In this review, we describe the importance of NAD&lt;sup&gt;+&lt;/sup&gt; in cisplatin-induced ototoxicity and discuss potential strategies for the prevention or treatment of cisplatin-induced ototoxicity with a particular focus on NAD&lt;sup&gt;+&lt;/sup&gt;-dependent cellular pathways.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033270</affiliation-url><afid>60033270</afid><affilname>Wonkwang University</affilname><name-variant>Wonkwang University</name-variant><affiliation-city>Iksan</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033270</affiliation-url><afid>60033270</afid><affilname>Wonkwang University</affilname><name-variant>Wonkwang University</name-variant><affiliation-city>Iksan</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033270</affiliation-url><afid>60033270</afid><affilname>Wonkwang University</affilname><name-variant>Wonkwang University</name-variant><affiliation-city>Iksan</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115181519</affiliation-url><afid>115181519</afid><affilname>PAEAN Biotechnology</affilname><name-variant>PAEAN Biotechnology</name-variant><affiliation-city>Daejeon</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">14</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56055182200</author-url><authid>56055182200</authid><authname>Kim H.</authname><surname>Kim</surname><given-name>Hyung Jin</given-name><initials>H.J.</initials><afid>60033270</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56597627100</author-url><authid>56597627100</authid><authname>Oh G.</authname><surname>Oh</surname><given-name>Gi Su</given-name><initials>G.S.</initials><afid>60033270</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:37034973800</author-url><authid>37034973800</authid><authname>Shen A.</authname><surname>Shen</surname><given-name>AiHua</given-name><initials>A.</initials><afid>60033270</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56180981700</author-url><authid>56180981700</authid><authname>Lee S.</authname><surname>Lee</surname><given-name>Su Bin</given-name><initials>S.B.</initials><afid>60033270</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56492728100</author-url><authid>56492728100</authid><authname>Khadka D.</authname><surname>Khadka</surname><given-name>Dipendra</given-name><initials>D.</initials><afid>60033270</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56492321300</author-url><authid>56492321300</authid><authname>Pandit A.</authname><surname>Pandit</surname><given-name>Arpana</given-name><initials>A.</initials><afid>60033270</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56603690100</author-url><authid>56603690100</authid><authname>Shim H.</authname><surname>Shim</surname><given-name>Hyeok</given-name><initials>H.</initials><afid>60033270</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56603394000</author-url><authid>56603394000</authid><authname>Yang S.</authname><surname>Yang</surname><given-name>Sei Hoon</given-name><initials>S.H.</initials><afid>60033270</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56603646200</author-url><authid>56603646200</authid><authname>Cho E.</authname><surname>Cho</surname><given-name>Eun Young</given-name><initials>E.Y.</initials><afid>60033270</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7404788254</author-url><authid>7404788254</authid><authname>Song J.</authname><surname>Song</surname><given-name>Jeho</given-name><initials>J.</initials><afid>60033270</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:26531342400</author-url><authid>26531342400</authid><authname>Kwak T.</authname><surname>Kwak</surname><given-name>Tae Hwan</given-name><initials>T.H.</initials><afid>115181519</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56457635800</author-url><authid>56457635800</authid><authname>Choe S.</authname><surname>Choe</surname><given-name>Seong Kyu</given-name><initials>S.K.</initials><afid>60033270</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7401895726</author-url><authid>7401895726</authid><authname>Park R.</authname><surname>Park</surname><given-name>Raekil</given-name><initials>R.</initials><afid>60033270</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:7102300026</author-url><authid>7102300026</authid><authname>So H.</authname><surname>So</surname><given-name>Hong Seob</given-name><initials>H.S.</initials><afid>60033270</afid></author><authkeywords>4-HNE | CBP | ERK | ICAM | IDH2 | IL | IκB | MAPK | MCP | Mdm2 | MIP | NAD&lt;sup&gt;+&lt;/sup&gt; | NF-κB | NOX | NOXA | NQO1 | OHCs | PARP | PCAF | PIG3 | PUMA | RANTES | ROS | SIRT | TNF | α-KGDH</authkeywords><intid>535768969</intid><source-id>13707</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928565191"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928565191?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928565191&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928565191&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0028390815001215"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928565191</prism:url><dc:identifier>SCOPUS_ID:84928565191</dc:identifier><eid>2-s2.0-84928565191</eid><dc:title>Sex differences in GABA&lt;inf&gt;B&lt;/inf&gt;R-GIRK signaling in layer 5/6 pyramidal neurons of the mouse prelimbic cortex</dc:title><dc:creator>Marron Fernandez De Velasco E.</dc:creator><prism:publicationName>Neuropharmacology</prism:publicationName><prism:issn>00283908</prism:issn><prism:eIssn>18737064</prism:eIssn><prism:volume>95</prism:volume><prism:pageRange>353-360</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.neuropharm.2015.03.029</prism:doi><pii>S0028390815001215</pii><dc:description>© 2015 Elsevier Ltd. All rights reserved. The medial prefrontal cortex (mPFC) has been implicated in multiple disorders characterized by clear sex differences, including schizophrenia, attention deficit hyperactivity disorder, post-traumatic stress disorder, depression, and drug addiction. These sex differences likely represent underlying differences in connectivity and/or the balance of neuronal excitability within the mPFC. Recently, we demonstrated that signaling via the metabotropic γ-aminobutyric acid receptor (GABA&lt;inf&gt;B&lt;/inf&gt;R) and G protein-gated inwardly-rectifying K&lt;sup&gt;+&lt;/sup&gt; (GIRK/Kir3) channels modulates the excitability of the key output neurons of the mPFC, the layer 5/6 pyramidal neurons. Here, we report a sex difference in the GABA&lt;inf&gt;B&lt;/inf&gt;R-GIRK signaling pathway in these neurons. Specifically, GABA&lt;inf&gt;B&lt;/inf&gt;R-dependent GIRK currents recorded in the prelimbic region of the mPFC were larger in adolescent male mice than in female counterparts. Interestingly, this sex difference was not observed in layer 5/6 pyramidal neurons of the adjacent infralimbic cortex, nor was it seen in young adult mice. The sex difference in GABA&lt;inf&gt;B&lt;/inf&gt;R-GIRK signaling is not attributable to different expression levels of signaling pathway components, but rather to a phosphorylation-dependent trafficking mechanism. Thus, sex differences related to some diseases associated with altered mPFC function may be explained in part by sex differences in GIRK-dependent signaling in mPFC pyramidal neurons.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005745</affiliation-url><afid>60005745</afid><affilname>University of Minnesota System</affilname><name-variant>University of Minnesota</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005745</affiliation-url><afid>60005745</afid><affilname>University of Minnesota System</affilname><name-variant>University of Minnesota</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000823</affiliation-url><afid>60000823</afid><affilname>Universidad de Castilla-La Mancha</affilname><name-variant>University of Castilla-La Mancha</name-variant><affiliation-city>Ciudad Real</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56607186200</author-url><authid>56607186200</authid><authname>Marron Fernandez De Velasco E.</authname><surname>Marron Fernandez De Velasco</surname><given-name>Ezequiel</given-name><initials>E.</initials><afid>60005745</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:17134912800</author-url><authid>17134912800</authid><authname>Hearing M.</authname><surname>Hearing</surname><given-name>Matthew</given-name><initials>M.</initials><afid>60005745</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56018030700</author-url><authid>56018030700</authid><authname>Xia Z.</authname><surname>Xia</surname><given-name>Zhilian</given-name><initials>Z.</initials><afid>60005745</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55782849800</author-url><authid>55782849800</authid><authname>Victoria N.</authname><surname>Victoria</surname><given-name>Nicole C.</given-name><initials>N.C.</initials><afid>60005745</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7005199225</author-url><authid>7005199225</authid><authname>Luján R.</authname><surname>Luján</surname><given-name>Rafael</given-name><initials>R.</initials><afid>60000823</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7004157253</author-url><authid>7004157253</authid><authname>Wickman K.</authname><surname>Wickman</surname><given-name>Kevin</given-name><initials>K.</initials><afid>60005745</afid></author><authkeywords>GABA | GIRK | Kir3 | Medial prefrontal cortex | Sex differences | Slice electrophysiology</authkeywords><intid>2035797364</intid><source-id>20435</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927660145"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927660145?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927660145&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927660145&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0031938415002073"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927660145</prism:url><dc:identifier>SCOPUS_ID:84927660145</dc:identifier><eid>2-s2.0-84927660145</eid><dc:title>Comparing interval and continuous exercise training regimens on neurotrophic factors in rat brain</dc:title><dc:creator>Afzalpour M.</dc:creator><prism:publicationName>Physiology and Behavior</prism:publicationName><prism:issn>00319384</prism:issn><prism:eIssn>1873507X</prism:eIssn><prism:volume>147</prism:volume><prism:pageRange>78-83</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.physbeh.2015.04.012</prism:doi><pii>S0031938415002073</pii><dc:description>© 2015 Elsevier Inc. The research literature suggests that oxidative stress and pro-inflammatory factors influence neurotrophins in vitro. However, there is insufficient information about their effects on exercise training conditions, especially during high intensity trainings. This study aimed to compare the effects of 6weeks of high intensity interval and continuous training regimens on brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), hydrogen peroxide (H&lt;inf&gt;2&lt;/inf&gt;O&lt;inf&gt;2&lt;/inf&gt;), and tumor necrosis factor alpha (TNF-α) in the rat brain. For this purpose, twenty-four Albino Wistar rats were divided into sedentary control (SC), high intensity interval training (HIIT), and continuous training (CT) groups. Both HIIT and CT regimens increased H&lt;inf&gt;2&lt;/inf&gt;O&lt;inf&gt;2&lt;/inf&gt; level and TNF-α concentration in the brain, and the alterations made were greater following HIIT than CT. In addition, both HIIT and CT regimens increased BDNF and GDNF concentrations significantly, with a higher elevation following HIIT than CT. Furthermore, H&lt;inf&gt;2&lt;/inf&gt;O&lt;inf&gt;2&lt;/inf&gt; level and TNF-α concentration correlated positively with both BDNF and GDNF concentrations. Generally, high intensity interval training regimen, rather than continuous training regimen, is highly potential to improve BDNF and GDNF through a greater increase in H&lt;inf&gt;2&lt;/inf&gt;O&lt;inf&gt;2&lt;/inf&gt; and TNF-α as oxidative stress and pro-inflammatory factors.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030265</affiliation-url><afid>60030265</afid><affilname>University of Birjand</affilname><name-variant>Birjand University</name-variant><affiliation-city>Birjand</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030265</affiliation-url><afid>60030265</afid><affilname>University of Birjand</affilname><name-variant>Birjand University</name-variant><affiliation-city>Birjand</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022425</affiliation-url><afid>60022425</afid><affilname>Birjand University of Medical Sciences</affilname><name-variant>Birjand University of Medical Sciences</name-variant><affiliation-city>Birjand</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60089223</affiliation-url><afid>60089223</afid><affilname>Gonabad University of Medical Sciences</affilname><name-variant>Gonabad University of Medical Sciences</name-variant><affiliation-city>Gonabad</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56593160400</author-url><authid>56593160400</authid><authname>Afzalpour M.</authname><surname>Afzalpour</surname><given-name>Mohammad Esmaiel</given-name><initials>M.E.</initials><afid>60030265</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56593259000</author-url><authid>56593259000</authid><authname>Chadorneshin H.</authname><surname>Chadorneshin</surname><given-name>Hossein Taheri</given-name><initials>H.T.</initials><afid>60030265</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35733812200</author-url><authid>35733812200</authid><authname>Foadoddini M.</authname><surname>Foadoddini</surname><given-name>Mohsen</given-name><initials>M.</initials><afid>60022425</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56593074400</author-url><authid>56593074400</authid><authname>Eivari H.</authname><surname>Eivari</surname><given-name>Hossein Abtahi</given-name><initials>H.A.</initials><afid>60089223</afid></author><authkeywords>Brain-derived neurotrophic factor | Continuous training | Glial cell line-derived neurotrophic factor | Hydrogen peroxide | Interval training | Tumor necrosis factor alpha</authkeywords><intid>1785648784</intid><source-id>24007</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927728686"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927728686?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927728686&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927728686&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0890406515000523"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927728686</prism:url><dc:identifier>SCOPUS_ID:84927728686</dc:identifier><eid>2-s2.0-84927728686</eid><dc:title>"It was like reading a detective novel": Using PAR to work together for culture change</dc:title><dc:creator>Fortune D.</dc:creator><prism:publicationName>Journal of Aging Studies</prism:publicationName><prism:issn>08904065</prism:issn><prism:volume>34</prism:volume><prism:pageRange>38-47</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jaging.2015.04.002</prism:doi><pii>S0890406515000523</pii><dc:description>© 2015 Elsevier Inc. Participatory action research (PAR), with its focus on engagement and collaboration, is uniquely suited to enhancing culture change initiatives in dementia care. Yet, there is limited literature of its application to culture change approaches in care settings, and even less in dementia specific care contexts. To address these gaps in the literature, the purpose of this paper is to examine the complexities of a PAR project aimed at changing the culture of dementia care in two diverse dementia care settings, including a long term care (LTC) and community care setting. Drawing from data gathered throughout the PAR process, we unpack the challenges experienced by participants working together to guide culture change within their respective care settings. These challenges include: overextending selves through culture change participation; fluctuating group membership; feeling uncertainty, confusion and apprehension about the process; frustratingly slow process; and seeking diverse group representation in decision making. We also highlight the potential for appreciative inquiry (AI) to be integrated with PAR to guide a process whereby participants involved in culture change initiatives can develop strategies to mitigate challenges they experience. We view the challenges and strategies shared here as being constructive to would-be culture change agents and hope this paper will move others to consider the use of PAR when engaging in culture change initiatives.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014171</affiliation-url><afid>60014171</afid><affilname>University of Waterloo</affilname><name-variant>Univ of Waterloo</name-variant><affiliation-city>Waterloo</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012468</affiliation-url><afid>60012468</afid><affilname>University of Windsor</affilname><name-variant>Univ of Windsor</name-variant><affiliation-city>Windsor</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36982932900</author-url><authid>36982932900</authid><authname>Fortune D.</authname><surname>Fortune</surname><given-name>Darla</given-name><initials>D.</initials><afid>60014171</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56594618900</author-url><authid>56594618900</authid><authname>McKeown J.</authname><surname>McKeown</surname><given-name>Janet</given-name><initials>J.</initials><afid>60014171</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003368303</author-url><authid>7003368303</authid><authname>Dupuis S.</authname><surname>Dupuis</surname><given-name>Sherry</given-name><initials>S.</initials><afid>60014171</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:11739329400</author-url><authid>11739329400</authid><authname>de Witt L.</authname><surname>de Witt</surname><given-name>Lorna</given-name><initials>L.</initials><afid>60012468</afid></author><authkeywords>Appreciative inquiry | Culture change | Dementia | Long-term care | Participatory action research</authkeywords><intid>1035660685</intid><source-id>29194</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929611341"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929611341?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929611341&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929611341&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0303846715001535"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929611341</prism:url><dc:identifier>SCOPUS_ID:84929611341</dc:identifier><eid>2-s2.0-84929611341</eid><dc:title>Pre-protection re-haemorrhage following aneurysmal subarachnoid haemorrhage: Where are we now?</dc:title><dc:creator>Davies B.</dc:creator><prism:publicationName>Clinical Neurology and Neurosurgery</prism:publicationName><prism:issn>03038467</prism:issn><prism:eIssn>18726968</prism:eIssn><prism:volume>135</prism:volume><prism:pageRange>22-26</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.clineuro.2015.04.017</prism:doi><pii>S0303846715001535</pii><dc:description>© 2015 Elsevier B.V. Abstract Background Re-haemorrhage is a negative, prognostic predictor of outcome in aneurysmal subarachnoid haemorrhage (aSAH). The process of aSAH care has changed however, and most reports on re-haemorrhage are from a time when aneurysms were treated predominantly by open microneurosurgery. The current frequency and impact of re-haemorrhage on outcome in the 'post-ISAT' era is therefore unknown. The aim of this study was to review current outcome, risk factors and causes for inpatient re-haemorrhage in aSAH patients. Method The departmental aSAH database was reviewed between Jan 2008 and March 2014 (N = 1008) to identify cases of re-haemorrhage. Re-haemorrhage was defined as inhospital deterioration in neurological status with CT confirmation of rebleeding. Binary logistic regression was used to (a) determine the impact of re-haemorrhage on outcome adjusted for age and injury severity and (b) to identify any independent predictors of its occurrence. Results Re-haemorrhage occurred in 55 (5.4%) of patients and most cases had occurred within 24 h of ictus (32, 58.1%). Re-haemorrhage was an independent predictor of death (AOR 10.0, p &lt; 0.0005, 95%CI 4.9, 20.2) and unfavourable outcome (AOR 5.8 p &lt; 0.0005, 95%CI 2.4, 14.0). Only WFNS grade on admission was an independent predictor (AOR 1.7, p &lt; 0.0005, 95%CI 1.4, 1.9) of re-haemorrhage. Of the patients who re-bled, in 20 there was no intention to treat due to severe brain injury and in the remainder, the majority occurred early (&lt;24 h) (19/35, 54%), or had complicated aneurysm morphology (10/35, 31%) which necessitated a delayed treatment strategy. Conclusions Re-haemorrhage remains a poor prognostic predictor in aSAH and the grade of SAH is an independent risk factor. Earlier treatment of complex aneurysms could offer the most immediate improvements in its incidence.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008873</affiliation-url><afid>60008873</afid><affilname>Salford Royal NHS FoundationTrust</affilname><name-variant>Salford Royal Hospitals NHS Trust</name-variant><affiliation-city>Salford</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>cp</subtype><subtypeDescription>Conference Paper</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55641809100</author-url><authid>55641809100</authid><authname>Davies B.</authname><surname>Davies</surname><given-name>Benjamin M.</given-name><initials>B.M.</initials><afid>60008873</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56651486700</author-url><authid>56651486700</authid><authname>Chung K.</authname><surname>Chung</surname><given-name>K. H Carlos</given-name><initials>K.H.C.</initials><afid>60008873</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55642014000</author-url><authid>55642014000</authid><authname>Dulhanty L.</authname><surname>Dulhanty</surname><given-name>Louise</given-name><initials>L.</initials><afid>60008873</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:36463361600</author-url><authid>36463361600</authid><authname>Galea J.</authname><surname>Galea</surname><given-name>James</given-name><initials>J.</initials><afid>60008873</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7201451586</author-url><authid>7201451586</authid><authname>Patel H.</authname><surname>Patel</surname><given-name>Hiren C.</given-name><initials>H.C.</initials><afid>60008873</afid></author><authkeywords>Aneurysm | Re-haemorrhage | Stroke | Subarachnoid haemorrhage</authkeywords><intid>1035983678</intid><article-number>4050</article-number><source-id>14895</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930226308"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930226308?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930226308&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930226308&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2214799315000715"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930226308</prism:url><dc:identifier>SCOPUS_ID:84930226308</dc:identifier><eid>2-s2.0-84930226308</eid><dc:title>Structure and function of plant protein-derived antihypertensive peptides</dc:title><dc:creator>Aluko R.</dc:creator><prism:publicationName>Current Opinion in Food Science</prism:publicationName><prism:issn>22147993</prism:issn><prism:volume>4</prism:volume><prism:pageRange>44-50</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cofs.2015.05.002</prism:doi><pii>S2214799315000715</pii><dc:description>© 2015 Elsevier Ltd. The main targets for antihypertensive peptides are renin and angiotensin converting enzyme (ACE). Plant protein-based inhibitory agents are first generated as enzymatic protein hydrolysates, which contain a pool of peptides with different sizes and effectiveness. Protein hydrolysate fractions that consist of mainly low molecular weight peptides (usually &lt;3. kDa) are more effective inhibitors of renin and ACE than the bigger peptides. Purifications of protein hydrolysates have yielded several peptides that inhibit in vitro renin and ACE activities in addition to exerting in vivo blood pressure reductions. The structural basis for enhanced peptide activity varies but generally peptides that contain proline, branched-chain amino acids and aromatic amino acids have strong inhibitory activities against renin and ACE.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009697</affiliation-url><afid>60009697</afid><affilname>University of Manitoba</affilname><name-variant>University of Manitoba</name-variant><affiliation-city>Winnipeg</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009697</affiliation-url><afid>60009697</afid><affilname>University of Manitoba</affilname><name-variant>University of Manitoba</name-variant><affiliation-city>Winnipeg</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603059584</author-url><authid>6603059584</authid><authname>Aluko R.</authname><surname>Aluko</surname><given-name>Rotimi E.</given-name><initials>R.E.</initials><afid>60009697</afid><afid>60009697</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603059584</author-url><authid>6603059584</authid><authname>Aluko R.</authname><surname>Aluko</surname><given-name>Rotimi E.</given-name><initials>R.E.</initials><afid>60009697</afid><afid>60009697</afid></author><intid>1036082135</intid><source-id>21100370190</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928639715"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928639715?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928639715&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928639715&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0887233315000776"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928639715</prism:url><dc:identifier>SCOPUS_ID:84928639715</dc:identifier><eid>2-s2.0-84928639715</eid><dc:title>Tl&lt;sup&gt;+&lt;/sup&gt; induces the permeability transition pore in Ca&lt;sup&gt;2+&lt;/sup&gt;-loaded rat liver mitochondria energized by glutamate and malate</dc:title><dc:creator>Korotkov S.</dc:creator><prism:publicationName>Toxicology in Vitro</prism:publicationName><prism:issn>08872333</prism:issn><prism:eIssn>18793177</prism:eIssn><prism:volume>29</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:pageRange>1034-1041</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.tiv.2015.04.006</prism:doi><pii>S0887233315000776</pii><dc:description>© 2015 Elsevier Ltd. It is known that Ca&lt;sup&gt;2+&lt;/sup&gt; and heavy metals more actively induce MPTP opening in mitochondria, energized by the I complex substrates. Thus, a rise in a Tl&lt;sup&gt;+&lt;/sup&gt;-induced MPTP was proposed in experiments on isolated rat liver mitochondria energized by the complex I substrate (glutamate and malate). Expose of the mitochondria to Ca&lt;sup&gt;2+&lt;/sup&gt; into a medium containing TlNO&lt;inf&gt;3&lt;/inf&gt;, glutamate, and malate as well as sucrose or KNO&lt;inf&gt;3&lt;/inf&gt; resulted in a decrease in state 3, state 4, or DNP-stimulated respiration as well as an increase of both mitochondrial swelling and δΨ&lt;inf&gt;mito&lt;/inf&gt; dissipation. The MPTP inhibitors, CsA and ADP, almost completely eliminated the effect of Ca&lt;sup&gt;2+&lt;/sup&gt;, which was more pronounced in the presence of the complex I substrates than the complex II substrate (succinate) and rotenone (Korotkov and Saris, 2011). The present study concludes that Tl&lt;sup&gt;+&lt;/sup&gt;-induced MPTP opening is more appreciable in mitochondria energized by glutamate and malate but not succinate in the presence of rotenone. We assume that the Tl&lt;sup&gt;+&lt;/sup&gt;-induced MPTP opening along with followed swelling and possible structural deformations of the complex I in Ca&lt;sup&gt;2+&lt;/sup&gt;-loaded mitochondria may be a part of the thallium toxicity mechanism on mitochondria in living organisms. At the same time, oxidation of Tl&lt;sup&gt;+&lt;/sup&gt; to Tl&lt;sup&gt;3+&lt;/sup&gt; by mitochondrial oxygen reactive species is proposed for the mechanism.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021331</affiliation-url><afid>60021331</afid><affilname>Russian Academy of Sciences</affilname><name-variant>Russian Academy of Sciences</name-variant><affiliation-city>Moscow</affiliation-city><affiliation-country>Russian Federation</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7005303300</author-url><authid>7005303300</authid><authname>Korotkov S.</authname><surname>Korotkov</surname><given-name>Sergey M.</given-name><initials>S.M.</initials><afid>60021331</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:15122027200</author-url><authid>15122027200</authid><authname>Emelyanova L.</authname><surname>Emelyanova</surname><given-name>Larisa V.</given-name><initials>L.V.</initials><afid>60021331</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:37077516200</author-url><authid>37077516200</authid><authname>Konovalova S.</authname><surname>Konovalova</surname><given-name>Svetlana A.</given-name><initials>S.A.</initials><afid>60021331</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6602890468</author-url><authid>6602890468</authid><authname>Brailovskaya I.</authname><surname>Brailovskaya</surname><given-name>Irina V.</given-name><initials>I.V.</initials><afid>60021331</afid></author><authkeywords>Mitochondrial complex I | Mitochondrial permeability transition | Mitochondrial respiration | Mitochondrial swelling | Rat liver mitochondria | Tl&lt;sup&gt;+&lt;/sup&gt;</authkeywords><intid>35813350</intid><source-id>25224</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930198272"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930198272?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930198272&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930198272&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0303264715000696"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930198272</prism:url><dc:identifier>SCOPUS_ID:84930198272</dc:identifier><eid>2-s2.0-84930198272</eid><dc:title>Ca&lt;sup&gt;2+&lt;/sup&gt; dysregulation in the endoplasmic reticulum related to Alzheimer's disease: A review on experimental progress and computational modeling</dc:title><dc:creator>Liang J.</dc:creator><prism:publicationName>BioSystems</prism:publicationName><prism:issn>03032647</prism:issn><prism:eIssn>18728324</prism:eIssn><prism:volume>134</prism:volume><prism:pageRange>1-15</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.biosystems.2015.05.003</prism:doi><pii>S0303264715000696</pii><dc:description>© 2015 Elsevier Ireland Ltd. Alzheimer's disease (AD) is a devastating, incurable neurodegenerative disease affecting millions of people worldwide. Dysregulation of intracellular Ca&lt;sup&gt;2+&lt;/sup&gt; signaling has been observed as an early event prior to the presence of clinical symptoms of AD and is believed to be a crucial factor contributing to its pathogenesis. The progressive and sustaining increase in the resting level of cytosolic Ca&lt;sup&gt;2+&lt;/sup&gt; will affect downstream activities and neural functions. This review focuses on the issues relating to the increasing Ca&lt;sup&gt;2+&lt;/sup&gt; release from the endoplasmic reticulum (ER) observed in AD neurons. Numerous research papers have suggested that the dysregulation of ER Ca&lt;sup&gt;2+&lt;/sup&gt; homeostasis is associated with mutations in the presenilin genes and amyloid-β oligomers. These disturbances could happen at many different points in the signaling process, directly affecting ER Ca&lt;sup&gt;2+&lt;/sup&gt; channels or interfering with related pathways, which makes it harder to reveal the underlying mechanisms. This review paper also shows that computational modeling is a powerful tool in Ca&lt;sup&gt;2+&lt;/sup&gt; signaling studies and discusses the progress in modeling related to Ca&lt;sup&gt;2+&lt;/sup&gt; dysregulation in AD research.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006625</affiliation-url><afid>60006625</afid><affilname>Lincoln University, New Zealand</affilname><name-variant>Lincoln University</name-variant><affiliation-city>Christchurch</affiliation-city><affiliation-country>New Zealand</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006625</affiliation-url><afid>60006625</afid><affilname>Lincoln University, New Zealand</affilname><name-variant>Lincoln University</name-variant><affiliation-city>Christchurch</affiliation-city><affiliation-country>New Zealand</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006625</affiliation-url><afid>60006625</afid><affilname>Lincoln University, New Zealand</affilname><name-variant>Lincoln University</name-variant><affiliation-city>Christchurch</affiliation-city><affiliation-country>New Zealand</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56662605900</author-url><authid>56662605900</authid><authname>Liang J.</authname><surname>Liang</surname><given-name>Jingyi</given-name><initials>J.</initials><afid>60006625</afid><afid>60006625</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56662605900</author-url><authid>56662605900</authid><authname>Liang J.</authname><surname>Liang</surname><given-name>Jingyi</given-name><initials>J.</initials><afid>60006625</afid><afid>60006625</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603001487</author-url><authid>6603001487</authid><authname>Kulasiri D.</authname><surname>Kulasiri</surname><given-name>Don</given-name><initials>D.</initials><afid>60006625</afid><afid>60006625</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603001487</author-url><authid>6603001487</authid><authname>Kulasiri D.</authname><surname>Kulasiri</surname><given-name>Don</given-name><initials>D.</initials><afid>60006625</afid><afid>60006625</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55820508900</author-url><authid>55820508900</authid><authname>Samarasinghe S.</authname><surname>Samarasinghe</surname><given-name>Sandhya</given-name><initials>S.</initials><afid>60006625</afid><afid>60006625</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55820508900</author-url><authid>55820508900</authid><authname>Samarasinghe S.</authname><surname>Samarasinghe</surname><given-name>Sandhya</given-name><initials>S.</initials><afid>60006625</afid><afid>60006625</afid></author><authkeywords>Alzheimer's disease | Amyloid-β | Ca&lt;sup&gt;2+&lt;/sup&gt; dysregulation | Computational modeling | Endoplasmic reticulum | Systems biology</authkeywords><intid>2036082391</intid><source-id>13794</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929306643"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929306643?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929306643&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929306643&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022519315001794"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929306643</prism:url><dc:identifier>SCOPUS_ID:84929306643</dc:identifier><eid>2-s2.0-84929306643</eid><dc:title>Phogly-PseAAC: Prediction of lysine phosphoglycerylation in proteins incorporating with position-specific propensity</dc:title><dc:creator>Xu Y.</dc:creator><prism:publicationName>Journal of Theoretical Biology</prism:publicationName><prism:issn>00225193</prism:issn><prism:eIssn>10958541</prism:eIssn><prism:volume>379</prism:volume><prism:pageRange>10-15</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jtbi.2015.04.016</prism:doi><pii>S0022519315001794</pii><dc:description>© 2015 Elsevier Ltd. Large-scale characterization of post-translational modifications (PTMs), such as posphorylation, acetylation and ubiquitination, has highlighted their importance in the regulation of a myriad of signaling events. However, as another type of PTMs-lysine phosphoglycerylation, the data of phosphoglycerylated sites has just been manually experimented in recent years. Given an uncharacterized protein sequence that contains many lysine residues, which one of them can be phosphoglycerylated and which one not? This is a challenging problem. In view of this, establishing a useful computational method and developing an efficient predictor are highly desired. Here a new predictor named Phogly-PseAAC was developed which incorporated with the position specific amino acid propensity. The feature importance through F-score value has also been ranked. The predictor with the best feature set obtained the accuracy 75.10%, sensitivity 68.87%, specificity 75.57% and MCC 0.2538 in LOO test cross validation with center nearest neighbor algorithm. Meanwhile, a web-server for Phogly-PseAAC is accessible at http://app.aporc.org/Phogly-PseAAC/. For the convenience of most experimental scientists, we have further provided a brief instruction for the web-server, by which users can easily get their desired results without the need to follow the complicated mathematics presented in this paper. It is anticipated that Phogly-PseAAC may become a useful high throughput tool for identifying the lysine phosphoglycerylation sites.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018273</affiliation-url><afid>60018273</afid><affilname>University of Science and Technology Beijing</affilname><name-variant>University of Science and Technology Beijing</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60087528</affiliation-url><afid>60087528</afid><affilname>Institute of Applied Mathematics, AMSS, CAS</affilname><name-variant>Chinese Academy of Sciences</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013551</affiliation-url><afid>60013551</afid><affilname>China Agricultural University</affilname><name-variant>China Agricultural University</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55695013500</author-url><authid>55695013500</authid><authname>Xu Y.</authname><surname>Xu</surname><given-name>Yan</given-name><initials>Y.</initials><afid>60018273</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56643514300</author-url><authid>56643514300</authid><authname>Ding Y.</authname><surname>Ding</surname><given-name>Ya Xin</given-name><initials>Y.X.</initials><afid>60018273</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55463465000</author-url><authid>55463465000</authid><authname>Ding J.</authname><surname>Ding</surname><given-name>Jun</given-name><initials>J.</initials><afid>60018273</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56323329100</author-url><authid>56323329100</authid><authname>Wu L.</authname><surname>Wu</surname><given-name>Ling Yun</given-name><initials>L.Y.</initials><afid>60087528</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7006830279</author-url><authid>7006830279</authid><authname>Deng N.</authname><surname>Deng</surname><given-name>Nai Yang</given-name><initials>N.Y.</initials><afid>60013551</afid></author><authkeywords>Amino acid propensity | F-score | Phosphoglycerylation</authkeywords><intid>535947017</intid><source-id>29663</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926483619"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926483619?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926483619&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926483619&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0306460315001252"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926483619</prism:url><dc:identifier>SCOPUS_ID:84926483619</dc:identifier><eid>2-s2.0-84926483619</eid><dc:title>A systematic review of secondhand tobacco smoke exposure and smoking behaviors: Smoking status, susceptibility, initiation, dependence, and cessation</dc:title><dc:creator>Okoli C.</dc:creator><prism:publicationName>Addictive Behaviors</prism:publicationName><prism:issn>03064603</prism:issn><prism:eIssn>18736327</prism:eIssn><prism:volume>47</prism:volume><prism:pageRange>22-32</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.addbeh.2015.03.018</prism:doi><pii>S0306460315001252</pii><dc:description>© 2015 Elsevier Ltd. Objectives: To examine the association between secondhand tobacco smoke exposure (SHSe) and smoking behaviors (smoking status, susceptibility, initiation, dependence, and cessation). Methods: Terms and keywords relevant to smoking behaviors and secondhand tobacco smoke exposure were used in a search of the PubMed database. Searches were limited to English language peer-reviewed studies up till December 2013. Included papers: a) had clearly defined measures of SHSe and b) had clearly defined measures of outcome variables of interest. A total of 119 studies were initially retrieved and reviewed. After further review of references from the retrieved studies, 35 studies were finally selected that met all eligibility criteria. Results: The reviewed studies consisted of thirty-five (89.7%) studies with differing measures of SHSe (including questionnaire and biological measures) and varying definitions of main outcome variables of interest between studies. The majority of the studies (77%) were cross-sectional in nature. The majority of studies found that SHSe was associated with greater likelihood of being a smoker, increased susceptibility and initiation of smoking, greater nicotine dependence among nonsmokers, and poorer smoking cessation. Conclusions: The review found positive associations between SHSe and smoking status, susceptibility, initiation and nicotine dependence and a negative association with smoking cessation. In light of design limitations, future prospective and clinical studies are needed to better understand the mechanisms whereby SHSe influences smoking behaviors.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015941</affiliation-url><afid>60015941</afid><affilname>University of Kentucky</affilname><name-variant>University of Kentucky</name-variant><affiliation-city>Lexington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015941</affiliation-url><afid>60015941</afid><affilname>University of Kentucky</affilname><name-variant>University of Kentucky</name-variant><affiliation-city>Lexington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:12772567400</author-url><authid>12772567400</authid><authname>Okoli C.</authname><surname>Okoli</surname><given-name>Chizimuzo T C</given-name><initials>C.T.C.</initials><afid>60015941</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56584165800</author-url><authid>56584165800</authid><authname>Kodet J.</authname><surname>Kodet</surname><given-name>Jonathan</given-name><initials>J.</initials><afid>60015941</afid></author><authkeywords>Nicotine dependence | Secondhand smoke | Smoking cessation | Smoking initiation | Smoking status | Smoking susceptibility</authkeywords><intid>1035448604</intid><source-id>24763</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84923264660"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84923264660?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84923264660&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84923264660&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0956713515000821"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84923264660</prism:url><dc:identifier>SCOPUS_ID:84923264660</dc:identifier><eid>2-s2.0-84923264660</eid><dc:title>Multiple mycotoxin co-occurrence in maize grown in three agro-ecological zones of Tanzania</dc:title><dc:creator>Kamala A.</dc:creator><prism:publicationName>Food Control</prism:publicationName><prism:issn>09567135</prism:issn><prism:volume>54</prism:volume><prism:pageRange>208-215</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.foodcont.2015.02.002</prism:doi><pii>S0956713515000821</pii><dc:description>© 2015 Elsevier Ltd. In this study, the co-occurrence of multiple mycotoxins in maize kernels collected from 300 households' stores in three agro-ecological zones in Tanzania was evaluated by using ultra high performance liquid chromatography/time-of-flight mass spectrometry (TOFMS) with a QuEChERS-based procedure as sample treatment. This method was validated for the analysis of the main eleven mycotoxins of health concern that can occur in maize: aflatoxin B1 (AFB1), aflatoxin B2 (AFB2), aflatoxin G1 (AFG1), aflatoxin G2 (AFG2), ochratoxin A (OTA), deoxynivalenol (DON), fumonisin B1 (FB1), fumonisin B2 (FB2), HT-2 toxin, T-2 toxin and zearalenone (ZEN). From each zone one major maize producing district for home consumption was chosen and 20 villages for each district were randomly selected for sampling. All mycotoxins of health concern, except for T-2 toxin, were detected in the maize samples. Particularly high levels of AFB1 (50%; 3-1,081μgkg-1), FB1 (73%; 16-18,184μgkg-1), FB2 (48%; 178-38,217μgkg-1) and DON (63%; 68-2,196μgkg-1) were observed. Some samples exceeded the maximum limits set in Tanzania for aflatoxins or in European regulations for other mycotoxins in unprocessed maize. Eighty seven percent of samples were contaminated with more than one mycotoxin, with 45% of samples co-contaminated by carcinogenic mycotoxins, aflatoxins and fumonisins. Significant differences in contamination pattern were observed among the three agro-ecological zones. The high incidence and at high levels (for some) of these mycotoxins in maize may have serious implications on the health of the consumers since maize constitute the staple food of most Tanzanian population. Effective strategies targeting more than one mycotoxin are encouraged to reduce contamination of maize with mycotoxins.</dc:description><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033316</affiliation-url><afid>60033316</afid><affilname>Universiteit Gent</affilname><name-variant>Ghent University</name-variant><affiliation-city>Ghent</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:106984502</affiliation-url><afid>106984502</afid><affilname>Tanzania Food and Drugs Authority</affilname><name-variant>Tanzania Food and Drugs Authority</name-variant><affiliation-city>Dar Es Salaam</affiliation-city><affiliation-country>Tanzania</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:106606660</affiliation-url><afid>106606660</afid><affilname>Cuenca University</affilname><name-variant>Cuenca University</name-variant><affiliation-city>Cuenca</affiliation-city><affiliation-country>Ecuador</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113474438</affiliation-url><afid>113474438</afid><affilname>Nelson Mandela African Institute of Science and Technology (NM-AIST)</affilname><name-variant>Nelson Mandela African Institute of Science and Technology (NM-AIST)</name-variant><affiliation-city/><affiliation-country>Tanzania</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033316</affiliation-url><afid>60033316</afid><affilname>Universiteit Gent</affilname><name-variant>Ghent University</name-variant><affiliation-city>Ghent</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60071594</affiliation-url><afid>60071594</afid><affilname>Sokoine University of Agriculture</affilname><name-variant>Sokoine University of Agriculture</name-variant><affiliation-city>Morogoro</affiliation-city><affiliation-country>Tanzania</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55287762700</author-url><authid>55287762700</authid><authname>Kamala A.</authname><surname>Kamala</surname><given-name>Analice</given-name><initials>A.</initials><afid>60033316</afid><afid>106984502</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55287762700</author-url><authid>55287762700</authid><authname>Kamala A.</authname><surname>Kamala</surname><given-name>Analice</given-name><initials>A.</initials><afid>60033316</afid><afid>106984502</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55597103900</author-url><authid>55597103900</authid><authname>Ortiz J.</authname><surname>Ortiz</surname><given-name>Johana</given-name><initials>J.</initials><afid>60033316</afid><afid>106606660</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55597103900</author-url><authid>55597103900</authid><authname>Ortiz J.</authname><surname>Ortiz</surname><given-name>Johana</given-name><initials>J.</initials><afid>60033316</afid><afid>106606660</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6507422898</author-url><authid>6507422898</authid><authname>Kimanya M.</authname><surname>Kimanya</surname><given-name>Martin</given-name><initials>M.</initials><afid>113474438</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:21233684700</author-url><authid>21233684700</authid><authname>Haesaert G.</authname><surname>Haesaert</surname><given-name>Geert</given-name><initials>G.</initials><afid>60033316</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55386270000</author-url><authid>55386270000</authid><authname>Donoso S.</authname><surname>Donoso</surname><given-name>Silvana</given-name><initials>S.</initials><afid>106606660</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56524453300</author-url><authid>56524453300</authid><authname>Tiisekwa B.</authname><surname>Tiisekwa</surname><given-name>Bendantuguka</given-name><initials>B.</initials><afid>60071594</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6602894942</author-url><authid>6602894942</authid><authname>De Meulenaer B.</authname><surname>De Meulenaer</surname><given-name>Bruno</given-name><initials>B.</initials><afid>60033316</afid></author><authkeywords>LC/MS chromatography | Maize | Mycotoxins | QuEChERS | Tanzania</authkeywords><intid>1034935031</intid><source-id>22577</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926512768"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926512768?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926512768&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926512768&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0309174015000820"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926512768</prism:url><dc:identifier>SCOPUS_ID:84926512768</dc:identifier><eid>2-s2.0-84926512768</eid><dc:title>The effect of dietary alfalfa and flax sprouts on rabbit meat antioxidant content, lipid oxidation and fatty acid composition</dc:title><dc:creator>Dal Bosco A.</dc:creator><prism:publicationName>Meat Science</prism:publicationName><prism:issn>03091740</prism:issn><prism:volume>106</prism:volume><prism:pageRange>31-37</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.meatsci.2015.03.021</prism:doi><pii>S0309174015000820</pii><dc:description>© 2015 Elsevier Ltd. The aim of this study was to determine the effect of dietary supplementation with flax and alfalfa sprouts on fatty acid, tocopherol and phytochemical contents of rabbit meat. Ninety weaned New Zealand White rabbits were assigned to three dietary groups: standard diet (S); standard diet. +. 20. g/d of alfalfa sprouts (A); and standard diet. +. 20. g/d of flax sprouts (F). In the F rabbits the Longissimus dorsi muscle showed a higher thio-barbituric acid-reactive value and at the same time significantly higher values of alpha-linolenic acid, total polyunsaturated and n-3 fatty acids. Additionally n-3/n-6 ratio and thrombogenic indices were improved. The meat of A rabbits showed intermediate values of the previously reported examined parameters. Dietary supplementation with sprouts produced meat with a higher total phytoestrogen content.The addition of fresh alfalfa and flax sprouts to commercial feed modified the fat content, fatty acid and phytochemical profile of the meat, but the flax ones worsened the oxidative status of meat.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003003</affiliation-url><afid>60003003</afid><affilname>Universita degli Studi di Perugia</affilname><name-variant>Università di Perugia</name-variant><affiliation-city>Perugia</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602560210</author-url><authid>6602560210</authid><authname>Dal Bosco A.</authname><surname>Dal Bosco</surname><given-name>A.</given-name><initials>A.</initials><afid>60003003</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004212390</author-url><authid>7004212390</authid><authname>Castellini C.</authname><surname>Castellini</surname><given-name>C.</given-name><initials>C.</initials><afid>60003003</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55402092200</author-url><authid>55402092200</authid><authname>Martino M.</authname><surname>Martino</surname><given-name>M.</given-name><initials>M.</initials><afid>60003003</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:54395625300</author-url><authid>54395625300</authid><authname>Mattioli S.</authname><surname>Mattioli</surname><given-name>S.</given-name><initials>S.</initials><afid>60003003</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6507275569</author-url><authid>6507275569</authid><authname>Marconi O.</authname><surname>Marconi</surname><given-name>O.</given-name><initials>O.</initials><afid>60003003</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:26028093400</author-url><authid>26028093400</authid><authname>Sileoni V.</authname><surname>Sileoni</surname><given-name>V.</given-name><initials>V.</initials><afid>60003003</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:36946451300</author-url><authid>36946451300</authid><authname>Ruggeri S.</authname><surname>Ruggeri</surname><given-name>S.</given-name><initials>S.</initials><afid>60003003</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6602224395</author-url><authid>6602224395</authid><authname>Tei F.</authname><surname>Tei</surname><given-name>F.</given-name><initials>F.</initials><afid>60003003</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6506813694</author-url><authid>6506813694</authid><authname>Benincasa P.</authname><surname>Benincasa</surname><given-name>P.</given-name><initials>P.</initials><afid>60003003</afid></author><authkeywords>Meat | N-3 Fatty acid | Phytochemicals | Rabbit | Sprouts | Tocopherols</authkeywords><intid>1535453130</intid><source-id>21219</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929151816"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929151816?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929151816&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929151816&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1046592815000881"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929151816</prism:url><dc:identifier>SCOPUS_ID:84929151816</dc:identifier><eid>2-s2.0-84929151816</eid><dc:title>Characterization of soluble RNA-dependent RNA polymerase from dengue virus serotype 2: The polyhistidine tag compromises the polymerase activity</dc:title><dc:creator>Kamkaew M.</dc:creator><prism:publicationName>Protein Expression and Purification</prism:publicationName><prism:issn>10465928</prism:issn><prism:volume>112</prism:volume><prism:pageRange>43-49</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.pep.2015.04.008</prism:doi><pii>S1046592815000881</pii><dc:description>© 2015 Elsevier Inc. The viral RNA polymerase is an attractive target for inhibition in the treatment of viral infections. In the case of dengue virus (DENV), a member of the genus Flavivirus, the RNA-dependent RNA polymerase (RdRp) activity resides in the C-terminal two-thirds of non-structural protein (NS) 5 responsible for the de novo synthesis of the viral RNA genome. Among four distinct, but closely related dengue serotypes, serotype 2 (DENV-2) produces more severe diseases than other serotypes. It has been reported that bacterial production of the recombinant DENV-2 RdRp was difficult due to its low expression and solubility levels. To facilitate functional and structural analyses, we here demonstrate complete protocols for overexpression and purification of soluble DENV-2 RdRp, increasing protein yields by a remarkable 10 times compared to earlier reports. Three different forms of DENV-2 RdRp as either N- or C-terminally His-tagged fusions, or without tag, were purified to homogeneity. We show here that the presence of both the N- and C-terminal His-tag had a deleterious effect on polymerase activity and, in contrast to earlier studies, our non-tagged RdRp did not require manganese ions to activate RNA polymerization. We also determined an apparent K&lt;inf&gt;d&lt;/inf&gt; value of 53 nM for binding to the 5′-UTR RNA by surface plasmon resonance (SPR). Our work provide a more suitable material for basic research of viral RdRp and for drug development.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012718</affiliation-url><afid>60012718</afid><affilname>Mahidol University</affilname><name-variant>Mahidol University</name-variant><affiliation-city>Nakon Pathom</affiliation-city><affiliation-country>Thailand</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56641826900</author-url><authid>56641826900</authid><authname>Kamkaew M.</authname><surname>Kamkaew</surname><given-name>Maliwan</given-name><initials>M.</initials><afid>60012718</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8282587500</author-url><authid>8282587500</authid><authname>Chimnaronk S.</authname><surname>Chimnaronk</surname><given-name>Sarin</given-name><initials>S.</initials><afid>60012718</afid></author><authkeywords>Dengue virus | In vitro polymerase assay | Polyhistidine tag | RNA-dependent RNA polymerase (RdRp) | Surface plasmon resonance</authkeywords><intid>535918642</intid><source-id>14259</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84919330728"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84919330728?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84919330728&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84919330728&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0928493114007930"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84919330728</prism:url><dc:identifier>SCOPUS_ID:84919330728</dc:identifier><eid>2-s2.0-84919330728</eid><dc:title>Nanomechanical characterization of heterogeneous and hierarchical biomaterials and tissues using nanoindentation: The role of finite mixture models</dc:title><dc:creator>Zadpoor A.</dc:creator><prism:publicationName>Materials Science and Engineering C</prism:publicationName><prism:issn>09284931</prism:issn><prism:volume>48</prism:volume><prism:pageRange>150-157</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.msec.2014.11.067</prism:doi><pii>S0928493114007930</pii><dc:description>© 2014 Elsevier B.V. Mechanical characterization of biological tissues and biomaterials at the nano-scale is often performed using nanoindentation experiments. The different constituents of the characterized materials will then appear in the histogram that shows the probability of measuring a certain range of mechanical properties. An objective technique is needed to separate the probability distributions that are mixed together in such a histogram. In this paper, finite mixture models (FMMs) are proposed as a tool capable of performing such types of analysis. Finite Gaussian mixture models assume that the measured probability distribution is a weighted combination of a finite number of Gaussian distributions with separate mean and standard deviation values. Dedicated optimization algorithms are available for fitting such a weighted mixture model to experimental data. Moreover, certain objective criteria are available to determine the optimum number of Gaussian distributions. In this paper, FMMs are used for interpreting the probability distribution functions representing the distributions of the elastic moduli of osteoarthritic human cartilage and co-polymeric microspheres. As for cartilage experiments, FMMs indicate that at least three mixture components are needed for describing the measured histogram. While the mechanical properties of the softer mixture components, often assumed to be associated with Glycosaminoglycans, were found to be more or less constant regardless of whether two or three mixture components were used, those of the second mixture component (i.e. collagen network) considerably changed depending on the number of mixture components. Regarding the co-polymeric microspheres, the optimum number of mixture components estimated by the FMM theory, i.e. 3, nicely matches the number of co-polymeric components used in the structure of the polymer. The computer programs used for the presented analyses are made freely available online for other researchers to use.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006288</affiliation-url><afid>60006288</afid><affilname>Delft University of Technology</affilname><name-variant>Delft University of Technology</name-variant><affiliation-city>Delft</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:9732943400</author-url><authid>9732943400</authid><authname>Zadpoor A.</authname><surname>Zadpoor</surname><given-name>Amir A.</given-name><initials>A.A.</initials><afid>60006288</afid></author><authkeywords>Finite mixture models | Nanoindentation | Soft polymeric biomaterials | Soft tissues</authkeywords><intid>34300186</intid><source-id>17813</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929572990"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929572990?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929572990&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929572990&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0165176515002013"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929572990</prism:url><dc:identifier>SCOPUS_ID:84929572990</dc:identifier><eid>2-s2.0-84929572990</eid><dc:title>The welfare economics of infectious happiness</dc:title><dc:creator>Povey R.</dc:creator><prism:publicationName>Economics Letters</prism:publicationName><prism:issn>01651765</prism:issn><prism:volume>133</prism:volume><prism:pageRange>1-3</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.econlet.2015.05.006</prism:doi><pii>S0165176515002013</pii><dc:description>© 2015 Elsevier B.V. We summarise evidence for infectious happiness, exploring implications for a number of welfare issues: labour oversupply due to relative income effects, altruistic donation, public goods contribution. Awareness of infectiousness is welfare-improving, but not first-best optimal. Government intervention remains potentially beneficial.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60104737</affiliation-url><afid>60104737</afid><affilname>Hertford College</affilname><name-variant>University of Oxford</name-variant><affiliation-city>Oxford</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56290741400</author-url><authid>56290741400</authid><authname>Povey R.</authname><surname>Povey</surname><given-name>Richard</given-name><initials>R.</initials><afid>60104737</afid></author><authkeywords>Donation | Happiness | Income | Infectiousness | Labour</authkeywords><intid>1035977046</intid><source-id>28490</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84923673415"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84923673415?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84923673415&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84923673415&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2352250X15000949"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84923673415</prism:url><dc:identifier>SCOPUS_ID:84923673415</dc:identifier><eid>2-s2.0-84923673415</eid><dc:title>Optimizing the exercise prescription for depression: The search for biomarkers of response</dc:title><dc:creator>Medina J.</dc:creator><prism:publicationName>Current Opinion in Psychology</prism:publicationName><prism:issn>2352250X</prism:issn><prism:volume>4</prism:volume><prism:pageRange>43-47</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.copsyc.2015.02.003</prism:doi><pii>S2352250X15000949</pii><dc:description>© 2015 Elsevier Ltd. There is growing support for the efficacy of exercise interventions for the treatment of individuals who present with mild-to-moderate depression. The variability in treatment response across studies and individuals suggests that the efficacy of exercise for depression will be most optimal when prescribed to individuals who are most prone to respond. The present article reviews contemporary theoretical accounts and recent empirical data pointing to neuroinflammatory states and neurotrophin production as possible biomarkers of the antidepressant response to exercise. The larger exercise and depression literatures provide justification for elevated levels of pro-inflammatory cytokines and deficits in BDNF production as putative matching variables. Although there is some empirical support for these hypotheses, it is clear that this research warrants replication and extension. We offer a few suggestions for future research in this emerging area.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013372</affiliation-url><afid>60013372</afid><affilname>University of Texas at Austin</affilname><name-variant>University of Texas</name-variant><affiliation-city>Austin</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013372</affiliation-url><afid>60013372</afid><affilname>University of Texas at Austin</affilname><name-variant>University of Texas</name-variant><affiliation-city>Austin</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36055220500</author-url><authid>36055220500</authid><authname>Medina J.</authname><surname>Medina</surname><given-name>Johnna L.</given-name><initials>J.L.</initials><afid>60013372</afid><afid>60013372</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36055220500</author-url><authid>36055220500</authid><authname>Medina J.</authname><surname>Medina</surname><given-name>Johnna L.</given-name><initials>J.L.</initials><afid>60013372</afid><afid>60013372</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55681567500</author-url><authid>55681567500</authid><authname>Jacquart J.</authname><surname>Jacquart</surname><given-name>Jolene</given-name><initials>J.</initials><afid>60013372</afid><afid>60013372</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55681567500</author-url><authid>55681567500</authid><authname>Jacquart J.</authname><surname>Jacquart</surname><given-name>Jolene</given-name><initials>J.</initials><afid>60013372</afid><afid>60013372</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7101674924</author-url><authid>7101674924</authid><authname>Smits J.</authname><surname>Smits</surname><given-name>Jasper A J</given-name><initials>J.A.J.</initials><afid>60013372</afid><afid>60013372</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7101674924</author-url><authid>7101674924</authid><authname>Smits J.</authname><surname>Smits</surname><given-name>Jasper A J</given-name><initials>J.A.J.</initials><afid>60013372</afid><afid>60013372</afid></author><intid>1535012730</intid><source-id>21100372442</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929486181"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929486181?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929486181&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929486181&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929486181</prism:url><dc:identifier>SCOPUS_ID:84929486181</dc:identifier><eid>2-s2.0-84929486181</eid><dc:title>Accurate vessel segmentation with constrained B-snake</dc:title><dc:creator>Cheng Y.</dc:creator><prism:publicationName>IEEE Transactions on Image Processing</prism:publicationName><prism:issn>10577149</prism:issn><prism:volume>24</prism:volume><prism:issueIdentifier>8</prism:issueIdentifier><prism:pageRange>2440-2455</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1109/TIP.2015.2417683</prism:doi><dc:description>© 2015 IEEE. We describean active contour framework with accurate shape and size constraints on the vessel cross-sectional planes to produce the vessel segmentation. It starts with a multiscale vessel axis tracing in a 3D computed tomography (CT) data, followed by vessel boundary delineation on the cross-sectional planes derived from the extracted axis. The vessel boundary surface is deformed under constrained movements on the cross sections and is voxelized to produce the final vascular segmentation. The novelty of this paper lies in the accurate contour point detection of thin vessels based on the CT scanning model, in the efficient implementation of missing contour points in the problematic regions and in the active contour model with accurate shape and size constraints. The main advantage of our framework is that it avoids disconnected and incomplete segmentation of the vessels in the problematic regions that contain touching vessels (vessels in close proximity to each other), diseased portions (pathologic structure attached to a vessel), and thin vessels. It is particularly suitable for accurate segmentation of thin and low contrast vessels. Our method is evaluated and demonstrated on CT data sets from our partner site, and its results are compared with three related methods. Our method is also tested on two publicly available databases and its results are compared with the recently published method. The applicability of the proposed method to some challenging clinical problems, the segmentation of the vessels in the problematic regions, is demonstrated with good results on both quantitative and qualitative experimentations; our segmentation algorithm can delineate vessel boundaries that have level of variability similar to those obtained manually.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019616</affiliation-url><afid>60019616</afid><affilname>Harbin Institute of Technology</affilname><name-variant>Harbin Institute of Technology</name-variant><affiliation-city>Harbin</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032407</affiliation-url><afid>60032407</afid><affilname>Chiba Institute of Technology</affilname><name-variant>Chiba Institute of Technology</name-variant><affiliation-city>Narashino</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024322</affiliation-url><afid>60024322</afid><affilname>Osaka University</affilname><name-variant>Osaka University</name-variant><affiliation-city>Suita</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:15828790700</author-url><authid>15828790700</authid><authname>Cheng Y.</authname><surname>Cheng</surname><given-name>Yuanzhi</given-name><initials>Y.</initials><afid>60019616</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55496250500</author-url><authid>55496250500</authid><authname>Hu X.</authname><surname>Hu</surname><given-name>Xin</given-name><initials>X.</initials><afid>60019616</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56648226800</author-url><authid>56648226800</authid><authname>Wang J.</authname><surname>Wang</surname><given-name>Ji</given-name><initials>J.</initials><afid>60019616</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55978208400</author-url><authid>55978208400</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Yadong</given-name><initials>Y.</initials><afid>60032407</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:54780895300</author-url><authid>54780895300</authid><authname>Tamura S.</authname><surname>Tamura</surname><given-name>Shinichi</given-name><initials>S.</initials><afid>60024322</afid></author><authkeywords>computed tomography angiography (CTA) | constrained B-snake | shape and size constraints | Vessel segmentation | vessel-axis-tracing</authkeywords><intid>1035959019</intid><article-number>7081358</article-number><source-id>25534</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927510193"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927510193?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927510193&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927510193&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0957417415000391"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927510193</prism:url><dc:identifier>SCOPUS_ID:84927510193</dc:identifier><eid>2-s2.0-84927510193</eid><dc:title>An empirical study of empty prediction of multi-label classification</dc:title><dc:creator>Liu S.</dc:creator><prism:publicationName>Expert Systems with Applications</prism:publicationName><prism:issn>09574174</prism:issn><prism:volume>42</prism:volume><prism:issueIdentifier>13</prism:issueIdentifier><prism:pageRange>5567-5579</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.eswa.2015.01.024</prism:doi><pii>S0957417415000391</pii><dc:description>©2015 Elsevier Ltd. All rights reserved. A detailed and extensive empirical study of empty prediction of multi-label classification is conducted in this paper and to the best of our knowledge this work is the first empirical study of this problem. Total 8 state of the art multi-label classification methods, BR, CC, CLR, HOMER, RAkEL, ECC, MLkNN, and BRkNN, are compared on 11 datasets. The empirical results clearly answer the two research questions, (1) whether empty prediction problems happen in commonly used state of the art multi-label classification methods and what their empty prediction rates (EPR) on different test sets are and (2) what multi-label classification methods are with overall highest/lowest EPRs. Specifically, it is empirically shown that every method considered all made empty predictions on different datasets. In addition, several thresholding methods which in theory can solve empty prediction are compared. The clear answers to the two research questions and the experimental findings are the main contributions of this work to multi-label classification.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Fudan University</affilname><name-variant>Department of Public Administration</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37104438000</author-url><authid>37104438000</authid><authname>Liu S.</authname><surname>Liu</surname><given-name>Shuhua</given-name><initials>S.</initials><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56386877000</author-url><authid>56386877000</authid><authname>Chen J.</authname><surname>Chen</surname><given-name>Jiun Hung</given-name><initials>J.H.</initials><afid/></author><authkeywords>Empty prediction | Multi-label classification</authkeywords><intid>35634685</intid><source-id>24201</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928408311"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928408311?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928408311&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928408311&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0928493115300011"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928408311</prism:url><dc:identifier>SCOPUS_ID:84928408311</dc:identifier><eid>2-s2.0-84928408311</eid><dc:title>Antioxidant activities of nano-bubble hydrogen-dissolved water assessed by ESR and 2,2′-bipyridyl methods</dc:title><dc:creator>Kato S.</dc:creator><prism:publicationName>Materials Science and Engineering C</prism:publicationName><prism:issn>09284931</prism:issn><prism:volume>53</prism:volume><prism:pageRange>7-10</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.msec.2015.03.064</prism:doi><pii>S0928493115300011</pii><dc:description>We prepared nano-bubble hydrogen-dissolved water (nano-H water) which contained hydrogen nano-bubbles of &lt; 717-nm diameter for 54% of total bubbles. In the DMPO-spin trap electron spin resonance (ESR) method, the DMPO-OH:MnO ratio, being attributed to amounts of hydroxyl radicals (OH), was 2.78 for pure water (dissolved hydrogen [DH].</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032427</affiliation-url><afid>60032427</afid><affilname>Hiroshima Prefectural University</affilname><name-variant>Prefectural University of Hiroshima</name-variant><affiliation-city>Shobara</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115184136</affiliation-url><afid>115184136</afid><affilname>600 MV Co., Ltd.</affilname><name-variant>600 MV Co., Ltd.</name-variant><affiliation-city>Hiroshima</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018873</affiliation-url><afid>60018873</afid><affilname>Mie University</affilname><name-variant>Mie University</name-variant><affiliation-city>Tsu</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112585374</affiliation-url><afid>112585374</afid><affilname>Butsuryo College of Osaka</affilname><name-variant>Osaka Butsuryo College</name-variant><affiliation-city>Osaka</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56473137800</author-url><authid>56473137800</authid><authname>Kato S.</authname><surname>Kato</surname><given-name>Shinya</given-name><initials>S.</initials><afid>60032427</afid><afid>60018873</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56473137800</author-url><authid>56473137800</authid><authname>Kato S.</authname><surname>Kato</surname><given-name>Shinya</given-name><initials>S.</initials><afid>60032427</afid><afid>60018873</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56604841900</author-url><authid>56604841900</authid><authname>Matsuoka D.</authname><surname>Matsuoka</surname><given-name>Daigo</given-name><initials>D.</initials><afid>115184136</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7007102044</author-url><authid>7007102044</authid><authname>Miwa N.</authname><surname>Miwa</surname><given-name>Nobuhiko</given-name><initials>N.</initials><afid>60032427</afid><afid>112585374</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7007102044</author-url><authid>7007102044</authid><authname>Miwa N.</authname><surname>Miwa</surname><given-name>Nobuhiko</given-name><initials>N.</initials><afid>60032427</afid><afid>112585374</afid></author><authkeywords>2,2′-Bipyridyl method | Antioxidant | Electron spin resonance | Hydrogen water</authkeywords><intid>2035773326</intid><source-id>17813</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929308729"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929308729?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929308729&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929308729&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0939641115002027"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929308729</prism:url><dc:identifier>SCOPUS_ID:84929308729</dc:identifier><eid>2-s2.0-84929308729</eid><dc:title>Low-density lipoprotein peptide-combined DNA nanocomplex as an efficient anticancer drug delivery vehicle</dc:title><dc:creator>Zhang N.</dc:creator><prism:publicationName>European Journal of Pharmaceutics and Biopharmaceutics</prism:publicationName><prism:issn>09396411</prism:issn><prism:eIssn>18733441</prism:eIssn><prism:volume>94</prism:volume><prism:pageRange>20-29</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ejpb.2015.04.022</prism:doi><pii>S0939641115002027</pii><dc:description>© 2015 Elsevier B.V. Abstract DNA is a type of potential biomaterials for drug delivery due to its nanoscale geometry, loading capacity of therapeutics, biocompatibility, and biodegradability. Unfortunately, DNA is easily degraded by DNases in the body circulation and has low intracellular uptake. In the present study, we selected three cationic polymers polyethylenimine (PEI), hexadecyl trimethyl ammonium bromide (CTAB), and low-density lipoprotein (LDL) receptor targeted peptide (RLT), to modify DNA and improve the issues. A potent anti-tumor anthracycline-doxorubicin (DOX) was intercalated into DNA non-covalently and the DOX/DNA was then combined with PEI, CTAB, and RLT, respectively. Compact nanocomplexes were formed by electrostatic interaction and could potentially protect DNA from DNases. More importantly, RLT had the potential to enhance intracellular uptake by LDL receptor mediated endocytosis. In a series of in vitro experiments, RLT complexed DNA enhanced intracellular delivery of DOX, increased tumor cell death and intracellular ROS production, and reduced intracellular elimination of DOX. All results suggested that the easily prepared and targeted RLT/DNA nanocomplexes had great potential to be developed into a formulation for doxorubicin with enhanced anti-tumor activity.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018554</affiliation-url><afid>60018554</afid><affilname>Zhengzhou University</affilname><name-variant>Zhengzhou University of Light Industry</name-variant><affiliation-city>Zhengzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018554</affiliation-url><afid>60018554</afid><affilname>Zhengzhou University</affilname><name-variant>Zhengzhou University of Light Industry</name-variant><affiliation-city>Zhengzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56643617400</author-url><authid>56643617400</authid><authname>Zhang N.</authname><surname>Zhang</surname><given-name>Nan</given-name><initials>N.</initials><afid>60018554</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56643768600</author-url><authid>56643768600</authid><authname>Tao J.</authname><surname>Tao</surname><given-name>Jun</given-name><initials>J.</initials><afid>60018554</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644068100</author-url><authid>56644068100</authid><authname>Hua H.</authname><surname>Hua</surname><given-name>Haiying</given-name><initials>H.</initials><afid>60018554</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56643746000</author-url><authid>56643746000</authid><authname>Sun P.</authname><surname>Sun</surname><given-name>Pengchao</given-name><initials>P.</initials><afid>60018554</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:14046462800</author-url><authid>14046462800</authid><authname>Zhao Y.</authname><surname>Zhao</surname><given-name>Yongxing</given-name><initials>Y.</initials><afid>60018554</afid></author><authkeywords>Cytotoxicity | DNA nanocomplex | Doxorubicin | Low-density lipoprotein peptide | RLT | Tumor targeting</authkeywords><intid>1785945308</intid><article-number>11913</article-number><source-id>21332</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925358514"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925358514?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925358514&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925358514&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S019188691500183X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925358514</prism:url><dc:identifier>SCOPUS_ID:84925358514</dc:identifier><eid>2-s2.0-84925358514</eid><dc:title>How innovative is your employee? The role of employee and supervisor Dark Triad personality traits in supervisor perceptions of employee innovative behavior</dc:title><dc:creator>Wisse B.</dc:creator><prism:publicationName>Personality and Individual Differences</prism:publicationName><prism:issn>01918869</prism:issn><prism:volume>82</prism:volume><prism:pageRange>158-162</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.paid.2015.03.020</prism:doi><pii>S019188691500183X</pii><dc:description>© 2015 Elsevier Ltd. Organizational researchers have focused on the potential benefits of the Dark Triad personality traits (i.e., psychopathy, Machiavellianism, and narcissism) in organizational contexts. The current research builds on this research, examining the link between employee and supervisor Dark Triad traits and perceived employee innovative behavior (idea generation, idea promotion, and idea implementation) on the workfloor. Regression analysis on the data of 306 pairs of employees and their supervisors revealed that employee Machiavellianism was negatively related and employee psychopathy was not related to supervisor ratings of employee innovative behavior. In addition, a positive relationship between employee narcissism and supervisor ratings of employee innovative behavior emerged. However, this effect was weakened by supervisor narcissism: only when supervisors themselves were low on narcissism did employee narcissism foster positive perceptions of employee innovative behavior (specifically idea promotion). We discuss the value of differentiating between the three Dark Triad traits and the subscales of innovative behavior in order to more fully understand supervisors' assessments of their employees.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010023</affiliation-url><afid>60010023</afid><affilname>Rijksuniversiteit Groningen</affilname><name-variant>University of Groningen</name-variant><affiliation-city>Groningen</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36132287500</author-url><authid>36132287500</authid><authname>Wisse B.</authname><surname>Wisse</surname><given-name>Barbara</given-name><initials>B.</initials><afid>60010023</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:9239245300</author-url><authid>9239245300</authid><authname>Barelds D.</authname><surname>Barelds</surname><given-name>Dick P H</given-name><initials>D.P.H.</initials><afid>60010023</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56267339500</author-url><authid>56267339500</authid><authname>Rietzschel E.</authname><surname>Rietzschel</surname><given-name>Eric F.</given-name><initials>E.F.</initials><afid>60010023</afid></author><authkeywords>Creativity | Dark triad | Innovative behavior | Machiavellianism | Narcissism | Psychopathy</authkeywords><intid>1785290695</intid><source-id>12807</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929208008"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929208008?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929208008&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929208008&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167488915001366"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929208008</prism:url><dc:identifier>SCOPUS_ID:84929208008</dc:identifier><eid>2-s2.0-84929208008</eid><dc:title>O-GlcNAcylation of eIF2α regulates the phospho-eIF2α-mediated ER stress response</dc:title><dc:creator>Jang I.</dc:creator><prism:publicationName>Biochimica et Biophysica Acta - Molecular Cell Research</prism:publicationName><prism:issn>01674889</prism:issn><prism:eIssn>18792596</prism:eIssn><prism:volume>1853</prism:volume><prism:issueIdentifier>8</prism:issueIdentifier><prism:pageRange>1860-1869</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbamcr.2015.04.017</prism:doi><pii>S0167488915001366</pii><dc:description>© 2015 Elsevier B.V. O-GlcNAcylation is highly involved in cellular stress responses including the endoplasmic reticulum (ER) stress response. For example, glucosamine-induced flux through the hexosamine biosynthetic pathway can promote ER stress and ER stress inducers can change the total cellular level of O-GlcNAcylation. However, it is largely unknown which component(s) of the unfolded protein response (UPR) is directly regulated by O-GlcNAcylation. In this study, eukaryotic translation initiation factor 2α (eIF2α), a major branch of the UPR, was O-GlcNAcylated at Ser 219, Thr 239, and Thr 241. Upon ER stress, eIF2α is phosphorylated at Ser 51 by phosphorylated PKR-like ER kinase and this inhibits global translation initiation, except for that of specific mRNAs, including activating transcription factor 4, that induce stress-responsive genes such as C/EBP homologous protein (CHOP). Hyper-. O-GlcNAcylation induced by O-GlcNAcase inhibitor (thiamet-G) treatment or O-GlcNAc transferase (OGT) overexpression hindered phosphorylation of eIF2α at Ser 51. The level of O-GlcNAcylation of eIF2α was changed by dithiothreitol treatment dependent on its phosphorylation at Ser 51. Point mutation of the O-GlcNAcylation sites of eIF2α increased its phosphorylation at Ser 51 and CHOP expression and resulted in increased apoptosis upon ER stress. These results suggest that O-GlcNAcylation of eIF2α affects its phosphorylation at Ser 51 and influences CHOP-mediated cell death. This O-GlcNAcylation of eIF2α was reproduced in thiamet-G-injected mouse liver. In conclusion, proper regulation of O-GlcNAcylation and phosphorylation of eIF2α is important to maintain cellular homeostasis upon ER stress.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016912</affiliation-url><afid>60016912</afid><affilname>Yonsei University</affilname><name-variant>Yonsei University</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60068696</affiliation-url><afid>60068696</afid><affilname>Korea Basic Science Institute</affilname><name-variant>Korea Basic Science Institute</name-variant><affiliation-city>Yusong</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016728</affiliation-url><afid>60016728</afid><affilname>Yonsei University College of Medicine</affilname><name-variant>Yonsei University College of Medicine</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016912</affiliation-url><afid>60016912</afid><affilname>Yonsei University</affilname><name-variant>Yonsei University</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35233446000</author-url><authid>35233446000</authid><authname>Jang I.</authname><surname>Jang</surname><given-name>Insook</given-name><initials>I.</initials><afid>60016912</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56580975100</author-url><authid>56580975100</authid><authname>Kim H.</authname><surname>Kim</surname><given-name>Han Byeol</given-name><initials>H.B.</initials><afid>60016912</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56640486900</author-url><authid>56640486900</authid><authname>Seo H.</authname><surname>Seo</surname><given-name>Hojoong</given-name><initials>H.</initials><afid>60016912</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55952463300</author-url><authid>55952463300</authid><authname>Kim J.</authname><surname>Kim</surname><given-name>Jin Young</given-name><initials>J.Y.</initials><afid>60068696</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:26649733700</author-url><authid>26649733700</authid><authname>Choi H.</authname><surname>Choi</surname><given-name>Hyeonjin</given-name><initials>H.</initials><afid>60016728</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7402295537</author-url><authid>7402295537</authid><authname>Yoo J.</authname><surname>Yoo</surname><given-name>Jong Shin</given-name><initials>J.S.</initials><afid>60068696</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56521079400</author-url><authid>56521079400</authid><authname>Kim J.</authname><surname>Kim</surname><given-name>Jae woo</given-name><initials>J.w.</initials><afid>60016912</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:14818894600</author-url><authid>14818894600</authid><authname>Cho J.</authname><surname>Cho</surname><given-name>Jin Won</given-name><initials>J.W.</initials><afid>60016912</afid></author><authkeywords>Apoptosis | CHOP | EIF2α | ER stress | O-GlcNAc | P-eIF2α</authkeywords><intid>535919263</intid><source-id>18408</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927946800"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927946800?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927946800&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927946800&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0008622315002535"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927946800</prism:url><dc:identifier>SCOPUS_ID:84927946800</dc:identifier><eid>2-s2.0-84927946800</eid><dc:title>Gelatin-assisted fabrication of graphene-based nacre with high strength, toughness, and electrical conductivity</dc:title><dc:creator>Lian M.</dc:creator><prism:publicationName>Carbon</prism:publicationName><prism:issn>00086223</prism:issn><prism:volume>89</prism:volume><prism:pageRange>279-289</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.carbon.2015.03.045</prism:doi><pii>S0008622315002535</pii><dc:description>© 2015 Elsevier Ltd. All rights reserved. In this study, a high-performance graphene-based nacre was prepared using gelatin as a bioadhesive with the aid of the bending cycle-induced "mechanical annealed" effect. By this method, this type of graphene-based nacre is endowed with high strength, toughness, and electrical conductive properties, which is very different from other study where only one or two of three properties were improved. The maximum ultimate tensile strength can reach as high as ∼630.4 MPa when the optimal amount of gelatin was 30 wt%. Meanwhile, it has a high electrical conductivity of ∼42,624 S/m. Most notably, the periodic bending-induced "mechanical annealing" could further increase the ultimate tensile strength tremendously. After 100 cycles of periodic bending, the ultimate strength reached ∼902.1 MPa, with a high electrical conductivity of ∼44,780 S/m.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025084</affiliation-url><afid>60025084</afid><affilname>Shanghai Jiaotong University</affilname><name-variant>Shanghai Jiaotong University</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60082199</affiliation-url><afid>60082199</afid><affilname>Shanghai University of Electric Power</affilname><name-variant>Shanghai University of Electric Power</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55758159800</author-url><authid>55758159800</authid><authname>Lian M.</authname><surname>Lian</surname><given-name>Min</given-name><initials>M.</initials><afid>60025084</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:54683952700</author-url><authid>54683952700</authid><authname>Fan J.</authname><surname>Fan</surname><given-name>Jinchen</given-name><initials>J.</initials><afid>60082199</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:37003054500</author-url><authid>37003054500</authid><authname>Shi Z.</authname><surname>Shi</surname><given-name>Zixing</given-name><initials>Z.</initials><afid>60025084</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56595820100</author-url><authid>56595820100</authid><authname>Zhang S.</authname><surname>Zhang</surname><given-name>Sai</given-name><initials>S.</initials><afid>60025084</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56109070200</author-url><authid>56109070200</authid><authname>Li H.</authname><surname>Li</surname><given-name>Hong</given-name><initials>H.</initials><afid>60025084</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56595946900</author-url><authid>56595946900</authid><authname>Yin J.</authname><surname>Yin</surname><given-name>Jie</given-name><initials>J.</initials><afid>60025084</afid></author><intid>1035697545</intid><source-id>25806</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928958184"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928958184?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928958184&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928958184&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0925443915001209"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928958184</prism:url><dc:identifier>SCOPUS_ID:84928958184</dc:identifier><eid>2-s2.0-84928958184</eid><dc:title>Diabetes-induced alterations in tissue collagen and carboxymethyllysine in rat kidneys: Association with increased collagen-degrading proteinases and amelioration by Cu(II)-selective chelation</dc:title><dc:creator>Brings S.</dc:creator><prism:publicationName>Biochimica et Biophysica Acta - Molecular Basis of Disease</prism:publicationName><prism:issn>09254439</prism:issn><prism:eIssn>1879260X</prism:eIssn><prism:volume>1852</prism:volume><prism:issueIdentifier>8</prism:issueIdentifier><prism:pageRange>1610-1618</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbadis.2015.04.014</prism:doi><pii>S0925443915001209</pii><dc:description>© 2015 Elsevier B.V. Advanced glycation end-products (AGEs) comprise a group of non-enzymatic post-translational modifications of proteins and are elevated in diabetic tissues. AGE-modification impairs the digestibility of collagen in vitro but little is known about its relation to collagen-degrading proteinases in vivo. N&lt;sup&gt;ε&lt;/sup&gt;-carboxymethyllysine (CML) is a stable AGE that forms on lysyl side-chains in the presence of glucose, probably via a transition metal-catalysed mechanism.Here, rats with streptozotocin-induced diabetes and non-diabetic controls were treated for 8. weeks with placebo or the Cu(II)-selective chelator, triethylenetetramine (TETA), commencing 8. weeks after disease induction. Actions of diabetes and drug treatment were measured on collagen and collagen-degrading proteinases in kidney tissue.The digestibility and CML content of collagen, and corresponding levels of mRNAs and collagen, were related to changes in collagen-degrading-proteinases. Collagen-degrading proteinases, cathepsin L (CTSL) and matrix metalloproteinase-2 (MMP-2) were increased in diabetic rats. CTSL-levels correlated strongly and positively with increased collagen-CML levels and inversely with decreased collagen digestibility in diabetes. The collagen-rich mesangium displayed a strong increase of CTSL in diabetes. TETA treatment normalised kidney collagen content and partially normalised levels of CML and CTSL.These data provide evidence for an adaptive proteinase response in diabetic kidneys, affected by excessive collagen-CML formation and decreased collagen digestibility. The normalisation of collagen and partial normalisation of CML- and CTSL-levels by TETA treatment supports the involvement of Cu(II) in CML formation and altered collagen metabolism in diabetic kidneys. Cu(II)-chelation by TETA may represent a treatment option to rectify collagen metabolism in diabetes independent of alterations in blood glucose levels.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005686</affiliation-url><afid>60005686</afid><affilname>University of Auckland</affilname><name-variant>University of Auckland</name-variant><affiliation-city>Auckland</affiliation-city><affiliation-country>New Zealand</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005686</affiliation-url><afid>60005686</afid><affilname>University of Auckland</affilname><name-variant>University of Auckland</name-variant><affiliation-city>Auckland</affiliation-city><affiliation-country>New Zealand</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005686</affiliation-url><afid>60005686</afid><affilname>University of Auckland</affilname><name-variant>University of Auckland</name-variant><affiliation-city>Auckland</affiliation-city><affiliation-country>New Zealand</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029204</affiliation-url><afid>60029204</afid><affilname>NHS Foundation Trust</affilname><name-variant>NHS Foundation Trust</name-variant><affiliation-city>Leeds</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026851</affiliation-url><afid>60026851</afid><affilname>University of Oxford</affilname><name-variant>Oxford University</name-variant><affiliation-city>Oxford</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">16</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:24173415400</author-url><authid>24173415400</authid><authname>Brings S.</authname><surname>Brings</surname><given-name>Sebastian</given-name><initials>S.</initials><afid>60005686</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56198000500</author-url><authid>56198000500</authid><authname>Zhang S.</authname><surname>Zhang</surname><given-name>Shaoping</given-name><initials>S.</initials><afid>60005686</afid><afid>60005686</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56198000500</author-url><authid>56198000500</authid><authname>Zhang S.</authname><surname>Zhang</surname><given-name>Shaoping</given-name><initials>S.</initials><afid>60005686</afid><afid>60005686</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56624200500</author-url><authid>56624200500</authid><authname>Choong Y.</authname><surname>Choong</surname><given-name>Yee S.</given-name><initials>Y.S.</initials><afid>60005686</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:43161192700</author-url><authid>43161192700</authid><authname>Hogl S.</authname><surname>Hogl</surname><given-name>Sebastian</given-name><initials>S.</initials><afid>60005686</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:50462210700</author-url><authid>50462210700</authid><authname>Middleditch M.</authname><surname>Middleditch</surname><given-name>Martin</given-name><initials>M.</initials><afid>60005686</afid><afid>60005686</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:50462210700</author-url><authid>50462210700</authid><authname>Middleditch M.</authname><surname>Middleditch</surname><given-name>Martin</given-name><initials>M.</initials><afid>60005686</afid><afid>60005686</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55486126100</author-url><authid>55486126100</authid><authname>Kamalov M.</authname><surname>Kamalov</surname><given-name>Meder</given-name><initials>M.</initials><afid>60005686</afid><afid>60005686</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55486126100</author-url><authid>55486126100</authid><authname>Kamalov M.</authname><surname>Kamalov</surname><given-name>Meder</given-name><initials>M.</initials><afid>60005686</afid><afid>60005686</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7005581932</author-url><authid>7005581932</authid><authname>Brimble M.</authname><surname>Brimble</surname><given-name>Margaret A.</given-name><initials>M.A.</initials><afid>60005686</afid><afid>60005686</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7005581932</author-url><authid>7005581932</authid><authname>Brimble M.</authname><surname>Brimble</surname><given-name>Margaret A.</given-name><initials>M.A.</initials><afid>60005686</afid><afid>60005686</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56623948100</author-url><authid>56623948100</authid><authname>Gong D.</authname><surname>Gong</surname><given-name>Deming</given-name><initials>D.</initials><afid>60005686</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7402355946</author-url><authid>7402355946</authid><authname>Cooper G.</authname><surname>Cooper</surname><given-name>Garth J S</given-name><initials>G.J.S.</initials><afid>60005686</afid><afid>60005686</afid><afid>60029204</afid><afid>60026851</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7402355946</author-url><authid>7402355946</authid><authname>Cooper G.</authname><surname>Cooper</surname><given-name>Garth J S</given-name><initials>G.J.S.</initials><afid>60005686</afid><afid>60005686</afid><afid>60029204</afid><afid>60026851</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7402355946</author-url><authid>7402355946</authid><authname>Cooper G.</authname><surname>Cooper</surname><given-name>Garth J S</given-name><initials>G.J.S.</initials><afid>60005686</afid><afid>60005686</afid><afid>60029204</afid><afid>60026851</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7402355946</author-url><authid>7402355946</authid><authname>Cooper G.</authname><surname>Cooper</surname><given-name>Garth J S</given-name><initials>G.J.S.</initials><afid>60005686</afid><afid>60005686</afid><afid>60029204</afid><afid>60026851</afid></author><authkeywords>Advanced glycation end-product | Autoxidative glycation | Cathepsin L | Collagen | Matrix metalloproteinase-2 | Triethylenetetramine</authkeywords><intid>1535876857</intid><source-id>21722</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928335757"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928335757?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928335757&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928335757&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0305750X1500073X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928335757</prism:url><dc:identifier>SCOPUS_ID:84928335757</dc:identifier><eid>2-s2.0-84928335757</eid><dc:title>Living Care-Fully: The Potential for an Ethics of Care in Livelihoods Approaches</dc:title><dc:creator>Hanrahan K.</dc:creator><prism:publicationName>World Development</prism:publicationName><prism:issn>0305750X</prism:issn><prism:eIssn>18735991</prism:eIssn><prism:volume>72</prism:volume><prism:pageRange>381-393</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.worlddev.2015.03.014</prism:doi><pii>S0305750X1500073X</pii><dc:description>© 2015 Elsevier Ltd. This article explores the potential contribution of a feminist ethics of care to livelihoods approaches. Current critiques argue that considerations of material outcomes have been prioritized at the expense of social well-being. I argue that autonomy and independence frame our current approaches to understanding how people support themselves. This has obscured the interdependent and contingent nature of connections that found our social lives and reduced social connections to an instrumental role. The potential for taking a care-full approach to livelihoods is examined through the unfolding negotiations of livelihood strategies between an elderly woman and her daughter-in-law in rural northern Ghana.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015941</affiliation-url><afid>60015941</afid><affilname>University of Kentucky</affilname><name-variant>University of Kentucky</name-variant><affiliation-city>Lexington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56150470800</author-url><authid>56150470800</authid><authname>Hanrahan K.</authname><surname>Hanrahan</surname><given-name>Kelsey B.</given-name><initials>K.B.</initials><afid>60015941</afid></author><authkeywords>Africa | Contingency | Ethics of care | Ghana | Interdependence | Livelihoods approaches</authkeywords><intid>1785767727</intid><source-id>30060</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929169969"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929169969?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929169969&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929169969&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167488915001299"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929169969</prism:url><dc:identifier>SCOPUS_ID:84929169969</dc:identifier><eid>2-s2.0-84929169969</eid><dc:title>The AKT/mTOR signaling pathway plays a key role in statin-induced myotoxicity</dc:title><dc:creator>Bonifacio A.</dc:creator><prism:publicationName>Biochimica et Biophysica Acta - Molecular Cell Research</prism:publicationName><prism:issn>01674889</prism:issn><prism:eIssn>18792596</prism:eIssn><prism:volume>1853</prism:volume><prism:issueIdentifier>8</prism:issueIdentifier><prism:pageRange>1841-1849</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbamcr.2015.04.010</prism:doi><pii>S0167488915001299</pii><dc:description>© 2015 Elsevier B.V. Statins are drugs that lower blood cholesterol levels and reduce cardiovascular morbidity and mortality. They are generally well-tolerated, but myopathy is a potentially severe adverse reaction of these compounds. The mechanisms by which statins induce myotoxicity are not completely understood, but may be related to inhibition of the AKT signaling pathway. The current studies were performed to explore the down-stream effects of the statin-associated inhibition of AKT within the AKT signaling pathway and on myocyte biology and morphology in C2C12 myotubes and in mice in vivo. We exposed C2C12 myotubes to 10. μM or 50. μM simvastatin, atorvastatin or rosuvastatin for 24. h. Simvastatin and atorvastatin inhibited AKT phosphorylation and were cytotoxic starting at 10. μM, whereas similar effects were observed for rosuvastatin at 50. μM. Inhibition of AKT phosphorylation was associated with impaired phosphorylation of S6 kinase, ribosomal protein S6, 4E-binding protein 1 and FoxO3a, resulting in reduced protein synthesis, accelerated myofibrillar degradation and atrophy of C2C12 myotubes. Furthermore, impaired AKT phosphorylation was associated with activation of caspases and PARP, reflecting induction of apoptosis. Similar findings were detected in skeletal muscle of mice treated orally with 5. mg/kg/day simvastatin for 3. weeks. In conclusion, this study highlights the importance of the AKT/mTOR signaling pathway in statin-induced myotoxicity and reveals potential drug targets for treatment of patients with statin-associated myopathies.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028287</affiliation-url><afid>60028287</afid><affilname>Universitatsspital Basel</affilname><name-variant>University Hospital Basel</name-variant><affiliation-city>Basel</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023588</affiliation-url><afid>60023588</afid><affilname>Universitat Basel</affilname><name-variant>University of Basel</name-variant><affiliation-city>Basel</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023588</affiliation-url><afid>60023588</afid><affilname>Universitat Basel</affilname><name-variant>University of Basel</name-variant><affiliation-city>Basel</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56385370600</author-url><authid>56385370600</authid><authname>Bonifacio A.</authname><surname>Bonifacio</surname><given-name>Annalisa</given-name><initials>A.</initials><afid>60028287</afid><afid>60023588</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56385370600</author-url><authid>56385370600</authid><authname>Bonifacio A.</authname><surname>Bonifacio</surname><given-name>Annalisa</given-name><initials>A.</initials><afid>60028287</afid><afid>60023588</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56641612800</author-url><authid>56641612800</authid><authname>Sanvee G.</authname><surname>Sanvee</surname><given-name>Gerda M.</given-name><initials>G.M.</initials><afid>60028287</afid><afid>60023588</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56641612800</author-url><authid>56641612800</authid><authname>Sanvee G.</authname><surname>Sanvee</surname><given-name>Gerda M.</given-name><initials>G.M.</initials><afid>60028287</afid><afid>60023588</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:25958614000</author-url><authid>25958614000</authid><authname>Bouitbir J.</authname><surname>Bouitbir</surname><given-name>Jamal</given-name><initials>J.</initials><afid>60028287</afid><afid>60023588</afid><afid>60023588</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:25958614000</author-url><authid>25958614000</authid><authname>Bouitbir J.</authname><surname>Bouitbir</surname><given-name>Jamal</given-name><initials>J.</initials><afid>60028287</afid><afid>60023588</afid><afid>60023588</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:25958614000</author-url><authid>25958614000</authid><authname>Bouitbir J.</authname><surname>Bouitbir</surname><given-name>Jamal</given-name><initials>J.</initials><afid>60028287</afid><afid>60023588</afid><afid>60023588</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7007006329</author-url><authid>7007006329</authid><authname>Krähenbühl S.</authname><surname>Krähenbühl</surname><given-name>Stephan</given-name><initials>S.</initials><afid>60028287</afid><afid>60023588</afid><afid>60023588</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7007006329</author-url><authid>7007006329</authid><authname>Krähenbühl S.</authname><surname>Krähenbühl</surname><given-name>Stephan</given-name><initials>S.</initials><afid>60028287</afid><afid>60023588</afid><afid>60023588</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7007006329</author-url><authid>7007006329</authid><authname>Krähenbühl S.</authname><surname>Krähenbühl</surname><given-name>Stephan</given-name><initials>S.</initials><afid>60028287</afid><afid>60023588</afid><afid>60023588</afid></author><authkeywords>AKT/mTOR signaling pathway | Apoptosis | Atorvastatin | Muscle atrophy | Rosuvastatin | Simvastatin</authkeywords><intid>1035913539</intid><source-id>18408</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929583361"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929583361?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929583361&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929583361&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167268115001079"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929583361</prism:url><dc:identifier>SCOPUS_ID:84929583361</dc:identifier><eid>2-s2.0-84929583361</eid><dc:title>Attention, intentions, and follow-through in preventive health behavior: Field experimental evidence on flu vaccination</dc:title><dc:creator>Bronchetti E.</dc:creator><prism:publicationName>Journal of Economic Behavior and Organization</prism:publicationName><prism:issn>01672681</prism:issn><prism:volume>116</prism:volume><prism:pageRange>270-291</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jebo.2015.04.003</prism:doi><pii>S0167268115001079</pii><dc:description>© 2015. Preventive health behaviors like flu vaccination have important benefits, but compliance is poor, and the reasons are not fully understood. We conducted a large study across six colleges (N= 9358), with a methodology that offers an unusual opportunity to look at three potential factors: inattention to information, informed intentions to not comply, and problems following through on intentions. We also tested three interventions in an RCT. We find that inattention to information is not the primary driver of low take-up, while informed decisions to not get the vaccine, but also lack of follow-through, are important factors. A financial intervention increased take-up and had persistent, positive effects on intentions for vaccination in future years. Two low-cost "nudges" did not increase vaccination rates, although the peer endorsement nudge increased exposure to information, especially if aligned with social networks.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002817</affiliation-url><afid>60002817</afid><affilname>Swarthmore College</affilname><name-variant>Swarthmore College</name-variant><affiliation-city>Swarthmore</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026851</affiliation-url><afid>60026851</afid><affilname>University of Oxford</affilname><name-variant>Oxford University</name-variant><affiliation-city>Oxford</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>IZA</affilname><affiliation-city/><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55070915900</author-url><authid>55070915900</authid><authname>Bronchetti E.</authname><surname>Bronchetti</surname><given-name>Erin Todd</given-name><initials>E.T.</initials><afid>60002817</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:16245412800</author-url><authid>16245412800</authid><authname>Huffman D.</authname><surname>Huffman</surname><given-name>David B.</given-name><initials>D.B.</initials><afid>60026851</afid><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:16245412800</author-url><authid>16245412800</authid><authname>Huffman D.</authname><surname>Huffman</surname><given-name>David B.</given-name><initials>D.B.</initials><afid>60026851</afid><afid/></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6507100917</author-url><authid>6507100917</authid><authname>Magenheim E.</authname><surname>Magenheim</surname><given-name>Ellen</given-name><initials>E.</initials><afid>60002817</afid></author><authkeywords>Decision making | Experiment | Inattention | Self-control problems</authkeywords><intid>35980558</intid><source-id>23865</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925109486"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925109486?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925109486&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925109486&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2213231715000270"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925109486</prism:url><dc:identifier>SCOPUS_ID:84925109486</dc:identifier><eid>2-s2.0-84925109486</eid><dc:title>Persistent oxidative stress in human neural stem cells exposed to low fluences of charged particles</dc:title><dc:creator>Baulch J.</dc:creator><prism:publicationName>Redox Biology</prism:publicationName><prism:issn>22132317</prism:issn><prism:volume>5</prism:volume><prism:pageRange>24-32</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.redox.2015.03.001</prism:doi><pii>S2213231715000270</pii><dc:description>© 2015 The Authors. Exposure to the space radiation environment poses risks for a range of deleterious health effects due to the unique types of radiation encountered. Galactic cosmic rays are comprised of a spectrum of highly energetic nuclei that deposit densely ionizing tracks of damage along the particle trajectory. These tracks are distinct from those generated by the more sparsely ionizing terrestrial radiations, and define the geometric distribution of the complex cellular damage that results when charged particles traverse the tissues of the body. The exquisite radiosensitivity of multipotent neural stem and progenitor cells found within the neurogenic regions of the brain predispose the central nervous system to elevated risks for radiation induced sequelae. Here we show that human neural stem cells (hNSC) exposed to different charged particles at space relevant fluences exhibit significant and persistent oxidative stress. Radiation induced oxidative stress was found to be most dependent on total dose rather than on the linear energy transfer of the incident particle. The use of redox sensitive fluorogenic dyes possessing relative specificity for hydroxyl radicals, peroxynitrite, nitric oxide (NO) and mitochondrial superoxide confirmed that most irradiation paradigms elevated reactive oxygen and nitrogen species (ROS and RNS, respectively) in hNSC over a 1 week interval following exposure. Nitric oxide synthase (NOS) was not the major source of elevated nitric oxides, as the use of NOS inhibitors had little effect on NO dependent fluorescence. Our data provide extensive evidence for the capability of low doses of charged particles to elicit marked changes in the metabolic profile of irradiated hNSC. Radiation induced changes in redox state may render the brain more susceptible to the development of neurocognitive deficits that could affect an astronaut's ability to perform complex tasks during extended missions in deep space.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007278</affiliation-url><afid>60007278</afid><affilname>UC Irvine</affilname><name-variant>University of California, Irvine</name-variant><affiliation-city>Irvine</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602411512</author-url><authid>6602411512</authid><authname>Baulch J.</authname><surname>Baulch</surname><given-name>Janet E.</given-name><initials>J.E.</initials><afid>60007278</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55929652700</author-url><authid>55929652700</authid><authname>Craver B.</authname><surname>Craver</surname><given-name>Brianna M.</given-name><initials>B.M.</initials><afid>60007278</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55532178500</author-url><authid>55532178500</authid><authname>Tran K.</authname><surname>Tran</surname><given-name>Katherine K.</given-name><initials>K.K.</initials><afid>60007278</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56270065000</author-url><authid>56270065000</authid><authname>Yu L.</authname><surname>Yu</surname><given-name>Liping</given-name><initials>L.</initials><afid>60007278</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56453153900</author-url><authid>56453153900</authid><authname>Chmielewski N.</authname><surname>Chmielewski</surname><given-name>Nicole</given-name><initials>N.</initials><afid>60007278</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55547136312</author-url><authid>55547136312</authid><authname>Allen B.</authname><surname>Allen</surname><given-name>Barrett D.</given-name><initials>B.D.</initials><afid>60007278</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7003719352</author-url><authid>7003719352</authid><authname>Limoli C.</authname><surname>Limoli</surname><given-name>Charles L.</given-name><initials>C.L.</initials><afid>60007278</afid></author><authkeywords>Charged particle | Human neural stem cells | Oxidative stress | Space radiation</authkeywords><intid>535269432</intid><source-id>21100242403</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929170892"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929170892?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929170892&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929170892&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0263224115002419"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929170892</prism:url><dc:identifier>SCOPUS_ID:84929170892</dc:identifier><eid>2-s2.0-84929170892</eid><dc:title>A new classifier for breast cancer detection based on Naïve Bayesian</dc:title><dc:creator>Karabatak M.</dc:creator><prism:publicationName>Measurement: Journal of the International Measurement Confederation</prism:publicationName><prism:issn>02632241</prism:issn><prism:volume>72</prism:volume><prism:pageRange>32-36</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.measurement.2015.04.028</prism:doi><pii>S0263224115002419</pii><dc:description>© 2015 Elsevier Ltd. All rights reserved. Breast cancer is known as the most common invasive cancer type among women and automatic breast cancer detection systems are in demand. Thus, various machine learning and pattern recognition techniques have been proposed to detect breast cancer. One of these techniques is the Bayes classifier. Naïve Bayesian (NB) is known to be a simple classifier, which is based on the Bayes theorem. There have been so many applications used in literature. In this paper, a new NB (weighted NB) classifier was proposed and its application on breast cancer detection was presented. Several experiments were conducted to evaluate the performance of the weighted NB on the breast cancer database. The experiments were realized with 5-fold cross validation test. Moreover, various performance evaluation techniques namely sensitivity, specificity and accuracy are considered. According to the experiments, the weighted NB obtained the following evaluation values. The calculated sensitivity, specificity and the accuracy values are 99.11%, 98.25%, and 98.54% respectively. Moreover, a comparison with the existing methods in the literature was presented. As a result, the performance of weighted NB is better than regular NB and many other existing methods.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004863</affiliation-url><afid>60004863</afid><affilname>Firat Universitesi</affilname><name-variant>Firat University</name-variant><affiliation-city>Elazig</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16230752700</author-url><authid>16230752700</authid><authname>Karabatak M.</authname><surname>Karabatak</surname><given-name>Murat</given-name><initials>M.</initials><afid>60004863</afid></author><authkeywords>Breast cancer detection | NB classifier | Performance evaluation tests | Weighted NB classifier</authkeywords><intid>35916316</intid><source-id>15424</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926462020"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926462020?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926462020&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926462020&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2214799314000277"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926462020</prism:url><dc:identifier>SCOPUS_ID:84926462020</dc:identifier><eid>2-s2.0-84926462020</eid><dc:title>Enhancing nutraceutical bioavailability through food matrix design</dc:title><dc:creator>McClements D.</dc:creator><prism:publicationName>Current Opinion in Food Science</prism:publicationName><prism:issn>22147993</prism:issn><prism:volume>4</prism:volume><prism:pageRange>1-6</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cofs.2014.12.008</prism:doi><pii>S2214799314000277</pii><dc:description>© 2014 Elsevier Ltd. Recent advances in the design of food matrices to improve the bioavailability of bioactive food components, such as nutraceuticals and vitamins, are reviewed. Nutraceuticals may be isolated from their natural origin and then incorporated into functional food products as functional ingredients. In this case, specially designed colloidal delivery systems are often needed to improve their dispersibility, stability, food compatibility, and bioavailability. Alternatively, nutraceuticals may be delivered as part of natural foods, such as fruits and vegetables. In this case, their bioavailability can be improved by consuming them with food matrices specifically designed to increase their bioavailability, that is, excipient foods. The utility of a new scheme (NuBACS) for classifying the major factors limiting the oral bioavailability of nutraceuticals is also highlighted.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014313</affiliation-url><afid>60014313</afid><affilname>University of Massachusetts Amherst</affilname><name-variant>University of Massachusetts</name-variant><affiliation-city>Amherst</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004582</affiliation-url><afid>60004582</afid><affilname>King Abdulaziz University</affilname><name-variant>King Abdulaziz University</name-variant><affiliation-city>Jeddah</affiliation-city><affiliation-country>Saudi Arabia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7005216193</author-url><authid>7005216193</authid><authname>McClements D.</authname><surname>McClements</surname><given-name>David Julian</given-name><initials>D.J.</initials><afid>60014313</afid><afid>60004582</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7005216193</author-url><authid>7005216193</authid><authname>McClements D.</authname><surname>McClements</surname><given-name>David Julian</given-name><initials>D.J.</initials><afid>60014313</afid><afid>60004582</afid></author><intid>2035447367</intid><source-id>21100370190</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84922976982"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84922976982?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84922976982&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84922976982&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0924796315000196"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84922976982</prism:url><dc:identifier>SCOPUS_ID:84922976982</dc:identifier><eid>2-s2.0-84922976982</eid><dc:title>Potential impact of climate change on the Intra-Americas Sea: Part-1. A dynamic downscaling of the CMIP5 model projections</dc:title><dc:creator>Liu Y.</dc:creator><prism:publicationName>Journal of Marine Systems</prism:publicationName><prism:issn>09247963</prism:issn><prism:volume>148</prism:volume><prism:pageRange>56-69</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jmarsys.2015.01.007</prism:doi><pii>S0924796315000196</pii><dc:description>© 2015 Elsevier B.V. This study examines the potential impact of anthropogenic greenhouse warming on the Intra-Americas Sea (IAS, Caribbean Sea and Gulf of Mexico) by downscaling the Coupled Model Intercomparison Project phase-5 (CMIP5) model simulations under historical and two future emission scenarios using an eddy-resolving resolution regional ocean model. The simulated volume transport by the western boundary current system in the IAS, including the Caribbean Current, Yucatan Current and Loop Current (LC), is reduced by 20-25% during the 21st century, consistent with a similar rate of reduction in the Atlantic Meridional Overturning Circulation (AMOC). The effect of the LC in the present climate is to warm the Gulf of Mexico (GoM). Therefore, the reduced LC and the associated weakening of the warm transient LC eddies have a cooling impact in the GoM, particularly during boreal spring in the northern deep basin, in agreement with an earlier dynamic downscaling study. In contrast to the reduced warming in the northern deep GoM, the downscaled model predicts an intense warming in the shallow (≤. 200. m) northeastern shelf of the GoM especially during boreal summer since there is no effective mechanism to dissipate the increased surface heating. Potential implications of the regionally distinctive warming trend pattern in the GoM on the marine ecosystems and hurricane intensifications during landfall are discussed. This study also explores the effects of 20th century warming and climate variability in the IAS using the regional ocean model forced with observed surface flux fields. The main modes of sea surface temperature variability in the IAS are linked to the Atlantic Multidecadal Oscillation and a meridional dipole pattern between the GoM and Caribbean Sea. It is also shown that variability of the IAS western boundary current system in the 20th century is largely driven by wind stress curl in the Sverdrup interior and the AMOC.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029251</affiliation-url><afid>60029251</afid><affilname>University of Miami</affilname><name-variant>University of Miami</name-variant><affiliation-city>Coral Gables</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021738</affiliation-url><afid>60021738</afid><affilname>NOAA Atlantic Oceanographic and Meteorological Laboratory</affilname><name-variant>National Oceanic and Atmospheric Administration</name-variant><affiliation-city>Miami</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027716</affiliation-url><afid>60027716</afid><affilname>National Oceanic and Atmospheric Administration</affilname><name-variant>National Oceanic and Atmospheric Administration</name-variant><affiliation-city>Washington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030822</affiliation-url><afid>60030822</afid><affilname>University of South Florida St. Petersburg</affilname><name-variant>University of South Florida</name-variant><affiliation-city>St Petersburg</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:105616418</affiliation-url><afid>105616418</afid><affilname>Roffer's Ocean Fishing Forecasting Service, Inc.</affilname><name-variant>Roffer's Ocean Fishing Forecasting Service, Inc.</name-variant><affiliation-city>Melbourne</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54780118900</author-url><authid>54780118900</authid><authname>Liu Y.</authname><surname>Liu</surname><given-name>Yanyun</given-name><initials>Y.</initials><afid>60029251</afid><afid>60021738</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54780118900</author-url><authid>54780118900</authid><authname>Liu Y.</authname><surname>Liu</surname><given-name>Yanyun</given-name><initials>Y.</initials><afid>60029251</afid><afid>60021738</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:27168081700</author-url><authid>27168081700</authid><authname>Lee S.</authname><surname>Lee</surname><given-name>Sang Ki</given-name><initials>S.K.</initials><afid>60029251</afid><afid>60021738</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:27168081700</author-url><authid>27168081700</authid><authname>Lee S.</authname><surname>Lee</surname><given-name>Sang Ki</given-name><initials>S.K.</initials><afid>60029251</afid><afid>60021738</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7004029924</author-url><authid>7004029924</authid><authname>Enfield D.</authname><surname>Enfield</surname><given-name>David B.</given-name><initials>D.B.</initials><afid>60029251</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:17346911300</author-url><authid>17346911300</authid><authname>Muhling B.</authname><surname>Muhling</surname><given-name>Barbara A.</given-name><initials>B.A.</initials><afid>60029251</afid><afid>60027716</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:17346911300</author-url><authid>17346911300</authid><authname>Muhling B.</authname><surname>Muhling</surname><given-name>Barbara A.</given-name><initials>B.A.</initials><afid>60029251</afid><afid>60027716</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6603373298</author-url><authid>6603373298</authid><authname>Lamkin J.</authname><surname>Lamkin</surname><given-name>John T.</given-name><initials>J.T.</initials><afid>60027716</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006003656</author-url><authid>7006003656</authid><authname>Muller-Karger F.</authname><surname>Muller-Karger</surname><given-name>Frank E.</given-name><initials>F.E.</initials><afid>60030822</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:23991433500</author-url><authid>23991433500</authid><authname>Roffer M.</authname><surname>Roffer</surname><given-name>Mitchell A.</given-name><initials>M.A.</initials><afid>105616418</afid></author><authkeywords>AMO | AMOC | Caribbean current | Caribbean Sea | Climate change | Dynamical downscaling | Global warming | Gulf of Mexico | Intra-Americas Sea | Loop current</authkeywords><intid>1784909044</intid><source-id>27786</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924967749"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924967749?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924967749&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924967749&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S009884721500043X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924967749</prism:url><dc:identifier>SCOPUS_ID:84924967749</dc:identifier><eid>2-s2.0-84924967749</eid><dc:title>Modulation of zinc-induced oxidative damage in Solanum melongena by 6-benzylaminopurine involves ascorbate-glutathione cycle metabolism</dc:title><dc:creator>Wu X.</dc:creator><prism:publicationName>Environmental and Experimental Botany</prism:publicationName><prism:issn>00988472</prism:issn><prism:volume>116</prism:volume><prism:pageRange>1-11</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.envexpbot.2015.03.004</prism:doi><pii>S009884721500043X</pii><dc:description>© 2015 Elsevier B.V. Cytokinins (CKs) play an important role in plant adaptation to environmental stresses. Ascorbate-glutathione (AsA-GSH) cycle is regarded as an essential mechanism for resistance of plants under stress conditions. In this study, the effects of 6-benzylaminopurine (BAP), a synthetic CK, on the growth, oxidative damage, AsA-GSH cycle metabolism, and hormone contents in the leaves of eggplant (Solanum melongena L.) seedlings were investigated under 10mM zinc (Zn) stress. Zn stress resulted in oxidative damage as evidenced by a decrease in eggplant growth and an increase in reactive oxygen species (ROS, H2O2, and O2 -) formation and membrane damage (lipid peroxidation and electrolyte leakage). However, application of exogenous BAP significantly alleviated the growth inhibition and oxidative damage caused by Zn stress. Importantly, BAP further enhanced the redox states of AsA and GSH, and the related enzyme activities involved in the AsA-GSH cycle such as ascorbate peroxidase (APX), glutathione reductase (GR), dehydroascorbate reductase (DHAR), monodehydroascorbate reductase (MDHAR), and glutathione synthetase (GS) in eggplants grown under Zn stress. Quantitative analysis revealed that BAP could induce the transcript levels of MDHAR and GS, but not DHAR in AsA-GSH cycle under Zn stress or non-stress conditions. GR expression was further increased by BAP application in the leaves of eggplants under Zn stress. Moreover, BAP shifted the hormonal balance toward a substantial increase in the levels of CK and auxin (IAA) but a decrease in abscisic acid (ABA) content in the leaves with or without Zn treatment. The results of the present study strongly suggest that BAP-enhanced resistance of eggplants against Zn toxicity is associated with the regulation of AsA-GSH cycle metabolism as an effective antioxidant system and the balance of hormones.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073637</affiliation-url><afid>60073637</afid><affilname>Shanghai Academy of Agricultural Sciences</affilname><name-variant>Shanghai Academy of Agricultural Sciences</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100824994</affiliation-url><afid>100824994</afid><affilname>Shanghai Key Laboratory of Protected Horticultural Technology</affilname><name-variant>Shanghai Key Lab. of Protected Horticultural Technology</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007381</affiliation-url><afid>60007381</afid><affilname>Yangzhou University</affilname><name-variant>Yangzhou University</name-variant><affiliation-city>Yangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073637</affiliation-url><afid>60073637</afid><affilname>Shanghai Academy of Agricultural Sciences</affilname><name-variant>Shanghai Academy of Agricultural Sciences</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56514261900</author-url><authid>56514261900</authid><authname>Wu X.</authname><surname>Wu</surname><given-name>Xuexia</given-name><initials>X.</initials><afid>60073637</afid><afid>100824994</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56514261900</author-url><authid>56514261900</authid><authname>Wu X.</authname><surname>Wu</surname><given-name>Xuexia</given-name><initials>X.</initials><afid>60073637</afid><afid>100824994</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55811017400</author-url><authid>55811017400</authid><authname>He J.</authname><surname>He</surname><given-name>Jie</given-name><initials>J.</initials><afid>60007381</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55535453500</author-url><authid>55535453500</authid><authname>Ding H.</authname><surname>Ding</surname><given-name>Haidong</given-name><initials>H.</initials><afid>60007381</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55892814600</author-url><authid>55892814600</authid><authname>Zhu Z.</authname><surname>Zhu</surname><given-name>Zongwen</given-name><initials>Z.</initials><afid>60073637</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:12762000200</author-url><authid>12762000200</authid><authname>Chen J.</authname><surname>Chen</surname><given-name>Jianlin</given-name><initials>J.</initials><afid>60073637</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56555490900</author-url><authid>56555490900</authid><authname>Xu S.</authname><surname>Xu</surname><given-name>Shuang</given-name><initials>S.</initials><afid>100824994</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:25639168300</author-url><authid>25639168300</authid><authname>Zha D.</authname><surname>Zha</surname><given-name>Dingshi</given-name><initials>D.</initials><afid>60073637</afid><afid>100824994</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:25639168300</author-url><authid>25639168300</authid><authname>Zha D.</authname><surname>Zha</surname><given-name>Dingshi</given-name><initials>D.</initials><afid>60073637</afid><afid>100824994</afid></author><authkeywords>6-Benzylaminopurine | Ascorbate-glutathione cycle | Cytokinin | Oxidative damage | Solanum melongena | Zinc stress</authkeywords><intid>1785233703</intid><source-id>18012</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84921514671"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84921514671?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84921514671&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84921514671&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915014011721"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84921514671</prism:url><dc:identifier>SCOPUS_ID:84921514671</dc:identifier><eid>2-s2.0-84921514671</eid><dc:title>Cholesterol modulates LRP5 expression in the vessel wall</dc:title><dc:creator>Borrell-Pages M.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>363-370</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2014.05.922</prism:doi><pii>S0021915014011721</pii><dc:description>© 2014 Elsevier Ireland Ltd. Objective: Macrophages are key players in atherosclerotic lesion formation and progression. We have recently demonstrated that lipid-loaded macrophages show activation of the canonical Wnt signaling pathway. Methods: To test the invivo role of the canonical Wnt pathway in atherosclerosis we used mice deficient in the Wnt signaling receptor LRP5 (LRP5-/-) fed a hypercholesterolemic diet (HC) to induce atherosclerosis. These dietary groups were further subdivided into two subgroups receiving their respective diets supplemented with 2% plant sterol esters (PSE). All mice remained on their assigned diets until age 18 weeks. Results: HC WT mice had mildly increased non-HDL cholesterol levels, developed aortic atherosclerotic lesions and showed upregulated expression levels of aortic Lrp5. HC LRP5-/- mice develop larger aortic atherosclerotic lesions than WT mice indicating that LRP5 has a protective function in atherosclerosis progression. The oral administration of PSE, a dietary cholesterol-lowering agent, had an effect in the expression levels of the Wnt signaling receptor and in atherosclerosis progression. We found that PSE reduced serum total cholesterol levels, abolished HC-induced LRP5 overexpression and reduced aortic atherosclerotic plaques. Conclusion: The proatherogenic effects of the excess of plasma lipids are in part mediated by modulation of LRP5 in the aorta. LRP5 and canonical Wnt signaling exert a protective defense mechanism against hyperlipidemia and atherosclerosis lesion progression.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009466</affiliation-url><afid>60009466</afid><affilname>Hospital de La Santa Creu I Sant Pau</affilname><name-variant>Hospital de la Santa Creu I Sant Pau</name-variant><affiliation-city>Barcelona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023020</affiliation-url><afid>60023020</afid><affilname>Universidad Autonoma de Barcelona</affilname><name-variant>Universitat Autonoma de Barcelona</name-variant><affiliation-city>Barcelona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><pubmed-id>24929284</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6507676297</author-url><authid>6507676297</authid><authname>Borrell-Pages M.</authname><surname>Borrell-Pages</surname><given-name>M.</given-name><initials>M.</initials><afid>60009466</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56239090000</author-url><authid>56239090000</authid><authname>Romero J.</authname><surname>Romero</surname><given-name>J. C.</given-name><initials>J.C.</initials><afid>60009466</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7102141956</author-url><authid>7102141956</authid><authname>Badimon L.</authname><surname>Badimon</surname><given-name>L.</given-name><initials>L.</initials><afid>60009466</afid><afid>60023020</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7102141956</author-url><authid>7102141956</authid><authname>Badimon L.</authname><surname>Badimon</surname><given-name>L.</given-name><initials>L.</initials><afid>60009466</afid><afid>60023020</afid></author><authkeywords>Atherosclerosis | Hypercholesterolemia | LRP5 | Macrophages | Plant sterol esters | Wnt pathway</authkeywords><intid>1534650306</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926464959"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926464959?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926464959&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926464959&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2213231715000312"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926464959</prism:url><dc:identifier>SCOPUS_ID:84926464959</dc:identifier><eid>2-s2.0-84926464959</eid><dc:title>High glucose, glucose fluctuation and carbonyl stress enhance brain microvascular endothelial barrier dysfunction: Implications for diabetic cerebral microvasculature</dc:title><dc:creator>Li W.</dc:creator><prism:publicationName>Redox Biology</prism:publicationName><prism:issn>22132317</prism:issn><prism:volume>5</prism:volume><prism:pageRange>80-90</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.redox.2015.03.005</prism:doi><pii>S2213231715000312</pii><dc:description>© 2015 The Authors. We previously demonstrated that in normal glucose (5 mM), methylglyoxal (MG, a model of carbonyl stress) induced brain microvascular endothelial cell (IHEC) dysfunction that was associated with occludin glycation and prevented by N-acetylcysteine (NAC). Herein, we investigated the impact of high glucose and low GSH, conditions that mimicked the diabetic state, on MG-induced IHEC dysfunction. MG-induced loss of transendothelial electrical resistance (TEER) was potentiated in IHECs cultured for 7 or 12days in 25. mM glucose (hyperglycemia); moreover, barrier function remained disrupted 6. h after cell transfer to normal glucose media (acute glycemic fluctuation). Notably, basal occludin glycation was elevated under these glycemic states. TEER loss was exaggerated by inhibition of glutathione (GSH) synthesis and abrogated by NAC, which corresponded to GSH decreases and increases, respectively. Significantly, glyoxalase II activity was attenuated in hyperglycemic cells. Moreover, hyperglycemia and GSH inhibition increased MG accumulation, consistent with a compromised capacity for MG elimination. α-Oxoaldehydes (MG plus glyoxal) levels were elevated in streptozotocin-induced diabetic rat plasma. Immunohistochemistry revealed a prevalence of MG-positive, but fewer occludin-positive microvessels in the diabetic brain in vivo, and Western analysis confirmed an increase in MG-occludin adducts. These results provide the first evidence that hyperglycemia and acute glucose fluctuation promote MG-occludin formation and exacerbate brain microvascular endothelial dysfunction. Low occludin expression and high glycated-occludin contents in diabetic brain in vivo are factors that would contribute to the dysfunction of the cerebral microvasculature during diabetes.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029426</affiliation-url><afid>60029426</afid><affilname>LSU Health Sciences Center - New Orleans</affilname><name-variant>Louisiana State University Health Sciences Center</name-variant><affiliation-city>New Orleans</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029426</affiliation-url><afid>60029426</afid><affilname>LSU Health Sciences Center - New Orleans</affilname><name-variant>Louisiana State University Health Sciences Center</name-variant><affiliation-city>New Orleans</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115131295</affiliation-url><afid>115131295</afid><affilname>Huazhong University of Science and oTechnology</affilname><name-variant>Huazhong University of Science and oTechnology</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56605565800</author-url><authid>56605565800</authid><authname>Li W.</authname><surname>Li</surname><given-name>Wei</given-name><initials>W.</initials><afid>60029426</afid><afid>115131295</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56605565800</author-url><authid>56605565800</authid><authname>Li W.</authname><surname>Li</surname><given-name>Wei</given-name><initials>W.</initials><afid>60029426</afid><afid>115131295</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7005688450</author-url><authid>7005688450</authid><authname>Maloney R.</authname><surname>Maloney</surname><given-name>Ronald E.</given-name><initials>R.E.</initials><afid>60029426</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7006646818</author-url><authid>7006646818</authid><authname>Aw T.</authname><surname>Aw</surname><given-name>Tak Yee</given-name><initials>T.Y.</initials><afid>60029426</afid><afid>60029426</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7006646818</author-url><authid>7006646818</authid><authname>Aw T.</authname><surname>Aw</surname><given-name>Tak Yee</given-name><initials>T.Y.</initials><afid>60029426</afid><afid>60029426</afid></author><authkeywords>Carbonyl stress &amp; endothelial GSH | Diabetic brain microvascular dysfunction | Hyperglycemia &amp; methylglyoxal | N-acetylcysteine &amp; endothelial barrier function | Occludin glycation &amp; brain endothelial barrier function | Streptozotocin &amp; diabetes</authkeywords><intid>535456274</intid><source-id>21100242403</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929339017"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929339017?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929339017&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929339017&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0300908415001340"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929339017</prism:url><dc:identifier>SCOPUS_ID:84929339017</dc:identifier><eid>2-s2.0-84929339017</eid><dc:title>The epinephrine increases tyrosine hydroxylase expression through upregulating thioredoxin-1 in PC12 cells</dc:title><dc:creator>Jia J.</dc:creator><prism:publicationName>Biochimie</prism:publicationName><prism:issn>03009084</prism:issn><prism:eIssn>61831638</prism:eIssn><prism:volume>115</prism:volume><prism:pageRange>52-58</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.biochi.2015.04.022</prism:doi><pii>S0300908415001340</pii><dc:description>© 2015 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). Abstract Epinephrine is a stress hormone which is sharply increased in response to acute stress and is continuously elevated during persistent stress. Thioredoxin-1 (Trx-1) is a redox regulating protein and is induced under various stresses. Our previous study has shown that epinephrine induces the expression of Trx-1. Tyrosine hydroxylase (TH) is the major rate-limiting enzyme in catecholamine biosynthesis in response to stress. However, how TH is regulated by epinephrine is still unknown. In the present study, we found that epinephrine increased the expression of TH in a dose- and time-dependent manner in PC12 cells, which was inhibited by propranolol (β-adrenergic receptor inhibitor), but not by phenoxybenzamine (α-adrenergic receptor inhibitor). The increase of TH was also inhibited by SQ22536 (adenylyl cyclase inhibitor), H-89(PKA inhibitor) and LY294002 (phosphatidylinositol 3 kinase inhibitor). More importantly, overexpression of Trx-1 significantly enhanced the expression of TH, while Trx-1 siRNA suppressed TH expression induced by epinephrine. These results suggest that Trx-1 is involved in TH expression induced by epinephrine in PC12 cells.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020675</affiliation-url><afid>60020675</afid><affilname>Kunming University of Science and Technology</affilname><name-variant>Kunming University of Science and Technology</name-variant><affiliation-city>Kunming</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55890501300</author-url><authid>55890501300</authid><authname>Jia J.</authname><surname>Jia</surname><given-name>Jin Jing</given-name><initials>J.J.</initials><afid>60020675</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55596789800</author-url><authid>55596789800</authid><authname>Zeng X.</authname><surname>Zeng</surname><given-name>Xian Si</given-name><initials>X.S.</initials><afid>60020675</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56643451800</author-url><authid>56643451800</authid><authname>Yang L.</authname><surname>Yang</surname><given-name>Li Hua</given-name><initials>L.H.</initials><afid>60020675</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35290703600</author-url><authid>35290703600</authid><authname>Bai J.</authname><surname>Bai</surname><given-name>Jie</given-name><initials>J.</initials><afid>60020675</afid></author><authkeywords>Epinephrine | Stress | Thioredoxin-1 | Tyrosine hydroxylase | β-adrenergic receptor</authkeywords><intid>1035940844</intid><article-number>4710</article-number><source-id>16874</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926429584"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926429584?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926429584&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926429584&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0925400515003743"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926429584</prism:url><dc:identifier>SCOPUS_ID:84926429584</dc:identifier><eid>2-s2.0-84926429584</eid><dc:title>Highly sensitive determination of nitrite using FMWCNTs-conducting polymer composite modified electrode</dc:title><dc:creator>Rajalakshmi K.</dc:creator><prism:publicationName>Sensors and Actuators, B: Chemical</prism:publicationName><prism:issn>09254005</prism:issn><prism:volume>215</prism:volume><prism:pageRange>119-124</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.snb.2015.03.050</prism:doi><pii>S0925400515003743</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. Nitrite is detected in 0.2 M phosphate buffer solution at pH 7.2 using a glassy carbon (GC) electrode modified with a nanostructured composite. The composite consists of 5-amino-1,3,4-thiadiazole-2-thiol (ATT) electrochemically deposited on acid functionalized multiwalled carbon nanotubes (FMWCNTs). After the deposition of p-ATT film on the FMWCNTs, SEM images reveal that components segregate and the diameter of the FMWCNTs increases from 58 to 139 nm. The oxidation peak potential for nitrite oxidation on the FMWCNTs-ATT polymer (p-ATT) composite-modified GC electrode shifts to a less positive potential and the accompanying oxidation current is two-fold greater compared to the nitrite oxidation at bare GC electrode. Further, nitrite is selectively oxidized at the composite modified GC electrode in the presence of 3300-fold excess of common interferents like sodium fluoride, sodium nitrate, calcium chloride, magnesium sulphate, potassium carbonate, calcium carbonate and zinc sulphate. The amperometric current response for nitrite oxidation linearly increases with the concentration of nitrite from 10 to 1000 nM. The limit of detection was found to be 0.2 nM (S/N = 3). Finally, the practical application of the present method was demonstrated by determining nitrite in milk samples.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60102020</affiliation-url><afid>60102020</afid><affilname>Gandhigram Rural University</affilname><name-variant>Gandhigram Rural University</name-variant><affiliation-city>Dindigul</affiliation-city><affiliation-country>India</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55932716500</author-url><authid>55932716500</authid><authname>Rajalakshmi K.</authname><surname>Rajalakshmi</surname><given-name>K.</given-name><initials>K.</initials><afid>60102020</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24782902100</author-url><authid>24782902100</authid><authname>John S.</authname><surname>John</surname><given-name>S. Abraham</given-name><initials>S.A.</initials><afid>60102020</afid></author><authkeywords>Amperometry | Carbon nanotubes-conducting polymer | composite | Nitrite | Selective determination</authkeywords><intid>1535452537</intid><source-id>25236</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924658849"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924658849?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924658849&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924658849&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2213231715000154"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924658849</prism:url><dc:identifier>SCOPUS_ID:84924658849</dc:identifier><eid>2-s2.0-84924658849</eid><dc:title>Redox signaling in acute pancreatitis</dc:title><dc:creator>Pérez S.</dc:creator><prism:publicationName>Redox Biology</prism:publicationName><prism:issn>22132317</prism:issn><prism:volume>5</prism:volume><prism:pageRange>1-14</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.redox.2015.01.014</prism:doi><pii>S2213231715000154</pii><dc:description>© 2015 The Authors. Acute pancreatitis is an inflammatory process of the pancreatic gland that eventually may lead to a severe systemic inflammatory response. A key event in pancreatic damage is the intracellular activation of NF-κB and zymogens, involving also calcium, cathepsins, pH disorders, autophagy, and cell death, particularly necrosis. This review focuses on the new role of redox signaling in acute pancreatitis. Oxidative stress and redox status are involved in the onset of acute pancreatitis and also in the development of the systemic inflammatory response, being glutathione depletion, xanthine oxidase activation, and thiol oxidation in proteins critical features of the disease in the pancreas. On the other hand, the release of extracellular hemoglobin into the circulation from the ascitic fluid in severe necrotizing pancreatitis enhances lipid peroxidation in plasma and the inflammatory infiltrate into the lung and up-regulates the HIF-VEGF pathway, contributing to the systemic inflammatory response. Therefore, redox signaling and oxidative stress contribute to the local and systemic inflammatory response during acute pancreatitis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002644</affiliation-url><afid>60002644</afid><affilname>Universitat de ValEncia</affilname><name-variant>Universitat de València</name-variant><affiliation-city>Valencia</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002644</affiliation-url><afid>60002644</afid><affilname>Universitat de ValEncia</affilname><name-variant>Universitat de València</name-variant><affiliation-city>Valencia</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37075489700</author-url><authid>37075489700</authid><authname>Pérez S.</authname><surname>Pérez</surname><given-name>Salvador</given-name><initials>S.</initials><afid>60002644</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7006676934</author-url><authid>7006676934</authid><authname>Pereda J.</authname><surname>Pereda</surname><given-name>Javier</given-name><initials>J.</initials><afid>60002644</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003886414</author-url><authid>7003886414</authid><authname>Sabater L.</authname><surname>Sabater</surname><given-name>Luis</given-name><initials>L.</initials><afid>60002644</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7102442723</author-url><authid>7102442723</authid><authname>Sastre J.</authname><surname>Sastre</surname><given-name>Juan</given-name><initials>J.</initials><afid>60002644</afid></author><authkeywords>Acute inflammation | Acute pancreatitis | Glutathione | Oxidative stress</authkeywords><intid>35188759</intid><source-id>21100242403</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84922688210"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84922688210?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84922688210&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84922688210&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0924796315000226"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84922688210</prism:url><dc:identifier>SCOPUS_ID:84922688210</dc:identifier><eid>2-s2.0-84922688210</eid><dc:title>Potential impact of climate change on the Intra-Americas Sea: Part 2. Implications for Atlantic bluefin tuna and skipjack tuna adult and larval habitats</dc:title><dc:creator>Muhling B.</dc:creator><prism:publicationName>Journal of Marine Systems</prism:publicationName><prism:issn>09247963</prism:issn><prism:volume>148</prism:volume><prism:pageRange>1-13</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jmarsys.2015.01.010</prism:doi><pii>S0924796315000226</pii><dc:description>© 2015 Elsevier B.V. Increasing water temperatures due to climate change will likely have significant impacts on distributions and life histories of Atlantic tunas. In this study, we combined predictive habitat models with a downscaled climate model to examine potential impacts on adults and larvae of Atlantic bluefin tuna (. Thunnus thynnus) and skipjack tuna (. Katsuwonus pelamis) in the Intra-Americas Sea (IAS). An additional downscaled model covering the 20th century was used to compare habitat fluctuations from natural variability to predicted future changes under two climate change scenarios: Representative Concentration Pathway (RCP) 4.5 (medium-low) and RCP 8.5 (high). Results showed marked temperature-induced habitat losses for both adult and larval bluefin tuna on their northern Gulf of Mexico spawning grounds. In contrast, habitat suitability for skipjack tuna increased as temperatures warmed. Model error was highest for the two skipjack tuna models, particularly at higher temperatures. This work suggests that influences of climate change on highly migratory Atlantic tuna species are likely to be substantial, but strongly species-specific. While impacts on fish populations remain uncertain, these changes in habitat suitability will likely alter the spatial and temporal availability of species to fishing fleets, and challenge equilibrium assumptions of environmental stability, upon which fisheries management benchmarks are based.</dc:description><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029251</affiliation-url><afid>60029251</afid><affilname>University of Miami</affilname><name-variant>University of Miami</name-variant><affiliation-city>Coral Gables</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027716</affiliation-url><afid>60027716</afid><affilname>National Oceanic and Atmospheric Administration</affilname><name-variant>National Oceanic and Atmospheric Administration</name-variant><affiliation-city>Washington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021738</affiliation-url><afid>60021738</afid><affilname>NOAA Atlantic Oceanographic and Meteorological Laboratory</affilname><name-variant>National Oceanic and Atmospheric Administration</name-variant><affiliation-city>Miami</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:105616418</affiliation-url><afid>105616418</afid><affilname>Roffer's Ocean Fishing Forecasting Service, Inc.</affilname><name-variant>Roffer's Ocean Fishing Forecasting Service, Inc.</name-variant><affiliation-city>Melbourne</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030822</affiliation-url><afid>60030822</afid><affilname>University of South Florida St. Petersburg</affilname><name-variant>University of South Florida</name-variant><affiliation-city>St Petersburg</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:17346911300</author-url><authid>17346911300</authid><authname>Muhling B.</authname><surname>Muhling</surname><given-name>Barbara A.</given-name><initials>B.A.</initials><afid>60029251</afid><afid>60027716</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:17346911300</author-url><authid>17346911300</authid><authname>Muhling B.</authname><surname>Muhling</surname><given-name>Barbara A.</given-name><initials>B.A.</initials><afid>60029251</afid><afid>60027716</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:54780118900</author-url><authid>54780118900</authid><authname>Liu Y.</authname><surname>Liu</surname><given-name>Yanyun</given-name><initials>Y.</initials><afid>60029251</afid><afid>60021738</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:54780118900</author-url><authid>54780118900</authid><authname>Liu Y.</authname><surname>Liu</surname><given-name>Yanyun</given-name><initials>Y.</initials><afid>60029251</afid><afid>60021738</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:27168081700</author-url><authid>27168081700</authid><authname>Lee S.</authname><surname>Lee</surname><given-name>Sang Ki</given-name><initials>S.K.</initials><afid>60029251</afid><afid>60021738</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:27168081700</author-url><authid>27168081700</authid><authname>Lee S.</authname><surname>Lee</surname><given-name>Sang Ki</given-name><initials>S.K.</initials><afid>60029251</afid><afid>60021738</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603373298</author-url><authid>6603373298</authid><authname>Lamkin J.</authname><surname>Lamkin</surname><given-name>John T.</given-name><initials>J.T.</initials><afid>60027716</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:23991433500</author-url><authid>23991433500</authid><authname>Roffer M.</authname><surname>Roffer</surname><given-name>Mitchell A.</given-name><initials>M.A.</initials><afid>105616418</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006003656</author-url><authid>7006003656</authid><authname>Muller-Karger F.</authname><surname>Muller-Karger</surname><given-name>Frank</given-name><initials>F.</initials><afid>60030822</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:20735578400</author-url><authid>20735578400</authid><authname>Walter J.</authname><surname>Walter</surname><given-name>John F.</given-name><initials>J.F.</initials><afid>60027716</afid></author><authkeywords>Atlantic bluefin tuna | Climate changes | Habitat | Niches | Skipjack tuna | Tuna fisheries</authkeywords><intid>1534854575</intid><source-id>27786</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927750319"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927750319?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927750319&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927750319&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S004268221500197X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927750319</prism:url><dc:identifier>SCOPUS_ID:84927750319</dc:identifier><eid>2-s2.0-84927750319</eid><dc:title>Error-prone pcr-based mutagenesis strategy for rapidly generating high-yield influenza vaccine candidates</dc:title><dc:creator>Ye J.</dc:creator><prism:publicationName>Virology</prism:publicationName><prism:issn>00426822</prism:issn><prism:eIssn>10960341</prism:eIssn><prism:volume>482</prism:volume><prism:pageRange>234-243</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.virol.2015.03.051</prism:doi><pii>S004268221500197X</pii><dc:description>© 2015 Elsevier Inc. Vaccination is the primary strategy for the prevention and control of influenza outbreaks. However, the manufacture of influenza vaccine requires a high-yield seed strain, and the conventional methods for generating such strains are time consuming. In this study, we developed a novel method to rapidly generate high-yield candidate vaccine strains by integrating error-prone PCR, site-directed mutagenesis strategies, and reverse genetics. We used this method to generate seed strains for the influenza A(H1N1)pdm09 virus and produced six high-yield candidate strains. We used a mouse model to assess the efficacy of two of the six candidate strains as a vaccine seed virus: both strains provided complete protection in mice against lethal challenge, thus validating our method. Results confirmed that the efficacy of these candidate vaccine seed strains was not affected by the yield-optimization procedure.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001526</affiliation-url><afid>60001526</afid><affilname>Mississippi State University</affilname><name-variant>Mississippi State University</name-variant><affiliation-city>Starkville</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001526</affiliation-url><afid>60001526</afid><affilname>Mississippi State University</affilname><name-variant>Mississippi State University</name-variant><affiliation-city>Starkville</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019905</affiliation-url><afid>60019905</afid><affilname>St. Jude Children Research Hospital</affilname><name-variant>St Jude Children's Research Hospital</name-variant><affiliation-city>Memphis</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007381</affiliation-url><afid>60007381</afid><affilname>Yangzhou University</affilname><name-variant>Yangzhou University</name-variant><affiliation-city>Yangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007381</affiliation-url><afid>60007381</afid><affilname>Yangzhou University</affilname><name-variant>Yangzhou University</name-variant><affiliation-city>Yangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56484974100</author-url><authid>56484974100</authid><authname>Ye J.</authname><surname>Ye</surname><given-name>Jianqiang</given-name><initials>J.</initials><afid>60001526</afid><afid>60007381</afid><afid>60007381</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56484974100</author-url><authid>56484974100</authid><authname>Ye J.</authname><surname>Ye</surname><given-name>Jianqiang</given-name><initials>J.</initials><afid>60001526</afid><afid>60007381</afid><afid>60007381</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56484974100</author-url><authid>56484974100</authid><authname>Ye J.</authname><surname>Ye</surname><given-name>Jianqiang</given-name><initials>J.</initials><afid>60001526</afid><afid>60007381</afid><afid>60007381</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56473292800</author-url><authid>56473292800</authid><authname>Wen F.</authname><surname>Wen</surname><given-name>Feng</given-name><initials>F.</initials><afid>60001526</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55862881000</author-url><authid>55862881000</authid><authname>Xu Y.</authname><surname>Xu</surname><given-name>Yifei</given-name><initials>Y.</initials><afid>60001526</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56473231900</author-url><authid>56473231900</authid><authname>Zhao N.</authname><surname>Zhao</surname><given-name>Nan</given-name><initials>N.</initials><afid>60001526</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56594319700</author-url><authid>56594319700</authid><authname>Long L.</authname><surname>Long</surname><given-name>Liping</given-name><initials>L.</initials><afid>60001526</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55843973600</author-url><authid>55843973600</authid><authname>Sun H.</authname><surname>Sun</surname><given-name>Hailiang</given-name><initials>H.</initials><afid>60001526</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56594004900</author-url><authid>56594004900</authid><authname>Yang J.</authname><surname>Yang</surname><given-name>Jialiang</given-name><initials>J.</initials><afid>60001526</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:18436658500</author-url><authid>18436658500</authid><authname>Cooley J.</authname><surname>Cooley</surname><given-name>Jim</given-name><initials>J.</initials><afid>60001526</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56595131400</author-url><authid>56595131400</authid><authname>Todd Pharr G.</authname><surname>Todd Pharr</surname><given-name>G.</given-name><initials>G.</initials><afid>60001526</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:35448064800</author-url><authid>35448064800</authid><authname>Webby R.</authname><surname>Webby</surname><given-name>Richard</given-name><initials>R.</initials><afid>60019905</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:9335365800</author-url><authid>9335365800</authid><authname>Wan X.</authname><surname>Wan</surname><given-name>Xiu Feng</given-name><initials>X.F.</initials><afid>60001526</afid></author><authkeywords>Error-prone PCR | High-yield strain | Influenza A virus | Vaccine | Vaccine production</authkeywords><intid>1535666390</intid><source-id>20886</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925601837"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925601837?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925601837&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925601837&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0926669015002228"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925601837</prism:url><dc:identifier>SCOPUS_ID:84925601837</dc:identifier><eid>2-s2.0-84925601837</eid><dc:title>Chromatographic analysis, antioxidant, anti-inflammatory, and xanthine oxidase inhibitory activities of ginger extracts and its reference compounds</dc:title><dc:creator>Nile S.</dc:creator><prism:publicationName>Industrial Crops and Products</prism:publicationName><prism:issn>09266690</prism:issn><prism:volume>70</prism:volume><prism:pageRange>238-244</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.indcrop.2015.03.033</prism:doi><pii>S0926669015002228</pii><dc:description>© 2015 Elsevier B.V. Ginger, Zingiber officinale Roscoe, is a spice used as a medicinal plant in many countries. We are the first to report the HPTLC analysis of ginger extract and analysis of their active principles with comparative antioxidant, anti-inflammatory, and xanthine oxidase inhibitory activities. The five fractions were obtained by using different polarity solvents with selective extraction procedure from ginger rhizomes and found that they revealed the difference in bioactivity against studied parameters. The ethyl acetate extract (EAE) showed significant antioxidant activity studied by DPPH, FRAP, and H&lt;inf&gt;2&lt;/inf&gt;O&lt;inf&gt;2&lt;/inf&gt; assay (IC&lt;inf&gt;50&lt;/inf&gt;±SEM [μg/mL]: 6.8±0.6, 12±0.2, and 20±2.5, respectively). In the xanthine/xanthine oxidase system, the antioxidant potentials of EAE and the water extract (WE) (% inhibition: 76% and 74%, respectively) were higher than those of the ethanol extract (EE), diethyl ether extract (DEE), and n-butanol extract (NBE). Regarding anti-inflammatory activity, EAE exhibited greater inhibition of lipoxidase (80%), and β-glucuronidase (78%) compared to hyaluronidase (46%) and diene-conjugates (37%). Chromatographic analysis revealed that several principal substances including 6-gingerol, 6-shogaol, and 6-paradol were responsible for the biological activities for ginger. Compound 6-gingerol revealed high FRAP-reducing activity (IC&lt;inf&gt;50&lt;/inf&gt;±SEM [μM]: 5±0.4). 6-Gingerol also significantly inhibited the activities of xanthine oxidase (85%), lipoxidase (87%), β-glucuronidase (85%), and hyaluronidase (56%), respectively. These results indicated that ginger rhizome fractions and its active constituents having promising antioxidant, anti-inflammatory, and anti-gout properties and might be used as potential natural drug against oxidative stress and inflammatory related diseases after successful in vivo study and clinical trials.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000142</affiliation-url><afid>60000142</afid><affilname>Konkuk University</affilname><name-variant>Konkuk University</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:33667853200</author-url><authid>33667853200</authid><authname>Nile S.</authname><surname>Nile</surname><given-name>Shivraj Hariram</given-name><initials>S.H.</initials><afid>60000142</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8836589500</author-url><authid>8836589500</authid><authname>Park S.</authname><surname>Park</surname><given-name>Se Won</given-name><initials>S.W.</initials><afid>60000142</afid></author><authkeywords>Anti-inflammatory | Antioxidant | Ginger | HPLC | HPTLC | Xanthine oxidase</authkeywords><intid>1535328216</intid><source-id>32791</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929623237"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929623237?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929623237&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929623237&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1050464815002314"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929623237</prism:url><dc:identifier>SCOPUS_ID:84929623237</dc:identifier><eid>2-s2.0-84929623237</eid><dc:title>Identification of a myeloperoxidase-like ortholog from rock bream (Oplegnathus fasciatus), deciphering its transcriptional responses to induced pathogen stress</dc:title><dc:creator>Elvitigala D.</dc:creator><prism:publicationName>Fish and Shellfish Immunology</prism:publicationName><prism:issn>10504648</prism:issn><prism:eIssn>10959947</prism:eIssn><prism:volume>45</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>477-485</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.fsi.2015.05.014</prism:doi><pii>S1050464815002314</pii><dc:description>© 2015 Elsevier Ltd. Myeloperoxidases (MPOs) are heme-linked oxidative stress-generating enzymes found abundantly in azurophilic granules of polymorphonuclear neutrophils. Mature MPOs act as potent antimicrobial agents by producing hypohalous acids using hydrogen peroxide and halide ions as substrates. These acids can readily oxidize reactive groups of biomolecules on invading microbes. In this study, we identified and characterized a homolog of MPO from rock bream (. Oplegnathus fasciatus), designated as RbMPO. We analyzed the RbMPO gene for its basal expression level in physiologically important tissues and for transcriptional changes under different pathogenic stress conditions. The complete coding sequence of RbMPO consisted of 2652 nucleotides encoding an 884 amino acid sequence with a predicted molecular mass of 99.7kDa. Our in silico analysis confirmed the typical MPO domain arrangement in RbMPO, including the propeptide, large chain and heavy chain, along with the heme peroxidase signature. Intriguingly, a C1q domain was also identified in the C-terminal region of the derived amino acid sequence. Most of the known functionally important residues of MPOs are found to be well conserved in RbMPO, showing a close evolutionary relationship with other teleostan MPOs, particularly with that of mandarin fish.. RbMPO exhibited a ubiquitous basal expression in physiologically relevant tissues, with particularly high expression levels in blood cells. Basal transcript levels of RbMPO in gill and spleen tissues were found to change upon different pathogen or pathogen-derived mitogen stimulation, with detectable inductive responses. Together, these data suggest the potential involvement of RbMPO in the innate immune response in rock bream.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023353</affiliation-url><afid>60023353</afid><affilname>Cheju National University</affilname><name-variant>Jeju National University</name-variant><affiliation-city>Jeju</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023353</affiliation-url><afid>60023353</afid><affilname>Cheju National University</affilname><name-variant>Jeju National University</name-variant><affiliation-city>Jeju</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60080958</affiliation-url><afid>60080958</afid><affilname>National Fisheries Research and Development Institute(NFRDI), Busan</affilname><name-variant>National Fisheries Research and Development Institute</name-variant><affiliation-city>Busan</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005273</affiliation-url><afid>60005273</afid><affilname>Korea University</affilname><name-variant>Korea University</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55209965400</author-url><authid>55209965400</authid><authname>Elvitigala D.</authname><surname>Elvitigala</surname><given-name>Don Anushka Sandaruwan</given-name><initials>D.A.S.</initials><afid>60023353</afid><afid>60023353</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55209965400</author-url><authid>55209965400</authid><authname>Elvitigala D.</authname><surname>Elvitigala</surname><given-name>Don Anushka Sandaruwan</given-name><initials>D.A.S.</initials><afid>60023353</afid><afid>60023353</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23037821700</author-url><authid>23037821700</authid><authname>Whang I.</authname><surname>Whang</surname><given-name>Ilson</given-name><initials>I.</initials><afid>60023353</afid><afid>60023353</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23037821700</author-url><authid>23037821700</authid><authname>Whang I.</authname><surname>Whang</surname><given-name>Ilson</given-name><initials>I.</initials><afid>60023353</afid><afid>60023353</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7006057717</author-url><authid>7006057717</authid><authname>Nam B.</authname><surname>Nam</surname><given-name>Bo Hye</given-name><initials>B.H.</initials><afid>60080958</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56541980800</author-url><authid>56541980800</authid><authname>Park H.</authname><surname>Park</surname><given-name>Hae Chul</given-name><initials>H.C.</initials><afid>60005273</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7601467203</author-url><authid>7601467203</authid><authname>Lee J.</authname><surname>Lee</surname><given-name>Jehee</given-name><initials>J.</initials><afid>60023353</afid><afid>60023353</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7601467203</author-url><authid>7601467203</authid><authname>Lee J.</authname><surname>Lee</surname><given-name>Jehee</given-name><initials>J.</initials><afid>60023353</afid><afid>60023353</afid></author><authkeywords>Myeloperoxidase | Pathogen stress | Rock bream | Spatial expression | Transcriptional modulation</authkeywords><intid>35987791</intid><source-id>15066</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927590205"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927590205?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927590205&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927590205&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S026974911500192X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927590205</prism:url><dc:identifier>SCOPUS_ID:84927590205</dc:identifier><eid>2-s2.0-84927590205</eid><dc:title>Titanium dioxide nanoparticles enhance mortality of fish exposed to bacterial pathogens</dc:title><dc:creator>Jovanović B.</dc:creator><prism:publicationName>Environmental Pollution</prism:publicationName><prism:issn>02697491</prism:issn><prism:eIssn>18736424</prism:eIssn><prism:volume>203</prism:volume><prism:pageRange>153-164</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.envpol.2015.04.003</prism:doi><pii>S026974911500192X</pii><dc:description>© 2015 The Authors. Nano-TiO&lt;inf&gt;2&lt;/inf&gt; is immunotoxic to fish and reduces the bactericidal function of fish neutrophils. Here, fathead minnows (Pimephales promelas) were exposed to low and high environmentally relevant concentration of nano-TiO&lt;inf&gt;2&lt;/inf&gt; (2 ng g&lt;sup&gt;-1&lt;/sup&gt; and 10 μg g&lt;sup&gt;-1&lt;/sup&gt; body weight, respectively), and were challenged with common fish bacterial pathogens, Aeromonas hydrophila or Edwardsiella ictaluri. Pre-exposure to nano-TiO&lt;inf&gt;2&lt;/inf&gt; significantly increased fish mortality during bacterial challenge. Nano-TiO&lt;inf&gt;2&lt;/inf&gt; concentrated in the kidney and spleen. Phagocytosis assay demonstrated that nano-TiO&lt;inf&gt;2&lt;/inf&gt; has the ability to diminish neutrophil phagocytosis of A. hydrophila. Fish injected with TiO&lt;inf&gt;2&lt;/inf&gt; nanoparticles displayed significant histopathology when compared to control fish. The interplay between nanoparticle exposure, immune system, histopathology, and infectious disease pathogenesis in any animal model has not been described before. By modulating fish immune responses and interfering with resistance to bacterial pathogens, manufactured nano-TiO&lt;inf&gt;2&lt;/inf&gt; has the potential to affect fish survival in a disease outbreak.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028717</affiliation-url><afid>60028717</afid><affilname>Ludwig-Maximilians-Universitat Munchen</affilname><name-variant>University of Munich</name-variant><affiliation-city>Munich</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115161631</affiliation-url><afid>115161631</afid><affilname>Pathogenesis, LLC</affilname><name-variant>Pathogenesis, LLC</name-variant><affiliation-city>Gainesville</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004354</affiliation-url><afid>60004354</afid><affilname>Iowa State University</affilname><name-variant>Iowa State University</name-variant><affiliation-city>Ames</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004354</affiliation-url><afid>60004354</afid><affilname>Iowa State University</affilname><name-variant>Iowa State University</name-variant><affiliation-city>Ames</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028717</affiliation-url><afid>60028717</afid><affilname>Ludwig-Maximilians-Universitat Munchen</affilname><name-variant>University of Munich</name-variant><affiliation-city>Munich</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36598601000</author-url><authid>36598601000</authid><authname>Jovanović B.</authname><surname>Jovanović</surname><given-name>Boris</given-name><initials>B.</initials><afid>60028717</afid><afid>60028717</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36598601000</author-url><authid>36598601000</authid><authname>Jovanović B.</authname><surname>Jovanović</surname><given-name>Boris</given-name><initials>B.</initials><afid>60028717</afid><afid>60028717</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7005024513</author-url><authid>7005024513</authid><authname>Whitley E.</authname><surname>Whitley</surname><given-name>Elizabeth M.</given-name><initials>E.M.</initials><afid>115161631</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56591164400</author-url><authid>56591164400</authid><authname>Kimura K.</authname><surname>Kimura</surname><given-name>Kayoko</given-name><initials>K.</initials><afid>60004354</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56592993300</author-url><authid>56592993300</authid><authname>Crumpton A.</authname><surname>Crumpton</surname><given-name>Adam</given-name><initials>A.</initials><afid>60004354</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:8318296600</author-url><authid>8318296600</authid><authname>Palić D.</authname><surname>Palić</surname><given-name>Dušan</given-name><initials>D.</initials><afid>60028717</afid></author><authkeywords>Bacteria | Disease resistance | Fish | Histopathology | Immune response | Nanoparticles | Titanium dioxide</authkeywords><intid>35646538</intid><source-id>23916</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929308692"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929308692?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929308692&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929308692&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0091743515001139"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929308692</prism:url><dc:identifier>SCOPUS_ID:84929308692</dc:identifier><eid>2-s2.0-84929308692</eid><dc:title>Impact of family history assessment on communication with family members and health care providers: A report from the Family Healthware™ Impact Trial (FHITr)</dc:title><dc:creator>Wang C.</dc:creator><prism:publicationName>Preventive Medicine</prism:publicationName><prism:issn>00917435</prism:issn><prism:eIssn>10960260</prism:eIssn><prism:volume>77</prism:volume><prism:pageRange>28-34</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ypmed.2015.04.007</prism:doi><pii>S0091743515001139</pii><dc:description>© 2015 Elsevier Inc.. Objective: This study examines the impact of Family Healthware™ on communication behaviors; specifically, communication with family members and health care providers about family health history. Methods: A total of 3786 participants were enrolled in the Family Healthware™ Impact Trial (FHITr) in the United States from 2005-7. The trial employed a two-arm cluster-randomized design, with primary care practices serving as the unit of randomization. Using generalized estimating equations (GEE), analyses focused on communication behaviors at 6. month follow-up, adjusting for age, site and practice clustering. Results: A significant interaction was observed between study arm and baseline communication status for the family communication outcomes (p's. &lt;. .01), indicating that intervention had effects of different magnitude between those already communicating at baseline and those who were not.Among participants who were not communicating at baseline, intervention participants had higher odds of communicating with family members about family history risk (OR. =. 1.24, p. =. 0.042) and actively collecting family history information at follow-up (OR. =. 2.67, p. =. 0.026). Family Healthware™ did not have a significant effect on family communication among those already communicating at baseline, or on provider communication, regardless of baseline communication status. Greater communication was observed among those at increased familial risk for a greater number of diseases. Conclusion: Family Healthware™ prompted more communication about family history with family members, among those who were not previously communicating. Efforts are needed to identify approaches to encourage greater sharing of family history information, particularly with health care providers.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018701</affiliation-url><afid>60018701</afid><affilname>Boston University School of Public Health</affilname><name-variant>Boston University School of Public Health</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025778</affiliation-url><afid>60025778</afid><affilname>University Michigan Ann Arbor</affilname><name-variant>University of Michigan</name-variant><affiliation-city>Ann Arbor</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025778</affiliation-url><afid>60025778</afid><affilname>University Michigan Ann Arbor</affilname><name-variant>University of Michigan</name-variant><affiliation-city>Ann Arbor</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025778</affiliation-url><afid>60025778</afid><affilname>University Michigan Ann Arbor</affilname><name-variant>University of Michigan</name-variant><affiliation-city>Ann Arbor</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007363</affiliation-url><afid>60007363</afid><affilname>Northwestern University</affilname><name-variant>Northwestern University</name-variant><affiliation-city>Evanston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60087823</affiliation-url><afid>60087823</afid><affilname>National Center for Biotechnology Information</affilname><name-variant>National Center for Biotechnology Information</name-variant><affiliation-city>Bethesda</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000305</affiliation-url><afid>60000305</afid><affilname>Case Western Reserve University</affilname><name-variant>Case Western Reserve University</name-variant><affiliation-city>Cleveland</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:102061069</affiliation-url><afid>102061069</afid><affilname>CDC</affilname><name-variant>CDC</name-variant><affiliation-city>Atlanta</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:106736413</affiliation-url><afid>106736413</afid><affilname>UCLA Center for Health Policy Research</affilname><name-variant>UCLA Center for Health Policy Research</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006577</affiliation-url><afid>60006577</afid><affilname>National Institutes of Health, Bethesda</affilname><name-variant>National Institute of Health</name-variant><affiliation-city>Bethesda</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007363</affiliation-url><afid>60007363</afid><affilname>Northwestern University</affilname><name-variant>Northwestern University</name-variant><affiliation-city>Evanston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:106934770</affiliation-url><afid>106934770</afid><affilname>North Shore University Health System</affilname><name-variant>NorthShore University Health System</name-variant><affiliation-city>Skokie</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001115</affiliation-url><afid>60001115</afid><affilname>University of Michigan</affilname><name-variant>University of Michigan</name-variant><affiliation-city>Ann Arbor</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010307</affiliation-url><afid>60010307</afid><affilname>University of Colorado at Denver</affilname><name-variant>University of Colorado Denver</name-variant><affiliation-city>Denver</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000305</affiliation-url><afid>60000305</afid><affilname>Case Western Reserve University</affilname><name-variant>Case Western Reserve University</name-variant><affiliation-city>Cleveland</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000787</affiliation-url><afid>60000787</afid><affilname>American Academy of Family Physicians</affilname><name-variant>Amer. Academy of Family Physicians</name-variant><affiliation-city>Leawood</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018701</affiliation-url><afid>60018701</afid><affilname>Boston University School of Public Health</affilname><name-variant>Boston University School of Public Health</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027165</affiliation-url><afid>60027165</afid><affilname>University of Rochester</affilname><name-variant>University of Rochester</name-variant><affiliation-city>Rochester</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027561</affiliation-url><afid>60027561</afid><affilname>University of Illinois at Chicago</affilname><name-variant>University of Illinois at Chicago</name-variant><affiliation-city>Chicago</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">33</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8238370900</author-url><authid>8238370900</authid><authname>Wang C.</authname><surname>Wang</surname><given-name>Catharine</given-name><initials>C.</initials><afid>60018701</afid><afid>60018701</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8238370900</author-url><authid>8238370900</authid><authname>Wang C.</authname><surname>Wang</surname><given-name>Catharine</given-name><initials>C.</initials><afid>60018701</afid><afid>60018701</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55443624400</author-url><authid>55443624400</authid><authname>Sen A.</authname><surname>Sen</surname><given-name>Ananda</given-name><initials>A.</initials><afid>60025778</afid><afid>60025778</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55443624400</author-url><authid>55443624400</authid><authname>Sen A.</authname><surname>Sen</surname><given-name>Ananda</given-name><initials>A.</initials><afid>60025778</afid><afid>60025778</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55574300200</author-url><authid>55574300200</authid><authname>Plegue M.</authname><surname>Plegue</surname><given-name>Melissa</given-name><initials>M.</initials><afid>60025778</afid><afid>60025778</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55574300200</author-url><authid>55574300200</authid><authname>Plegue M.</authname><surname>Plegue</surname><given-name>Melissa</given-name><initials>M.</initials><afid>60025778</afid><afid>60025778</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7006467693</author-url><authid>7006467693</authid><authname>Ruffin M.</authname><surname>Ruffin</surname><given-name>Mack T.</given-name><initials>M.T.</initials><afid>60025778</afid><afid>106934770</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7006467693</author-url><authid>7006467693</authid><authname>Ruffin M.</authname><surname>Ruffin</surname><given-name>Mack T.</given-name><initials>M.T.</initials><afid>60025778</afid><afid>106934770</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7102722867</author-url><authid>7102722867</authid><authname>O'Neill S.</authname><surname>O'Neill</surname><given-name>Suzanne M.</given-name><initials>S.M.</initials><afid>60007363</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56644421000</author-url><authid>56644421000</authid><authname>Rubinstein W.</authname><surname>Rubinstein</surname><given-name>Wendy S.</given-name><initials>W.S.</initials><afid>60087823</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7004519489</author-url><authid>7004519489</authid><authname>Acheson L.</authname><surname>Acheson</surname><given-name>Louise S.</given-name><initials>L.S.</initials><afid>60000305</afid><afid>60010307</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7004519489</author-url><authid>7004519489</authid><authname>Acheson L.</authname><surname>Acheson</surname><given-name>Louise S.</given-name><initials>L.S.</initials><afid>60000305</afid><afid>60010307</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56644231500</author-url><authid>56644231500</authid><authname>Yoon P.</authname><surname>Yoon</surname><given-name>Paula W.</given-name><initials>P.W.</initials><afid>102061069</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:35312587400</author-url><authid>35312587400</authid><authname>Valdez R.</authname><surname>Valdez</surname><given-name>Rodolfo</given-name><initials>R.</initials><afid>102061069</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56644978900</author-url><authid>56644978900</authid><authname>Irizarry-De La Cruz M.</authname><surname>Irizarry-De La Cruz</surname><given-name>Margie</given-name><initials>M.</initials><afid>102061069</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56470362700</author-url><authid>56470362700</authid><authname>Khoury M.</authname><surname>Khoury</surname><given-name>Muin J.</given-name><initials>M.J.</initials><afid>102061069</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7201694090</author-url><authid>7201694090</authid><authname>Jorgensen C.</authname><surname>Jorgensen</surname><given-name>Cynthia</given-name><initials>C.</initials><afid>102061069</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:6603162680</author-url><authid>6603162680</authid><authname>Scheuner M.</authname><surname>Scheuner</surname><given-name>Maren T.</given-name><initials>M.T.</initials><afid>102061069</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:6701797583</author-url><authid>6701797583</authid><authname>Rubinstein W.</authname><surname>Rubinstein</surname><given-name>Wendy S.</given-name><initials>W.S.</initials><afid>106736413</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:55259386200</author-url><authid>55259386200</authid><authname>O'Neill S.</authname><surname>O'Neill</surname><given-name>Suzanne M.</given-name><initials>S.M.</initials><afid>60006577</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:56550220800</author-url><authid>56550220800</authid><authname>Rothrock N.</authname><surname>Rothrock</surname><given-name>Nan</given-name><initials>N.</initials><afid>60007363</afid></author><author seq="17"><author-url>http://api.elsevier.com/content/author/author_id:7102153197</author-url><authid>7102153197</authid><authname>Beaumont J.</authname><surname>Beaumont</surname><given-name>Jennifer L.</given-name><initials>J.L.</initials><afid>106934770</afid></author><author seq="18"><author-url>http://api.elsevier.com/content/author/author_id:56643632300</author-url><authid>56643632300</authid><authname>Khan S.</authname><surname>Khan</surname><given-name>Shaheen</given-name><initials>S.</initials><afid>106934770</afid></author><author seq="19"><author-url>http://api.elsevier.com/content/author/author_id:56644266700</author-url><authid>56644266700</authid><authname>Ali D.</authname><surname>Ali</surname><given-name>Dawood</given-name><initials>D.</initials><afid>106934770</afid></author><author seq="20"><author-url>http://api.elsevier.com/content/author/author_id:6701464837</author-url><authid>6701464837</authid><authname>Nease D.</authname><surname>Nease</surname><given-name>Donald</given-name><initials>D.</initials><afid>60001115</afid></author><author seq="21"><author-url>http://api.elsevier.com/content/author/author_id:7006131112</author-url><authid>7006131112</authid><authname>Zyzanski S.</authname><surname>Zyzanski</surname><given-name>Stephen J.</given-name><initials>S.J.</initials><afid>60000305</afid></author><author seq="22"><author-url>http://api.elsevier.com/content/author/author_id:7006373826</author-url><authid>7006373826</authid><authname>Wiesner G.</authname><surname>Wiesner</surname><given-name>Georgia L.</given-name><initials>G.L.</initials><afid>60000305</afid></author><author seq="23"><author-url>http://api.elsevier.com/content/author/author_id:56643931300</author-url><authid>56643931300</authid><authname>Werner J.</authname><surname>Werner</surname><given-name>James</given-name><initials>J.</initials><afid>60000305</afid></author><author seq="24"><author-url>http://api.elsevier.com/content/author/author_id:7006526463</author-url><authid>7006526463</authid><authname>Pace W.</authname><surname>Pace</surname><given-name>Wilson D.</given-name><initials>W.D.</initials><afid>60000305</afid></author><author seq="25"><author-url>http://api.elsevier.com/content/author/author_id:6701331682</author-url><authid>6701331682</authid><authname>Galliher J.</authname><surname>Galliher</surname><given-name>James M.</given-name><initials>J.M.</initials><afid>60000787</afid></author><author seq="26"><author-url>http://api.elsevier.com/content/author/author_id:56644133700</author-url><authid>56644133700</authid><authname>Brandt E.</authname><surname>Brandt</surname><given-name>Elias</given-name><initials>E.</initials><afid>60000787</afid></author><author seq="27"><author-url>http://api.elsevier.com/content/author/author_id:34569937100</author-url><authid>34569937100</authid><authname>Gramling R.</authname><surname>Gramling</surname><given-name>Robert</given-name><initials>R.</initials><afid>60027165</afid></author><author seq="28"><author-url>http://api.elsevier.com/content/author/author_id:56649479300</author-url><authid>56649479300</authid><authname>Starzyk E.</authname><surname>Starzyk</surname><given-name>Erin J.</given-name><initials>E.J.</initials><afid>60027561</afid></author><authkeywords>Chronic disease | Dose effects | Family communication | Family history assessment | Provider communication</authkeywords><intid>1535944743</intid><source-id>17665</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930210867"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930210867?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930210867&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930210867&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0014489415001307"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930210867</prism:url><dc:identifier>SCOPUS_ID:84930210867</dc:identifier><eid>2-s2.0-84930210867</eid><dc:title>A component of the mitochondrial outer membrane proteome of T. brucei probably contains covalent bound fatty acids</dc:title><dc:creator>Albisetti A.</dc:creator><prism:publicationName>Experimental Parasitology</prism:publicationName><prism:issn>00144894</prism:issn><prism:eIssn>10902449</prism:eIssn><prism:volume>155</prism:volume><prism:pageRange>49-57</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.exppara.2015.05.006</prism:doi><pii>S0014489415001307</pii><dc:description>© 2015 Elsevier Inc. A subclass of eukaryotic proteins is subject to modification with fatty acids, the most common of which are palmitic and myristic acid. Protein acylation allows association with cellular membranes in the absence of transmembrane domains. Here we examine POMP39, a protein previously described to be present in the outer mitochondrial membrane proteome (POMP) of the protozoan parasite Trypanosoma brucei. POMP39 lacks canonical transmembrane domains, but is likely both myristoylated and palmitoylated on its N-terminus. Interestingly, the protein is also dually localized on the surface of the mitochondrion as well as in the flagellum of both insect-stage and the bloodstream form of the parasites. Upon abolishing of global protein acylation or mutation of the myristoylation site, POMP39 relocates to the cytosol. RNAi-mediated ablation of the protein neither causes a growth phenotype in insect-stage nor bloodstream form trypanosomes.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020486</affiliation-url><afid>60020486</afid><affilname>Universitat Bern</affilname><name-variant>University of Berne</name-variant><affiliation-city>Bern</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010586</affiliation-url><afid>60010586</afid><affilname>Universitat Ulm</affilname><name-variant>Universität Ulm</name-variant><affiliation-city>Ulm</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60102125</affiliation-url><afid>60102125</afid><affilname>Universite de Bordeaux</affilname><name-variant>Université de Bordeaux</name-variant><affiliation-city>Bordeaux</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56584300100</author-url><authid>56584300100</authid><authname>Albisetti A.</authname><surname>Albisetti</surname><given-name>Anna</given-name><initials>A.</initials><afid>60020486</afid><afid>60102125</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56584300100</author-url><authid>56584300100</authid><authname>Albisetti A.</authname><surname>Albisetti</surname><given-name>Anna</given-name><initials>A.</initials><afid>60020486</afid><afid>60102125</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24469484400</author-url><authid>24469484400</authid><authname>Wiese S.</authname><surname>Wiese</surname><given-name>Sebastian</given-name><initials>S.</initials><afid>60020486</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7402385016</author-url><authid>7402385016</authid><authname>Schneider A.</authname><surname>Schneider</surname><given-name>André</given-name><initials>A.</initials><afid>60010586</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:24401845400</author-url><authid>24401845400</authid><authname>Niemann M.</authname><surname>Niemann</surname><given-name>Moritz</given-name><initials>M.</initials><afid>60020486</afid></author><authkeywords>African trypanosomes | Dual localization of proteins | Mitochondrial outer membrane proteome | Myristoylation/palmitoylation | Protein acylation | Protein targeting</authkeywords><intid>2036082604</intid><source-id>21875</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930042223"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930042223?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930042223&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930042223&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1388198114002522"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930042223</prism:url><dc:identifier>SCOPUS_ID:84930042223</dc:identifier><eid>2-s2.0-84930042223</eid><dc:title>The emerging roles of lipids in circadian control</dc:title><dc:creator>Adamovich Y.</dc:creator><prism:publicationName>Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids</prism:publicationName><prism:issn>13881981</prism:issn><prism:eIssn>18792618</prism:eIssn><prism:volume>1851</prism:volume><prism:issueIdentifier>8</prism:issueIdentifier><prism:pageRange>1017-1025</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbalip.2014.11.013</prism:doi><pii>S1388198114002522</pii><dc:description>© 2014 Elsevier B.V. All rights reserved. Lipids play vital roles in a wide variety of cellular functions. They act as structural components in cell membranes, serve as a major form of energy storage, and function as key signaling molecules. Mounting evidence points towards a tight interplay between lipids and circadian clocks. In mammals, circadian clocks regulate the daily physiology and metabolism, and disruption of circadian rhythmicity is associated with altered lipid homeostasis and pathologies such as fatty liver and obesity. Concomitantly, emerging evidence suggest that lipids are embedded within the core clock circuitry and participate in circadian control. Recent advances in lipidomics methodologies and their application in chronobiology studies have shed new light on the cross talk between circadian clocks and lipid homeostasis. We review herein the latest literature related to the involvement of lipids in circadian clock's function and highlight the contribution of circadian lipidomics studies to our understanding of circadian rhythmicity and lipid homeostasis. This article is part of a Special Issue entitled Brain Lipids.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017563</affiliation-url><afid>60017563</afid><affilname>Weizmann Institute of Science Israel</affilname><name-variant>Weizmann Institute of Science</name-variant><affiliation-city>Rehovot</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23487863000</author-url><authid>23487863000</authid><authname>Adamovich Y.</authname><surname>Adamovich</surname><given-name>Yaarit</given-name><initials>Y.</initials><afid>60017563</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56455068100</author-url><authid>56455068100</authid><authname>Aviram R.</authname><surname>Aviram</surname><given-name>Rona</given-name><initials>R.</initials><afid>60017563</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005187779</author-url><authid>7005187779</authid><authname>Asher G.</authname><surname>Asher</surname><given-name>Gad</given-name><initials>G.</initials><afid>60017563</afid></author><authkeywords>Circadian | Clocks | Lipidomics | Lipids | Metabolomics | Nutrition</authkeywords><intid>36055990</intid><source-id>16831</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930182754"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930182754?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930182754&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930182754&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0898656815001345"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930182754</prism:url><dc:identifier>SCOPUS_ID:84930182754</dc:identifier><eid>2-s2.0-84930182754</eid><dc:title>Enhancer of zeste homolog-2 (EZH2) methyltransferase regulates transgelin/smooth muscle-22α expression in endothelial cells in response to interleukin-1β and transforming growth factor-β2</dc:title><dc:creator>Maleszewska M.</dc:creator><prism:publicationName>Cellular Signalling</prism:publicationName><prism:issn>08986568</prism:issn><prism:eIssn>18733913</prism:eIssn><prism:volume>27</prism:volume><prism:issueIdentifier>8</prism:issueIdentifier><prism:pageRange>1589-1596</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cellsig.2015.04.008</prism:doi><pii>S0898656815001345</pii><dc:description>© 2015 Elsevier Inc. Smooth muscle-22α (SM22α), encoded by transgelin (. TAGLN), is expressed in mesenchymal lineage cells, including myofibroblasts and smooth muscle cells. It is an F-actin binding protein that regulates the organization of actin cytoskeleton, cellular contractility and motility. SM22α is crucial for the maintenance of smooth muscle cell phenotype and its function. SM22α is also expressed in the processes of mesenchymal transition of epithelial (EMT) or endothelial cells (EndMT). The expression of TAGLN/SM22α is induced by transforming growth factor-β (TGFβ) signaling and enhanced by concomitant interleukin-1β (IL-1β) signaling. We investigated the epigenetic regulation of TAGLN expression by enhancer of zeste homolog-2 (EZH2), the methyltransferase of Polycomb, in the context of TGFβ and IL-1β signaling in endothelial cells. We demonstrate that the expression of EZH2 in endothelial cells was regulated by the inflammatory cytokine IL-1β. A decrease in both expression and activity of EZH2 led to an increase in TAGLN expression. Inhibition of EZH2 augmented TGFβ2-induced SM22α expression. The decrease of EZH2 levels in endothelial cells co-stimulated with IL-1β and TGFβ2 correlated with decreased H3K27me3 levels at the TAGLN proximal promoter. Moreover, the SM22α expression increased. Taken together, this suggests that EZH2 regulates the chromatin structure at the TAGLN promoter through tri-methylation of H3K27. EZH2 therefore acts as an epigenetic integrator of IL-1β and TGFβ2 signaling, providing an example of how cellular signaling can be resolved at the level of epigenetic regulation. Since IL-1β and TGFβ2 represent the pro-inflammatory and pro-fibrotic conditions during vascular fibroproliferative disease, we surmise that EZH2, as the molecule that integrates their signaling, could also be a promising target for development of future therapy.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006027</affiliation-url><afid>60006027</afid><affilname>Universitair Medisch Centrum Groningen</affilname><name-variant>University Medical Center Groningen</name-variant><affiliation-city>Groningen</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60103814</affiliation-url><afid>60103814</afid><affilname>Max Planck Institute for Biology of Ageing</affilname><name-variant>Max Planck Institute for Biology of Ageing</name-variant><affiliation-city>Koln</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55257237900</author-url><authid>55257237900</authid><authname>Maleszewska M.</authname><surname>Maleszewska</surname><given-name>Monika</given-name><initials>M.</initials><afid>60006027</afid><afid>60103814</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55257237900</author-url><authid>55257237900</authid><authname>Maleszewska M.</authname><surname>Maleszewska</surname><given-name>Monika</given-name><initials>M.</initials><afid>60006027</afid><afid>60103814</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56623131400</author-url><authid>56623131400</authid><authname>Gjaltema R.</authname><surname>Gjaltema</surname><given-name>Rutger A F</given-name><initials>R.A.F.</initials><afid>60006027</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:15757529900</author-url><authid>15757529900</authid><authname>Krenning G.</authname><surname>Krenning</surname><given-name>Guido</given-name><initials>G.</initials><afid>60006027</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35519198600</author-url><authid>35519198600</authid><authname>Harmsen M.</authname><surname>Harmsen</surname><given-name>Martin C.</given-name><initials>M.C.</initials><afid>60006027</afid></author><authkeywords>Chromatin | Endothelial cell | EZH2 | Fibrosis | Inflammation | SM22α</authkeywords><intid>1786079798</intid><source-id>18487</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926648585"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926648585?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926648585&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926648585&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0957417415001578"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926648585</prism:url><dc:identifier>SCOPUS_ID:84926648585</dc:identifier><eid>2-s2.0-84926648585</eid><dc:title>Hybrid prediction model with missing value imputation for medical data</dc:title><dc:creator>Purwar A.</dc:creator><prism:publicationName>Expert Systems with Applications</prism:publicationName><prism:issn>09574174</prism:issn><prism:volume>42</prism:volume><prism:issueIdentifier>13</prism:issueIdentifier><prism:pageRange>5621-5631</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.eswa.2015.02.050</prism:doi><pii>S0957417415001578</pii><dc:description>© 2015 Elsevier Ltd. All rights reserved. Accurate prediction in the presence of large number of missing values in the data set has always been a challenging problem. Most of hybrid models to address this challenge have either deleted the missing instances from the data set (popularly known as case deletion) or have used some default way to fill the missing values. This paper, presents a novel hybrid prediction model with missing value imputation (HPM-MI) that analyze various imputation techniques using simple K-means clustering and apply the best one to a data set. The proposed hybrid model is the first one to use combination of K-means clustering with Multilayer Perceptron. K-means clustering is also used to validate class labels of given data (incorrectly classified instances are deleted i.e. pattern extracted from original data) before applying classifier. The proposed system has significantly improved data quality by use of best imputation technique after quantitative analysis of eleven imputation approaches. The efficiency of proposed model as predictive classification system is investigated on three benchmark medical data sets namely Pima Indians Diabetes, Wisconsin Breast Cancer, and Hepatitis from the UCI Repository of Machine Learning. In addition to accuracy, sensitivity, specificity; kappa statistics and the area under ROC are also computed. The experimental results show HPM-MI has produced accuracy, sensitivity, specificity, kappa and ROC as 99.82%, 100%, 99.74%, 0.996 and 1.0 respectively for Pima Indian Diabetes data set, 99.39%, 99.31%, 99.54%, 0.986, and 1.0 respectively for breast cancer data set and 99.08%, 100%, 96.55%, 0.978 and 0.99 respectively for Hepatitis data set. Results are best in comparison with existing methods. Further, the performance of our model is measured and analyzed as function of missing rate and train-test ratio using 2D synthetic data set and Wisconsin Diagnostics Breast Cancer Data Sets. Results are promising and therefore the proposed model will be very useful in prediction for medical domain especially when numbers of missing value are large in the data set.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>JIIT Noida</affilname><name-variant>Department of Computer Science and Information Technology</name-variant><affiliation-city/><affiliation-country>India</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35753696900</author-url><authid>35753696900</authid><authname>Purwar A.</authname><surname>Purwar</surname><given-name>Archana</given-name><initials>A.</initials><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35578864800</author-url><authid>35578864800</authid><authname>Singh S.</authname><surname>Singh</surname><given-name>Sandeep Kumar</given-name><initials>S.K.</initials><afid/></author><authkeywords>Data mining | K-means clustering | Missing value imputation | Multilayer Perceptron (MLP)</authkeywords><intid>1535483448</intid><source-id>24201</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925603507"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925603507?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925603507&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925603507&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2213231715000191"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925603507</prism:url><dc:identifier>SCOPUS_ID:84925603507</dc:identifier><eid>2-s2.0-84925603507</eid><dc:title>An educational overview of the chemistry, biochemistry and therapeutic aspects of Mn porphyrins - From superoxide dismutation to H2O2-driven pathways</dc:title><dc:creator>Batinic-Haberle I.</dc:creator><prism:publicationName>Redox Biology</prism:publicationName><prism:issn>22132317</prism:issn><prism:volume>5</prism:volume><prism:pageRange>43-65</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.redox.2015.01.017</prism:doi><pii>S2213231715000191</pii><dc:description>© 2015 The Authors. Most of the SOD mimics thus far developed belong to the classes of Mn-(MnPs) and Fe porphyrins(FePs), Mn(III) salens, Mn(II) cyclic polyamines and metal salts. Due to their remarkable stability we have predominantly explored Mn porphyrins, aiming initially at mimicking kinetics and thermodynamics of the catalysis of O2 - dismutation by SOD enzymes. Several MnPs are of potency similar to SOD enzymes. The in vivo bioavailability and toxicity of MnPs have been addressed also. Numerous in vitro and in vivo studies indicate their impressive therapeutic efficacy. Increasing insight into complex cellular redox biology has been accompanied by increasing awareness of complex redox chemistry of MnPs. During O2 - dismutation process, the most powerful Mn porphyrin-based SOD mimics reduce and oxidize O2 - with close to identical rate constants. MnPs reduce and oxidize other reactive species also (none of them specific to MnPs), acting as reductants (antioxidant) and pro-oxidants. Distinction must be made between the type of reactions of MnPs and the favorable therapeutic effects we observe; the latter may be of either anti- or pro-oxidative nature. H2O2/MnP mediated oxidation of protein thiols and its impact on cellular transcription seems to dominate redox biology of MnPs. It has been thus far demonstrated that the ability of MnPs to catalyze O2 - dismutation parallels all other reactivities (such as ONOO- reduction) and in turn their therapeutic efficacies. Assuming that all diseases have in common the perturbation of cellular redox environment, developing SOD mimics still seems to be the appropriate strategy for the design of potent redox-active therapeutics.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008724</affiliation-url><afid>60008724</afid><affilname>Duke University</affilname><name-variant>Duke University</name-variant><affiliation-city>Durham</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008724</affiliation-url><afid>60008724</afid><affilname>Duke University</affilname><name-variant>Duke University</name-variant><affiliation-city>Durham</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008724</affiliation-url><afid>60008724</afid><affilname>Duke University</affilname><name-variant>Duke University</name-variant><affiliation-city>Durham</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7003877847</author-url><authid>7003877847</authid><authname>Batinic-Haberle I.</authname><surname>Batinic-Haberle</surname><given-name>Ines</given-name><initials>I.</initials><afid>60008724</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23037219600</author-url><authid>23037219600</authid><authname>Tovmasyan A.</authname><surname>Tovmasyan</surname><given-name>Artak</given-name><initials>A.</initials><afid>60008724</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6603802395</author-url><authid>6603802395</authid><authname>Spasojevic I.</authname><surname>Spasojevic</surname><given-name>Ivan</given-name><initials>I.</initials><afid>60008724</afid><afid>60008724</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6603802395</author-url><authid>6603802395</authid><authname>Spasojevic I.</authname><surname>Spasojevic</surname><given-name>Ivan</given-name><initials>I.</initials><afid>60008724</afid><afid>60008724</afid></author><authkeywords>Fe porphyrin-based SOD mimics | Mechanism(s) of action(s) of Mn porphyrins | Mn-porphyrin-based non-SOD mimics | Mn-porphyrin-based SOD mimics | Reactivities of Mn porphyrins in aqueous solutions, cells and animals | Therapeutic effects</authkeywords><intid>35328787</intid><source-id>21100242403</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925457255"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925457255?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925457255&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925457255&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0958694615000515"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925457255</prism:url><dc:identifier>SCOPUS_ID:84925457255</dc:identifier><eid>2-s2.0-84925457255</eid><dc:title>Use of an extremely polar 100-m column in combination with a cyanoalkyl polysiloxane column to complement the study of milk fats with different fatty acid profiles</dc:title><dc:creator>de la Fuente M.</dc:creator><prism:publicationName>International Dairy Journal</prism:publicationName><prism:issn>09586946</prism:issn><prism:volume>47</prism:volume><prism:pageRange>52-63</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.idairyj.2015.02.010</prism:doi><pii>S0958694615000515</pii><dc:description>© 2015 Elsevier Ltd. A detailed dairy fat fatty acid (FA) profile can generally be achieved by gas chromatography using capillary columns with polar cyanoalkyl polysiloxane stationary phases (CPSP). However some compounds overlap and cannot be discriminated after a single run. In this work a new, extremely polar phase column (SLB-IL111) was used to complement the analysis carried out by a CPSP column. Separation of the FAs in a variety of milk fats using both a 100-m SLB-IL111 column and a 100-m CP-Sil 88 column was carried out and a more complete profile was established. The combination of results was useful to discriminate FA pairs, i.e., 10:1/11:0, cis-10 12:1/13:0, iso 17:0/. trans-9 16:1, anteiso 17:0/. cis-9 16:1, trans-16 18:1/. cis-14 18:1, trans-11 cis-15 18:2/. trans-10 cis-15 18:2 and trans-7 cis-9 18:2/. cis-9 trans-11 18:2. Furthermore trans-8 and trans-13/14 18:1 isomers were also well discriminated. The use of both columns allowed detection in milk of some lactone and keto FAs.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026796</affiliation-url><afid>60026796</afid><affilname>Universidad Autonoma de Madrid</affilname><name-variant>Universidad Autónoma de Madrid</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7102943785</author-url><authid>7102943785</authid><authname>de la Fuente M.</authname><surname>de la Fuente</surname><given-name>Miguel Angel</given-name><initials>M.A.</initials><afid>60026796</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:26436440300</author-url><authid>26436440300</authid><authname>Rodríguez-Pino V.</authname><surname>Rodríguez-Pino</surname><given-name>Valle</given-name><initials>V.</initials><afid>60026796</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56567629500</author-url><authid>56567629500</authid><authname>Juárez M.</authname><surname>Juárez</surname><given-name>Manuela</given-name><initials>M.</initials><afid>60026796</afid></author><intid>35296223</intid><source-id>51565</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928922832"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928922832?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928922832&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928922832&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0001706X15001102"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928922832</prism:url><dc:identifier>SCOPUS_ID:84928922832</dc:identifier><eid>2-s2.0-84928922832</eid><dc:title>Economic evaluation of chagas disease screening in Spain</dc:title><dc:creator>Imaz-Iglesia I.</dc:creator><prism:publicationName>Acta Tropica</prism:publicationName><prism:issn>0001706X</prism:issn><prism:eIssn>18736254</prism:eIssn><prism:volume>148</prism:volume><prism:pageRange>77-88</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.actatropica.2015.04.014</prism:doi><pii>S0001706X15001102</pii><dc:description>© 2015 Elsevier B.V. Although Spain is the European country with the highest Chagas disease burden, the country does not have a national control program of the disease. The purpose of this study is to evaluate the efficiency of several strategies for Chagas disease screening among Latin American residents living in Spain.The following screening strategies were evaluated: (1) non-screening; (2) screening of the Latin American pregnant women and their newborns; (3) screening also the relatives of the positive pregnant women; (4) screening also the relatives of the negative pregnant women. A cost-utility analysis was carried out to compare the four strategies from two perspectives, the societal and the Spanish National Health System (SNHS). A decision tree representing the clinical evolution of Chagas disease throughout patient's life was built. The strategies were compared through the incremental cost-utility ratio, using euros as cost measurement and quality-adjusted life years as utility measurement. A sensitivity analysis was performed to test the model parameters and their influence on the results.We found the "Non-screening" as the most expensive and less effective of the evaluated strategies, from both the societal and the SNHS perspectives. Among the screening evaluated strategies the most efficient was, from both perspectives, to extent the antenatal screening of the Latin American pregnant women and their newborns up to the relatives of the positive women. Several parameters influenced significantly on the sensitivity analyses, particularly the chronic treatment efficacy or the prevalence of Chagas disease.In conclusion, for the general Latin American immigrants living in Spain the most efficient would be to screen the Latin American mothers, their newborns and the close relatives of the mothers with a positive serology. However for higher prevalence immigrant population the most efficient intervention would be to extend the program to the close relatives of the negative mothers.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001602</affiliation-url><afid>60001602</afid><affilname>Instituto de Salud Carlos III</affilname><name-variant>Instituto de Salud Carlos III</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025844</affiliation-url><afid>60025844</afid><affilname>Hospital Universitario Puerta de Hierro</affilname><name-variant>Hospital Universitario Puerta de Hierro</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032461</affiliation-url><afid>60032461</afid><affilname>Hospital Clinico San Carlos de Madrid</affilname><name-variant>Hospital Universitario San Carlos</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112755741</affiliation-url><afid>112755741</afid><affilname>Canary Foundation for Health Research</affilname><name-variant>Canary Foundation for Health Research</name-variant><affiliation-city/><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001602</affiliation-url><afid>60001602</afid><affilname>Instituto de Salud Carlos III</affilname><name-variant>Instituto de Salud Carlos III</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024257</affiliation-url><afid>60024257</afid><affilname>Hospital Universitario de la Princesa</affilname><name-variant>Hospital Universitario de la Princesa</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027800</affiliation-url><afid>60027800</afid><affilname>Universidad de Alcala</affilname><name-variant>Universidad de Alcalá</name-variant><affiliation-city>Alcala de Henares</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56622990000</author-url><authid>56622990000</authid><authname>Imaz-Iglesia I.</authname><surname>Imaz-Iglesia</surname><given-name>Iñaki</given-name><initials>I.</initials><afid>60001602</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56622613100</author-url><authid>56622613100</authid><authname>Miguel L.</authname><surname>Miguel</surname><given-name>Lucía García San</given-name><initials>L.G.S.</initials><afid>60025844</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56029894500</author-url><authid>56029894500</authid><authname>Ayala-Morillas L.</authname><surname>Ayala-Morillas</surname><given-name>L. Eduardo</given-name><initials>L.E.</initials><afid>60032461</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:26021172500</author-url><authid>26021172500</authid><authname>García-Pérez L.</authname><surname>García-Pérez</surname><given-name>Lidia</given-name><initials>L.</initials><afid>112755741</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7003381805</author-url><authid>7003381805</authid><authname>González-Enríquez J.</authname><surname>González-Enríquez</surname><given-name>Jesús</given-name><initials>J.</initials><afid>60001602</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:16416468600</author-url><authid>16416468600</authid><authname>Blasco-Hernández T.</authname><surname>Blasco-Hernández</surname><given-name>Teresa</given-name><initials>T.</initials><afid>60001602</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56623102000</author-url><authid>56623102000</authid><authname>Martín-Águeda M.</authname><surname>Martín-Águeda</surname><given-name>María Belén</given-name><initials>M.B.</initials><afid>60024257</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6701556861</author-url><authid>6701556861</authid><authname>Sarría-Santamera A.</authname><surname>Sarría-Santamera</surname><given-name>Antonio</given-name><initials>A.</initials><afid>60027800</afid></author><authkeywords>Chagas disease | Costs and costs analysis | Screening | Spain</authkeywords><intid>1535862169</intid><source-id>21288</source-id></entry></search-results>
